Skip to main content
CodeRx
↑↓ move↵ open CodeRx

Billing and Coding: Echocardiography

Medicare Coverage Database article A56625

Article

Contractor
Palmetto GBA
States (A/B MAC)
AL, GA, NC, SC, TN, VA, WV
Effective
Oct 1, 2026
Contractor numbers
10111, 10112, 10211, 10212, 10311, 10312, 11201, 11202, 11301, 11302, 11401, 11402, 11501, 11502
Read the article's coding instructions on CMS — which codes go together, documentation, and frequency limits — before billing. CodeRx lists the codes, not the instructions.

Drug codes in this article

HCPCS Level II drug codes the article lists (other codes it lists are not shown).

Covered ICD-10-CM codes (3,553)

Diagnosis codes the article lists as supporting medical necessity, grouped as in the article, with CMS's descriptions.

Group 1 · 100 codes

  • Q20.0Common arterial trunk
  • Q20.1Double outlet right ventricle
  • Q20.2Double outlet left ventricle
  • Q20.3Discordant ventriculoarterial connection
  • Q20.4Double inlet ventricle
  • Q20.5Discordant atrioventricular connection
  • Q20.6Isomerism of atrial appendages
  • Q20.8Other congenital malformations of cardiac chambers and connections
  • Q21.0Ventricular septal defect
  • Q21.10Atrial septal defect, unspecified
  • Q21.11Secundum atrial septal defect
  • Q21.12Patent foramen ovale
  • Q21.13Coronary sinus atrial septal defect
  • Q21.14Superior sinus venosus atrial septal defect
  • Q21.15Inferior sinus venosus atrial septal defect
  • Q21.16Sinus venosus atrial septal defect, unspecified
  • Q21.19Other specified atrial septal defect
  • Q21.20Atrioventricular septal defect, unspecified as to partial or complete
  • Q21.21Partial atrioventricular septal defect
  • Q21.22Transitional atrioventricular septal defect
  • Q21.23Complete atrioventricular septal defect
  • Q21.3Tetralogy of Fallot
  • Q21.4Aortopulmonary septal defect
  • Q21.8Other congenital malformations of cardiac septa
  • Q21.9Congenital malformation of cardiac septum, unspecified
  • Q22.0Pulmonary valve atresia
  • Q22.1Congenital pulmonary valve stenosis
  • Q22.2Congenital pulmonary valve insufficiency
  • Q22.3Other congenital malformations of pulmonary valve
  • Q22.4Congenital tricuspid stenosis
  • Q22.5Ebstein's anomaly
  • Q22.6Hypoplastic right heart syndrome
  • Q22.8Other congenital malformations of tricuspid valve
  • Q22.9Congenital malformation of tricuspid valve, unspecified
  • Q23.0Congenital stenosis of aortic valve
  • Q23.1Congenital insufficiency of aortic valve
  • Q23.2Congenital mitral stenosis
  • Q23.3Congenital mitral insufficiency
  • Q23.4Hypoplastic left heart syndrome
  • Q23.81Bicuspid aortic valve
  • Q23.82Congenital mitral valve cleft leaflet
  • Q23.88Other congenital malformations of aortic and mitral valves
  • Q23.9Congenital malformation of aortic and mitral valves, unspecified
  • Q24.0Dextrocardia
  • Q24.1Levocardia
  • Q24.2Cor triatriatum
  • Q24.3Pulmonary infundibular stenosis
  • Q24.4Congenital subaortic stenosis
  • Q24.5Malformation of coronary vessels
  • Q24.8Other specified congenital malformations of heart
  • Q25.0Patent ductus arteriosus
  • Q25.1Coarctation of aorta
  • Q25.21Interruption of aortic arch
  • Q25.29Other atresia of aorta
  • Q25.3Supravalvular aortic stenosis
  • Q25.40Congenital malformation of aorta unspecified
  • Q25.41Absence and aplasia of aorta
  • Q25.42Hypoplasia of aorta
  • Q25.43Congenital aneurysm of aorta
  • Q25.44Congenital dilation of aorta
  • Q25.45Double aortic arch
  • Q25.46Tortuous aortic arch
  • Q25.47Right aortic arch
  • Q25.48Anomalous origin of subclavian artery
  • Q25.49Other congenital malformations of aorta
  • Q25.5Atresia of pulmonary artery
  • Q25.6Stenosis of pulmonary artery
  • Q25.71Coarctation of pulmonary artery
  • Q25.72Congenital pulmonary arteriovenous malformation
  • Q25.79Other congenital malformations of pulmonary artery
  • Q25.8Other congenital malformations of other great arteries
  • Q25.9Congenital malformation of great arteries, unspecified
  • Q26.0Congenital stenosis of vena cava
  • Q26.1Persistent left superior vena cava
  • Q26.2Total anomalous pulmonary venous connection
  • Q26.3Partial anomalous pulmonary venous connection
  • Q26.4Anomalous pulmonary venous connection, unspecified
  • Q26.8Other congenital malformations of great veins
  • Q26.9Congenital malformation of great vein, unspecified
  • Q87.40Marfan syndrome, unspecified
  • Q87.410Marfan syndrome with aortic dilation
  • Q87.418Marfan syndrome with other cardiovascular manifestations
  • Q87.86Kleefstra syndrome
  • Q87.88CTNNB1 syndrome
  • Q89.3Situs inversus
  • S22.5XXAFlail chest, initial encounter for closed fracture
  • S22.5XXBFlail chest, initial encounter for open fracture
  • S22.5XXDFlail chest, subsequent encounter for fracture with routine healing
  • S22.5XXGFlail chest, subsequent encounter for fracture with delayed healing
  • S22.5XXKFlail chest, subsequent encounter for fracture with nonunion
  • S22.5XXSFlail chest, sequela
  • T80.211ABloodstream infection due to central venous catheter, initial encounter
  • T80.211DBloodstream infection due to central venous catheter, subsequent encounter
  • T80.211SBloodstream infection due to central venous catheter, sequela
  • T80.212ALocal infection due to central venous catheter, initial encounter
  • T80.212DLocal infection due to central venous catheter, subsequent encounter
  • T80.212SLocal infection due to central venous catheter, sequela
  • T80.218AOther infection due to central venous catheter, initial encounter
  • T80.218DOther infection due to central venous catheter, subsequent encounter
  • T80.218SOther infection due to central venous catheter, sequela

Group 2 · 1467 codes

  • A18.84Tuberculosis of heart
  • A52.01Syphilitic aneurysm of aorta
  • A52.02Syphilitic aortitis
  • A52.03Syphilitic endocarditis
  • A52.06Other syphilitic heart involvement
  • A54.83Gonococcal heart infection
  • A69.20Lyme disease, unspecified
  • A69.29Other conditions associated with Lyme disease
  • B33.20Viral carditis, unspecified
  • B33.21Viral endocarditis
  • B33.22Viral myocarditis
  • B33.23Viral pericarditis
  • B37.6Candidal endocarditis
  • B44.81Allergic bronchopulmonary aspergillosis
  • B57.0Acute Chagas' disease with heart involvement
  • B57.2Chagas' disease (chronic) with heart involvement
  • B58.81Toxoplasma myocarditis
  • C38.0Malignant neoplasm of heart
  • C38.8Malignant neoplasm of overlapping sites of heart, mediastinum and pleura
  • C45.2Mesothelioma of pericardium
  • D15.1Benign neoplasm of heart
  • D86.85Sarcoid myocarditis
  • D86.9Sarcoidosis, unspecified
  • E83.110Hereditary hemochromatosis
  • E83.111Hemochromatosis due to repeated red blood cell transfusions
  • E83.118Other hemochromatosis
  • E83.119Hemochromatosis, unspecified
  • E83.19Other disorders of iron metabolism
  • E85.0Non-neuropathic heredofamilial amyloidosis
  • E85.1Neuropathic heredofamilial amyloidosis
  • E85.2Heredofamilial amyloidosis, unspecified
  • E85.3Secondary systemic amyloidosis
  • E85.4Organ-limited amyloidosis
  • E85.81Light chain (AL) amyloidosis
  • E85.82Wild-type transthyretin-related (ATTR) amyloidosis
  • E85.89Other amyloidosis
  • E85.9Amyloidosis, unspecified
  • E86.0Dehydration
  • E86.1Hypovolemia
  • E86.9Volume depletion, unspecified
  • E87.70Fluid overload, unspecified
  • E87.71Transfusion associated circulatory overload
  • E87.79Other fluid overload
  • G45.1Carotid artery syndrome (hemispheric)
  • G45.2Multiple and bilateral precerebral artery syndromes
  • G45.3Amaurosis fugax
  • G45.8Other transient cerebral ischemic attacks and related syndromes
  • G45.9Transient cerebral ischemic attack, unspecified
  • G46.0Middle cerebral artery syndrome
  • G46.1Anterior cerebral artery syndrome
  • G46.2Posterior cerebral artery syndrome
  • H34.01Transient retinal artery occlusion, right eye
  • H34.02Transient retinal artery occlusion, left eye
  • H34.03Transient retinal artery occlusion, bilateral
  • H34.11Central retinal artery occlusion, right eye
  • H34.12Central retinal artery occlusion, left eye
  • H34.13Central retinal artery occlusion, bilateral
  • H34.211Partial retinal artery occlusion, right eye
  • H34.212Partial retinal artery occlusion, left eye
  • H34.213Partial retinal artery occlusion, bilateral
  • H34.231Retinal artery branch occlusion, right eye
  • H34.232Retinal artery branch occlusion, left eye
  • H34.233Retinal artery branch occlusion, bilateral
  • H34.821Venous engorgement, right eye
  • H34.822Venous engorgement, left eye
  • H34.823Venous engorgement, bilateral
  • H34.9Unspecified retinal vascular occlusion
  • I01.0Acute rheumatic pericarditis
  • I01.1Acute rheumatic endocarditis
  • I01.2Acute rheumatic myocarditis
  • I01.8Other acute rheumatic heart disease
  • I02.0Rheumatic chorea with heart involvement
  • I05.0Rheumatic mitral stenosis
  • I05.1Rheumatic mitral insufficiency
  • I05.2Rheumatic mitral stenosis with insufficiency
  • I05.8Other rheumatic mitral valve diseases
  • I05.9Rheumatic mitral valve disease, unspecified
  • I06.0Rheumatic aortic stenosis
  • I06.1Rheumatic aortic insufficiency
  • I06.2Rheumatic aortic stenosis with insufficiency
  • I06.8Other rheumatic aortic valve diseases
  • I06.9Rheumatic aortic valve disease, unspecified
  • I07.0Rheumatic tricuspid stenosis
  • I07.1Rheumatic tricuspid insufficiency
  • I07.2Rheumatic tricuspid stenosis and insufficiency
  • I07.8Other rheumatic tricuspid valve diseases
  • I07.9Rheumatic tricuspid valve disease, unspecified
  • I08.0Rheumatic disorders of both mitral and aortic valves
  • I08.1Rheumatic disorders of both mitral and tricuspid valves
  • I08.2Rheumatic disorders of both aortic and tricuspid valves
  • I08.3Combined rheumatic disorders of mitral, aortic and tricuspid valves
  • I08.8Other rheumatic multiple valve diseases
  • I08.9Rheumatic multiple valve disease, unspecified
  • I09.0Rheumatic myocarditis
  • I09.1Rheumatic diseases of endocardium, valve unspecified
  • I09.2Chronic rheumatic pericarditis
  • I09.81Rheumatic heart failure
  • I09.89Other specified rheumatic heart diseases
  • I09.9Rheumatic heart disease, unspecified
  • I10Essential (primary) hypertension
  • I11.0Hypertensive heart disease with heart failure
  • I11.9Hypertensive heart disease without heart failure
  • I12.0Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease
  • I12.9Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
  • I13.0Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
  • I13.10Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
  • I13.11Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
  • I13.2Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
  • I15.0Renovascular hypertension
  • I15.1Hypertension secondary to other renal disorders
  • I15.2Hypertension secondary to endocrine disorders
  • I15.8Other secondary hypertension
  • I15.9Secondary hypertension, unspecified
  • I16.0Hypertensive urgency
  • I16.1Hypertensive emergency
  • I16.9Hypertensive crisis, unspecified
  • I20.0Unstable angina
  • I20.1Angina pectoris with documented spasm
  • I20.81Angina pectoris with coronary microvascular dysfunction
  • I20.89Other forms of angina pectoris
  • I20.9Angina pectoris, unspecified
  • I21.01ST elevation (STEMI) myocardial infarction involving left main coronary artery
  • I21.02ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
  • I21.09ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall
  • I21.11ST elevation (STEMI) myocardial infarction involving right coronary artery
  • I21.19ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
  • I21.21ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery
  • I21.29ST elevation (STEMI) myocardial infarction involving other sites
  • I21.4Non-ST elevation (NSTEMI) myocardial infarction
  • I21.9Acute myocardial infarction, unspecified
  • I21.A1Myocardial infarction type 2
  • I21.A9Other myocardial infarction type
  • I21.BMyocardial infarction with coronary microvascular dysfunction
  • I22.0Subsequent ST elevation (STEMI) myocardial infarction of anterior wall
  • I22.1Subsequent ST elevation (STEMI) myocardial infarction of inferior wall
  • I22.2Subsequent non-ST elevation (NSTEMI) myocardial infarction
  • I22.8Subsequent ST elevation (STEMI) myocardial infarction of other sites
  • I23.0Hemopericardium as current complication following acute myocardial infarction
  • I23.1Atrial septal defect as current complication following acute myocardial infarction
  • I23.2Ventricular septal defect as current complication following acute myocardial infarction
  • I23.3Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction
  • I23.4Rupture of chordae tendineae as current complication following acute myocardial infarction
  • I23.5Rupture of papillary muscle as current complication following acute myocardial infarction
  • I23.6Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction
  • I23.7Postinfarction angina
  • I23.8Other current complications following acute myocardial infarction
  • I24.0Acute coronary thrombosis not resulting in myocardial infarction
  • I24.1Dressler's syndrome
  • I24.81Acute coronary microvascular dysfunction
  • I24.89Other forms of acute ischemic heart disease
  • I24.9Acute ischemic heart disease, unspecified
  • I25.10Atherosclerotic heart disease of native coronary artery without angina pectoris
  • I25.110Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
  • I25.111Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm
  • I25.112Atherosclerotic heart disease of native coronary artery with refractory angina pectoris
  • I25.118Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
  • I25.119Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris
  • I25.2Old myocardial infarction
  • I25.3Aneurysm of heart
  • I25.41Coronary artery aneurysm
  • I25.42Coronary artery dissection
  • I25.5Ischemic cardiomyopathy
  • I25.6Silent myocardial ischemia
  • I25.700Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris
  • I25.701Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm
  • I25.702Atherosclerosis of coronary artery bypass graft(s), unspecified, with refractory angina pectoris
  • I25.708Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris
  • I25.709Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris
  • I25.710Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris
  • I25.711Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.712Atherosclerosis of autologous vein coronary artery bypass graft(s) with refractory angina pectoris
  • I25.718Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.719Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.720Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris
  • I25.721Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.722Atherosclerosis of autologous artery coronary artery bypass graft(s) with refractory angina pectoris
  • I25.728Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.729Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.730Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris
  • I25.731Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.732Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris
  • I25.738Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.739Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.750Atherosclerosis of native coronary artery of transplanted heart with unstable angina
  • I25.751Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm
  • I25.752Atherosclerosis of native coronary artery of transplanted heart with refractory angina pectoris
  • I25.758Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris
  • I25.759Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris
  • I25.760Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina
  • I25.761Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm
  • I25.762Atherosclerosis of bypass graft of coronary artery of transplanted heart with refractory angina pectoris
  • I25.768Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris
  • I25.769Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris
  • I25.790Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris
  • I25.791Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.792Atherosclerosis of other coronary artery bypass graft(s) with refractory angina pectoris
  • I25.798Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.799Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.810Atherosclerosis of coronary artery bypass graft(s) without angina pectoris
  • I25.811Atherosclerosis of native coronary artery of transplanted heart without angina pectoris
  • I25.812Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris
  • I25.85Chronic coronary microvascular dysfunction
  • I25.89Other forms of chronic ischemic heart disease
  • I25.9Chronic ischemic heart disease, unspecified
  • I26.01Septic pulmonary embolism with acute cor pulmonale
  • I26.02Saddle embolus of pulmonary artery with acute cor pulmonale
  • I26.03Cement embolism of pulmonary artery with acute cor pulmonale
  • I26.04Fat embolism of pulmonary artery with acute cor pulmonale
  • I26.09Other pulmonary embolism with acute cor pulmonale
  • I26.90Septic pulmonary embolism without acute cor pulmonale
  • I26.92Saddle embolus of pulmonary artery without acute cor pulmonale
  • I26.93Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale
  • I26.94Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale
  • I26.95Cement embolism of pulmonary artery without acute cor pulmonale
  • I26.96Fat embolism of pulmonary artery without acute cor pulmonale
  • I27.0Primary pulmonary hypertension
  • I27.20Pulmonary hypertension, unspecified
  • I27.21Secondary pulmonary arterial hypertension
  • I27.22Pulmonary hypertension due to left heart disease
  • I27.23Pulmonary hypertension due to lung diseases and hypoxia
  • I27.24Chronic thromboembolic pulmonary hypertension
  • I27.29Other secondary pulmonary hypertension
  • I27.82Chronic pulmonary embolism
  • I27.83Eisenmenger's syndrome
  • I27.840Fontan-associated liver disease [FALD]
  • I27.841Fontan-associated lymphatic dysfunction
  • I27.848Other Fontan-associated condition
  • I27.849Fontan related circulation, unspecified
  • I27.89Other specified pulmonary heart diseases
  • I28.0Arteriovenous fistula of pulmonary vessels
  • I28.1Aneurysm of pulmonary artery
  • I30.0Acute nonspecific idiopathic pericarditis
  • I30.1Infective pericarditis
  • I30.8Other forms of acute pericarditis
  • I30.9Acute pericarditis, unspecified
  • I31.0Chronic adhesive pericarditis
  • I31.1Chronic constrictive pericarditis
  • I31.2Hemopericardium, not elsewhere classified
  • I31.31Malignant pericardial effusion in diseases classified elsewhere
  • I31.39Other pericardial effusion (noninflammatory)
  • I31.4Cardiac tamponade
  • I31.8Other specified diseases of pericardium
  • I31.9Disease of pericardium, unspecified
  • I32Pericarditis in diseases classified elsewhere
  • I33.0Acute and subacute infective endocarditis
  • I33.9Acute and subacute endocarditis, unspecified
  • I34.0Nonrheumatic mitral (valve) insufficiency
  • I34.1Nonrheumatic mitral (valve) prolapse
  • I34.2Nonrheumatic mitral (valve) stenosis
  • I34.9Nonrheumatic mitral valve disorder, unspecified
  • I35.0Nonrheumatic aortic (valve) stenosis
  • I35.1Nonrheumatic aortic (valve) insufficiency
  • I35.2Nonrheumatic aortic (valve) stenosis with insufficiency
  • I35.8Other nonrheumatic aortic valve disorders
  • I35.9Nonrheumatic aortic valve disorder, unspecified
  • I36.0Nonrheumatic tricuspid (valve) stenosis
  • I36.1Nonrheumatic tricuspid (valve) insufficiency
  • I36.2Nonrheumatic tricuspid (valve) stenosis with insufficiency
  • I36.8Other nonrheumatic tricuspid valve disorders
  • I36.9Nonrheumatic tricuspid valve disorder, unspecified
  • I37.0Nonrheumatic pulmonary valve stenosis
  • I37.1Nonrheumatic pulmonary valve insufficiency
  • I37.2Nonrheumatic pulmonary valve stenosis with insufficiency
  • I37.8Other nonrheumatic pulmonary valve disorders
  • I37.9Nonrheumatic pulmonary valve disorder, unspecified
  • I38Endocarditis, valve unspecified
  • I39Endocarditis and heart valve disorders in diseases classified elsewhere
  • I40.0Infective myocarditis
  • I40.1Isolated myocarditis
  • I40.8Other acute myocarditis
  • I41Myocarditis in diseases classified elsewhere
  • I42.00Dilated cardiomyopathy, unspecified
  • I42.01Familial-genetic dilated cardiomyopathy
  • I42.09Other dilated cardiomyopathy
  • I42.1Obstructive hypertrophic cardiomyopathy
  • I42.2Other hypertrophic cardiomyopathy
  • I42.3Endomyocardial (eosinophilic) disease
  • I42.4Endocardial fibroelastosis
  • I42.5Other restrictive cardiomyopathy
  • I42.6Alcoholic cardiomyopathy
  • I42.7Cardiomyopathy due to drug and external agent
  • I42.81Arrhythmogenic cardiomyopathy
  • I42.89Other cardiomyopathies not elsewhere classified
  • I43Cardiomyopathy in diseases classified elsewhere
  • I44.0Atrioventricular block, first degree
  • I44.1Atrioventricular block, second degree
  • I44.2Atrioventricular block, complete
  • I44.30Unspecified atrioventricular block
  • I44.4Left anterior fascicular block
  • I44.5Left posterior fascicular block
  • I44.60Unspecified fascicular block
  • I44.69Other fascicular block
  • I44.7Left bundle-branch block, unspecified
  • I45.0Right fascicular block
  • I45.10Unspecified right bundle-branch block
  • I45.19Other right bundle-branch block
  • I46.2Cardiac arrest due to underlying cardiac condition
  • I46.8Cardiac arrest due to other underlying condition
  • I46.9Cardiac arrest, cause unspecified
  • I47.0Re-entry ventricular arrhythmia
  • I47.11Inappropriate sinus tachycardia, so stated
  • I47.22Catecholaminergic polymorphic ventricular tachycardia [CPVT]
  • I48.0Paroxysmal atrial fibrillation
  • I48.11Longstanding persistent atrial fibrillation
  • I48.19Other persistent atrial fibrillation
  • I48.20Chronic atrial fibrillation, unspecified
  • I48.21Permanent atrial fibrillation
  • I48.3Typical atrial flutter
  • I48.4Atypical atrial flutter
  • I48.91Unspecified atrial fibrillation
  • I48.92Unspecified atrial flutter
  • I49.01Ventricular fibrillation
  • I49.02Ventricular flutter
  • I49.2Junctional premature depolarization
  • I49.5Sick sinus syndrome
  • I49.81Brugada syndrome
  • I49.82Ventricular bigeminy
  • I49.89Other specified cardiac arrhythmias not elsewhere classified
  • I50.1Left ventricular failure, unspecified
  • I50.20Unspecified systolic (congestive) heart failure
  • I50.21Acute systolic (congestive) heart failure
  • I50.22Chronic systolic (congestive) heart failure
  • I50.23Acute on chronic systolic (congestive) heart failure
  • I50.30Unspecified diastolic (congestive) heart failure
  • I50.31Acute diastolic (congestive) heart failure
  • I50.32Chronic diastolic (congestive) heart failure
  • I50.33Acute on chronic diastolic (congestive) heart failure
  • I50.40Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.41Acute combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.42Chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.43Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.810Right heart failure, unspecified
  • I50.811Acute right heart failure
  • I50.812Chronic right heart failure
  • I50.813Acute on chronic right heart failure
  • I50.814Right heart failure due to left heart failure
  • I50.82Biventricular heart failure
  • I50.83High output heart failure
  • I50.84End stage heart failure
  • I50.89Other heart failure
  • I50.9Heart failure, unspecified
  • I51.0Cardiac septal defect, acquired
  • I51.1Rupture of chordae tendineae, not elsewhere classified
  • I51.2Rupture of papillary muscle, not elsewhere classified
  • I51.3Intracardiac thrombosis, not elsewhere classified
  • I51.4Myocarditis, unspecified
  • I51.5Myocardial degeneration
  • I51.7Cardiomegaly
  • I51.81Takotsubo syndrome
  • I51.89Other ill-defined heart diseases
  • I52Other heart disorders in diseases classified elsewhere
  • I63.411Cerebral infarction due to embolism of right middle cerebral artery
  • I63.412Cerebral infarction due to embolism of left middle cerebral artery
  • I63.413Cerebral infarction due to embolism of bilateral middle cerebral arteries
  • I63.421Cerebral infarction due to embolism of right anterior cerebral artery
  • I63.422Cerebral infarction due to embolism of left anterior cerebral artery
  • I63.423Cerebral infarction due to embolism of bilateral anterior cerebral arteries
  • I63.431Cerebral infarction due to embolism of right posterior cerebral artery
  • I63.432Cerebral infarction due to embolism of left posterior cerebral artery
  • I63.433Cerebral infarction due to embolism of bilateral posterior cerebral arteries
  • I63.441Cerebral infarction due to embolism of right cerebellar artery
  • I63.442Cerebral infarction due to embolism of left cerebellar artery
  • I63.443Cerebral infarction due to embolism of bilateral cerebellar arteries
  • I63.49Cerebral infarction due to embolism of other cerebral artery
  • I63.511Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery
  • I63.512Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery
  • I63.513Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries
  • I63.521Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery
  • I63.522Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery
  • I63.523Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries
  • I63.531Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery
  • I63.532Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery
  • I63.533Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries
  • I63.541Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery
  • I63.542Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery
  • I63.543Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries
  • I63.59Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery
  • I63.81Other cerebral infarction due to occlusion or stenosis of small artery
  • I63.89Other cerebral infarction
  • I66.01Occlusion and stenosis of right middle cerebral artery
  • I66.02Occlusion and stenosis of left middle cerebral artery
  • I66.03Occlusion and stenosis of bilateral middle cerebral arteries
  • I66.11Occlusion and stenosis of right anterior cerebral artery
  • I66.12Occlusion and stenosis of left anterior cerebral artery
  • I66.13Occlusion and stenosis of bilateral anterior cerebral arteries
  • I66.21Occlusion and stenosis of right posterior cerebral artery
  • I66.22Occlusion and stenosis of left posterior cerebral artery
  • I66.23Occlusion and stenosis of bilateral posterior cerebral arteries
  • I66.3Occlusion and stenosis of cerebellar arteries
  • I66.8Occlusion and stenosis of other cerebral arteries
  • I67.0Dissection of cerebral arteries, nonruptured
  • I67.841Reversible cerebrovascular vasoconstriction syndrome
  • I67.848Other cerebrovascular vasospasm and vasoconstriction
  • I67.89Other cerebrovascular disease
  • I70.0Atherosclerosis of aorta
  • I71.010Dissection of ascending aorta
  • I71.011Dissection of aortic arch
  • I71.012Dissection of descending thoracic aorta
  • I71.019Dissection of thoracic aorta, unspecified
  • I71.02Dissection of abdominal aorta
  • I71.03Dissection of thoracoabdominal aorta
  • I71.20Thoracic aortic aneurysm, without rupture, unspecified
  • I71.21Aneurysm of the ascending aorta, without rupture
  • I71.22Aneurysm of the aortic arch, without rupture
  • I71.23Aneurysm of the descending thoracic aorta, without rupture
  • I71.40Abdominal aortic aneurysm, without rupture, unspecified
  • I71.41Pararenal abdominal aortic aneurysm, without rupture
  • I71.42Juxtarenal abdominal aortic aneurysm, without rupture
  • I71.43Infrarenal abdominal aortic aneurysm, without rupture
  • I71.60Thoracoabdominal aortic aneurysm, without rupture, unspecified
  • I71.61Supraceliac aneurysm of the thoracoabdominal aorta, without rupture
  • I71.62Paravisceral aneurysm of the thoracoabdominal aorta, without rupture
  • I73.89Other specified peripheral vascular diseases
  • I74.11Embolism and thrombosis of thoracic aorta
  • I74.19Embolism and thrombosis of other parts of aorta
  • I79.0Aneurysm of aorta in diseases classified elsewhere
  • I79.1Aortitis in diseases classified elsewhere
  • I79.8Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere
  • I87.1Compression of vein
  • I95.1Orthostatic hypotension
  • I95.89Other hypotension
  • I95.9Hypotension, unspecified
  • I97.0Postcardiotomy syndrome
  • I97.110Postprocedural cardiac insufficiency following cardiac surgery
  • I97.111Postprocedural cardiac insufficiency following other surgery
  • I97.120Postprocedural cardiac arrest following cardiac surgery
  • I97.121Postprocedural cardiac arrest following other surgery
  • I97.130Postprocedural heart failure following cardiac surgery
  • I97.131Postprocedural heart failure following other surgery
  • I97.190Other postprocedural cardiac functional disturbances following cardiac surgery
  • I97.191Other postprocedural cardiac functional disturbances following other surgery
  • I97.710Intraoperative cardiac arrest during cardiac surgery
  • I97.711Intraoperative cardiac arrest during other surgery
  • I97.790Other intraoperative cardiac functional disturbances during cardiac surgery
  • I97.791Other intraoperative cardiac functional disturbances during other surgery
  • I97.88Other intraoperative complications of the circulatory system, not elsewhere classified
  • I97.89Other postprocedural complications and disorders of the circulatory system, not elsewhere classified
  • J80Acute respiratory distress syndrome
  • J81.0Acute pulmonary edema
  • J95.1Acute pulmonary insufficiency following thoracic surgery
  • J95.2Acute pulmonary insufficiency following nonthoracic surgery
  • J95.3Chronic pulmonary insufficiency following surgery
  • J95.821Acute postprocedural respiratory failure
  • J95.822Acute and chronic postprocedural respiratory failure
  • J95.84Transfusion-related acute lung injury (TRALI)
  • J95.87Transfusion-associated dyspnea (TAD)
  • J96.00Acute respiratory failure, unspecified whether with hypoxia or hypercapnia
  • J96.01Acute respiratory failure with hypoxia
  • J96.02Acute respiratory failure with hypercapnia
  • J96.20Acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia
  • J96.21Acute and chronic respiratory failure with hypoxia
  • J96.22Acute and chronic respiratory failure with hypercapnia
  • J98.51Mediastinitis
  • J98.59Other diseases of mediastinum, not elsewhere classified
  • M30.0Polyarteritis nodosa
  • M30.2Juvenile polyarteritis
  • M30.3Mucocutaneous lymph node syndrome [Kawasaki]
  • M30.8Other conditions related to polyarteritis nodosa
  • M31.4Aortic arch syndrome [Takayasu]
  • M31.7Microscopic polyangiitis
  • M32.0Drug-induced systemic lupus erythematosus
  • M32.11Endocarditis in systemic lupus erythematosus
  • M32.12Pericarditis in systemic lupus erythematosus
  • M32.19Other organ or system involvement in systemic lupus erythematosus
  • M32.8Other forms of systemic lupus erythematosus
  • M32.9Systemic lupus erythematosus, unspecified
  • M34.0Progressive systemic sclerosis
  • M34.1CR(E)ST syndrome
  • M34.2Systemic sclerosis induced by drug and chemical
  • M34.89Other systemic sclerosis
  • M34.9Systemic sclerosis, unspecified
  • Q20.0Common arterial trunk
  • Q20.1Double outlet right ventricle
  • Q20.2Double outlet left ventricle
  • Q20.3Discordant ventriculoarterial connection
  • Q20.4Double inlet ventricle
  • Q20.5Discordant atrioventricular connection
  • Q20.6Isomerism of atrial appendages
  • Q20.8Other congenital malformations of cardiac chambers and connections
  • Q21.0Ventricular septal defect
  • Q21.10Atrial septal defect, unspecified
  • Q21.11Secundum atrial septal defect
  • Q21.12Patent foramen ovale
  • Q21.13Coronary sinus atrial septal defect
  • Q21.14Superior sinus venosus atrial septal defect
  • Q21.15Inferior sinus venosus atrial septal defect
  • Q21.16Sinus venosus atrial septal defect, unspecified
  • Q21.19Other specified atrial septal defect
  • Q21.20Atrioventricular septal defect, unspecified as to partial or complete
  • Q21.21Partial atrioventricular septal defect
  • Q21.22Transitional atrioventricular septal defect
  • Q21.23Complete atrioventricular septal defect
  • Q21.3Tetralogy of Fallot
  • Q21.4Aortopulmonary septal defect
  • Q21.8Other congenital malformations of cardiac septa
  • Q21.9Congenital malformation of cardiac septum, unspecified
  • Q22.0Pulmonary valve atresia
  • Q22.1Congenital pulmonary valve stenosis
  • Q22.2Congenital pulmonary valve insufficiency
  • Q22.3Other congenital malformations of pulmonary valve
  • Q22.4Congenital tricuspid stenosis
  • Q22.5Ebstein's anomaly
  • Q22.6Hypoplastic right heart syndrome
  • Q22.8Other congenital malformations of tricuspid valve
  • Q22.9Congenital malformation of tricuspid valve, unspecified
  • Q23.0Congenital stenosis of aortic valve
  • Q23.1Congenital insufficiency of aortic valve
  • Q23.2Congenital mitral stenosis
  • Q23.3Congenital mitral insufficiency
  • Q23.4Hypoplastic left heart syndrome
  • Q23.81Bicuspid aortic valve
  • Q23.82Congenital mitral valve cleft leaflet
  • Q23.88Other congenital malformations of aortic and mitral valves
  • Q23.9Congenital malformation of aortic and mitral valves, unspecified
  • Q24.0Dextrocardia
  • Q24.1Levocardia
  • Q24.2Cor triatriatum
  • Q24.3Pulmonary infundibular stenosis
  • Q24.4Congenital subaortic stenosis
  • Q24.5Malformation of coronary vessels
  • Q24.6Congenital heart block
  • Q24.8Other specified congenital malformations of heart
  • Q25.0Patent ductus arteriosus
  • Q25.1Coarctation of aorta
  • Q25.21Interruption of aortic arch
  • Q25.29Other atresia of aorta
  • Q25.3Supravalvular aortic stenosis
  • Q25.40Congenital malformation of aorta unspecified
  • Q25.41Absence and aplasia of aorta
  • Q25.42Hypoplasia of aorta
  • Q25.43Congenital aneurysm of aorta
  • Q25.44Congenital dilation of aorta
  • Q25.45Double aortic arch
  • Q25.46Tortuous aortic arch
  • Q25.47Right aortic arch
  • Q25.48Anomalous origin of subclavian artery
  • Q25.49Other congenital malformations of aorta
  • Q25.5Atresia of pulmonary artery
  • Q25.6Stenosis of pulmonary artery
  • Q25.71Coarctation of pulmonary artery
  • Q25.72Congenital pulmonary arteriovenous malformation
  • Q25.79Other congenital malformations of pulmonary artery
  • Q25.8Other congenital malformations of other great arteries
  • Q25.9Congenital malformation of great arteries, unspecified
  • Q26.0Congenital stenosis of vena cava
  • Q26.1Persistent left superior vena cava
  • Q26.2Total anomalous pulmonary venous connection
  • Q26.3Partial anomalous pulmonary venous connection
  • Q26.4Anomalous pulmonary venous connection, unspecified
  • Q26.8Other congenital malformations of great veins
  • Q26.9Congenital malformation of great vein, unspecified
  • Q87.410Marfan syndrome with aortic dilation
  • Q87.418Marfan syndrome with other cardiovascular manifestations
  • Q87.86Kleefstra syndrome
  • Q87.88CTNNB1 syndrome
  • Q89.3Situs inversus
  • R00.1Bradycardia, unspecified
  • R00.8Other abnormalities of heart beat
  • R00.9Unspecified abnormalities of heart beat
  • R01.0Benign and innocent cardiac murmurs
  • R01.1Cardiac murmur, unspecified
  • R01.2Other cardiac sounds
  • R06.00Dyspnea, unspecified
  • R06.01Orthopnea
  • R06.02Shortness of breath
  • R06.03Acute respiratory distress
  • R06.09Other forms of dyspnea
  • R06.2Wheezing
  • R06.3Periodic breathing
  • R06.81Apnea, not elsewhere classified
  • R06.82Tachypnea, not elsewhere classified
  • R06.89Other abnormalities of breathing
  • R07.2Precordial pain
  • R07.82Intercostal pain
  • R07.89Other chest pain
  • R07.9Chest pain, unspecified
  • R50.2Drug induced fever
  • R50.81Fever presenting with conditions classified elsewhere
  • R50.9Fever, unspecified
  • R55Syncope and collapse
  • R57.0Cardiogenic shock
  • R57.1Hypovolemic shock
  • R57.8Other shock
  • R57.9Shock, unspecified
  • R60.0Localized edema
  • R60.1Generalized edema
  • R65.21Severe sepsis with septic shock
  • R78.81Bacteremia
  • R94.31Abnormal electrocardiogram [ECG] [EKG]
  • S21.301AUnspecified open wound of right front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.301DUnspecified open wound of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.301SUnspecified open wound of right front wall of thorax with penetration into thoracic cavity, sequela
  • S21.302AUnspecified open wound of left front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.302DUnspecified open wound of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.302SUnspecified open wound of left front wall of thorax with penetration into thoracic cavity, sequela
  • S21.311ALaceration without foreign body of right front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.311DLaceration without foreign body of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.311SLaceration without foreign body of right front wall of thorax with penetration into thoracic cavity, sequela
  • S21.312ALaceration without foreign body of left front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.312DLaceration without foreign body of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.312SLaceration without foreign body of left front wall of thorax with penetration into thoracic cavity, sequela
  • S21.321ALaceration with foreign body of right front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.321DLaceration with foreign body of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.321SLaceration with foreign body of right front wall of thorax with penetration into thoracic cavity, sequela
  • S21.322ALaceration with foreign body of left front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.322DLaceration with foreign body of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.322SLaceration with foreign body of left front wall of thorax with penetration into thoracic cavity, sequela
  • S21.331APuncture wound without foreign body of right front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.331DPuncture wound without foreign body of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.331SPuncture wound without foreign body of right front wall of thorax with penetration into thoracic cavity, sequela
  • S21.332APuncture wound without foreign body of left front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.332DPuncture wound without foreign body of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.332SPuncture wound without foreign body of left front wall of thorax with penetration into thoracic cavity, sequela
  • S21.341APuncture wound with foreign body of right front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.341DPuncture wound with foreign body of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.341SPuncture wound with foreign body of right front wall of thorax with penetration into thoracic cavity, sequela
  • S21.342APuncture wound with foreign body of left front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.342DPuncture wound with foreign body of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.342SPuncture wound with foreign body of left front wall of thorax with penetration into thoracic cavity, sequela
  • S21.351AOpen bite of right front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.351DOpen bite of right front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.351SOpen bite of right front wall of thorax with penetration into thoracic cavity, sequela
  • S21.352AOpen bite of left front wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.352DOpen bite of left front wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.352SOpen bite of left front wall of thorax with penetration into thoracic cavity, sequela
  • S21.401AUnspecified open wound of right back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.401DUnspecified open wound of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.401SUnspecified open wound of right back wall of thorax with penetration into thoracic cavity, sequela
  • S21.402AUnspecified open wound of left back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.402DUnspecified open wound of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.402SUnspecified open wound of left back wall of thorax with penetration into thoracic cavity, sequela
  • S21.411ALaceration without foreign body of right back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.411DLaceration without foreign body of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.411SLaceration without foreign body of right back wall of thorax with penetration into thoracic cavity, sequela
  • S21.412ALaceration without foreign body of left back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.412DLaceration without foreign body of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.412SLaceration without foreign body of left back wall of thorax with penetration into thoracic cavity, sequela
  • S21.421ALaceration with foreign body of right back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.421DLaceration with foreign body of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.421SLaceration with foreign body of right back wall of thorax with penetration into thoracic cavity, sequela
  • S21.422ALaceration with foreign body of left back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.422DLaceration with foreign body of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.422SLaceration with foreign body of left back wall of thorax with penetration into thoracic cavity, sequela
  • S21.431APuncture wound without foreign body of right back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.431DPuncture wound without foreign body of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.431SPuncture wound without foreign body of right back wall of thorax with penetration into thoracic cavity, sequela
  • S21.432APuncture wound without foreign body of left back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.432DPuncture wound without foreign body of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.432SPuncture wound without foreign body of left back wall of thorax with penetration into thoracic cavity, sequela
  • S21.441APuncture wound with foreign body of right back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.441DPuncture wound with foreign body of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.441SPuncture wound with foreign body of right back wall of thorax with penetration into thoracic cavity, sequela
  • S21.442APuncture wound with foreign body of left back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.442DPuncture wound with foreign body of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.442SPuncture wound with foreign body of left back wall of thorax with penetration into thoracic cavity, sequela
  • S21.451AOpen bite of right back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.451DOpen bite of right back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.451SOpen bite of right back wall of thorax with penetration into thoracic cavity, sequela
  • S21.452AOpen bite of left back wall of thorax with penetration into thoracic cavity, initial encounter
  • S21.452DOpen bite of left back wall of thorax with penetration into thoracic cavity, subsequent encounter
  • S21.452SOpen bite of left back wall of thorax with penetration into thoracic cavity, sequela
  • S22.5XXAFlail chest, initial encounter for closed fracture
  • S22.5XXBFlail chest, initial encounter for open fracture
  • S22.5XXDFlail chest, subsequent encounter for fracture with routine healing
  • S22.5XXGFlail chest, subsequent encounter for fracture with delayed healing
  • S22.5XXKFlail chest, subsequent encounter for fracture with nonunion
  • S22.5XXSFlail chest, sequela
  • S25.00XAUnspecified injury of thoracic aorta, initial encounter
  • S25.00XDUnspecified injury of thoracic aorta, subsequent encounter
  • S25.00XSUnspecified injury of thoracic aorta, sequela
  • S25.01XAMinor laceration of thoracic aorta, initial encounter
  • S25.01XDMinor laceration of thoracic aorta, subsequent encounter
  • S25.01XSMinor laceration of thoracic aorta, sequela
  • S25.02XAMajor laceration of thoracic aorta, initial encounter
  • S25.02XDMajor laceration of thoracic aorta, subsequent encounter
  • S25.02XSMajor laceration of thoracic aorta, sequela
  • S25.09XAOther specified injury of thoracic aorta, initial encounter
  • S25.09XDOther specified injury of thoracic aorta, subsequent encounter
  • S25.09XSOther specified injury of thoracic aorta, sequela
  • S25.20XAUnspecified injury of superior vena cava, initial encounter
  • S25.20XDUnspecified injury of superior vena cava, subsequent encounter
  • S25.20XSUnspecified injury of superior vena cava, sequela
  • S25.21XAMinor laceration of superior vena cava, initial encounter
  • S25.21XDMinor laceration of superior vena cava, subsequent encounter
  • S25.21XSMinor laceration of superior vena cava, sequela
  • S25.22XAMajor laceration of superior vena cava, initial encounter
  • S25.22XDMajor laceration of superior vena cava, subsequent encounter
  • S25.22XSMajor laceration of superior vena cava, sequela
  • S25.29XAOther specified injury of superior vena cava, initial encounter
  • S25.29XDOther specified injury of superior vena cava, subsequent encounter
  • S25.29XSOther specified injury of superior vena cava, sequela
  • S25.401AUnspecified injury of right pulmonary blood vessels, initial encounter
  • S25.401DUnspecified injury of right pulmonary blood vessels, subsequent encounter
  • S25.401SUnspecified injury of right pulmonary blood vessels, sequela
  • S25.402AUnspecified injury of left pulmonary blood vessels, initial encounter
  • S25.402DUnspecified injury of left pulmonary blood vessels, subsequent encounter
  • S25.402SUnspecified injury of left pulmonary blood vessels, sequela
  • S25.411AMinor laceration of right pulmonary blood vessels, initial encounter
  • S25.411DMinor laceration of right pulmonary blood vessels, subsequent encounter
  • S25.411SMinor laceration of right pulmonary blood vessels, sequela
  • S25.412AMinor laceration of left pulmonary blood vessels, initial encounter
  • S25.412DMinor laceration of left pulmonary blood vessels, subsequent encounter
  • S25.412SMinor laceration of left pulmonary blood vessels, sequela
  • S25.421AMajor laceration of right pulmonary blood vessels, initial encounter
  • S25.421DMajor laceration of right pulmonary blood vessels, subsequent encounter
  • S25.421SMajor laceration of right pulmonary blood vessels, sequela
  • S25.422AMajor laceration of left pulmonary blood vessels, initial encounter
  • S25.422DMajor laceration of left pulmonary blood vessels, subsequent encounter
  • S25.422SMajor laceration of left pulmonary blood vessels, sequela
  • S25.491AOther specified injury of right pulmonary blood vessels, initial encounter
  • S25.491DOther specified injury of right pulmonary blood vessels, subsequent encounter
  • S25.491SOther specified injury of right pulmonary blood vessels, sequela
  • S25.492AOther specified injury of left pulmonary blood vessels, initial encounter
  • S25.492DOther specified injury of left pulmonary blood vessels, subsequent encounter
  • S25.492SOther specified injury of left pulmonary blood vessels, sequela
  • S26.00XAUnspecified injury of heart with hemopericardium, initial encounter
  • S26.00XDUnspecified injury of heart with hemopericardium, subsequent encounter
  • S26.00XSUnspecified injury of heart with hemopericardium, sequela
  • S26.01XAContusion of heart with hemopericardium, initial encounter
  • S26.01XDContusion of heart with hemopericardium, subsequent encounter
  • S26.01XSContusion of heart with hemopericardium, sequela
  • S26.020AMild laceration of heart with hemopericardium, initial encounter
  • S26.020DMild laceration of heart with hemopericardium, subsequent encounter
  • S26.020SMild laceration of heart with hemopericardium, sequela
  • S26.021AModerate laceration of heart with hemopericardium, initial encounter
  • S26.021DModerate laceration of heart with hemopericardium, subsequent encounter
  • S26.021SModerate laceration of heart with hemopericardium, sequela
  • S26.022AMajor laceration of heart with hemopericardium, initial encounter
  • S26.022DMajor laceration of heart with hemopericardium, subsequent encounter
  • S26.022SMajor laceration of heart with hemopericardium, sequela
  • S26.09XAOther injury of heart with hemopericardium, initial encounter
  • S26.09XDOther injury of heart with hemopericardium, subsequent encounter
  • S26.09XSOther injury of heart with hemopericardium, sequela
  • S26.10XAUnspecified injury of heart without hemopericardium, initial encounter
  • S26.10XDUnspecified injury of heart without hemopericardium, subsequent encounter
  • S26.10XSUnspecified injury of heart without hemopericardium, sequela
  • S26.11XAContusion of heart without hemopericardium, initial encounter
  • S26.11XDContusion of heart without hemopericardium, subsequent encounter
  • S26.11XSContusion of heart without hemopericardium, sequela
  • S26.12XALaceration of heart without hemopericardium, initial encounter
  • S26.12XDLaceration of heart without hemopericardium, subsequent encounter
  • S26.12XSLaceration of heart without hemopericardium, sequela
  • S26.19XAOther injury of heart without hemopericardium, initial encounter
  • S26.19XDOther injury of heart without hemopericardium, subsequent encounter
  • S26.19XSOther injury of heart without hemopericardium, sequela
  • S26.90XAUnspecified injury of heart, unspecified with or without hemopericardium, initial encounter
  • S26.90XDUnspecified injury of heart, unspecified with or without hemopericardium, subsequent encounter
  • S26.90XSUnspecified injury of heart, unspecified with or without hemopericardium, sequela
  • S26.91XAContusion of heart, unspecified with or without hemopericardium, initial encounter
  • S26.91XDContusion of heart, unspecified with or without hemopericardium, subsequent encounter
  • S26.91XSContusion of heart, unspecified with or without hemopericardium, sequela
  • S26.92XALaceration of heart, unspecified with or without hemopericardium, initial encounter
  • S26.92XDLaceration of heart, unspecified with or without hemopericardium, subsequent encounter
  • S26.92XSLaceration of heart, unspecified with or without hemopericardium, sequela
  • S26.99XAOther injury of heart, unspecified with or without hemopericardium, initial encounter
  • S26.99XDOther injury of heart, unspecified with or without hemopericardium, subsequent encounter
  • S26.99XSOther injury of heart, unspecified with or without hemopericardium, sequela
  • S28.1XXATraumatic amputation (partial) of part of thorax, except breast, initial encounter
  • S28.1XXDTraumatic amputation (partial) of part of thorax, except breast, subsequent encounter
  • S28.1XXSTraumatic amputation (partial) of part of thorax, except breast, sequela
  • S29.8XXAOther specified injuries of thorax, initial encounter
  • S29.8XXDOther specified injuries of thorax, subsequent encounter
  • S29.8XXSOther specified injuries of thorax, sequela
  • T36.0X5DAdverse effect of penicillins, subsequent encounter
  • T36.0X5SAdverse effect of penicillins, sequela
  • T36.1X5DAdverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
  • T36.1X5SAdverse effect of cephalosporins and other beta-lactam antibiotics, sequela
  • T36.2X5DAdverse effect of chloramphenicol group, subsequent encounter
  • T36.2X5SAdverse effect of chloramphenicol group, sequela
  • T36.3X5DAdverse effect of macrolides, subsequent encounter
  • T36.3X5SAdverse effect of macrolides, sequela
  • T36.4X5DAdverse effect of tetracyclines, subsequent encounter
  • T36.4X5SAdverse effect of tetracyclines, sequela
  • T36.5X5DAdverse effect of aminoglycosides, subsequent encounter
  • T36.5X5SAdverse effect of aminoglycosides, sequela
  • T36.6X5DAdverse effect of rifampicins, subsequent encounter
  • T36.6X5SAdverse effect of rifampicins, sequela
  • T36.7X5DAdverse effect of antifungal antibiotics, systemically used, subsequent encounter
  • T36.7X5SAdverse effect of antifungal antibiotics, systemically used, sequela
  • T36.8X5DAdverse effect of other systemic antibiotics, subsequent encounter
  • T36.8X5SAdverse effect of other systemic antibiotics, sequela
  • T36.95XDAdverse effect of unspecified systemic antibiotic, subsequent encounter
  • T36.95XSAdverse effect of unspecified systemic antibiotic, sequela
  • T37.0X5DAdverse effect of sulfonamides, subsequent encounter
  • T37.0X5SAdverse effect of sulfonamides, sequela
  • T37.1X5DAdverse effect of antimycobacterial drugs, subsequent encounter
  • T37.1X5SAdverse effect of antimycobacterial drugs, sequela
  • T37.2X5DAdverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter
  • T37.2X5SAdverse effect of antimalarials and drugs acting on other blood protozoa, sequela
  • T37.3X5DAdverse effect of other antiprotozoal drugs, subsequent encounter
  • T37.3X5SAdverse effect of other antiprotozoal drugs, sequela
  • T37.4X5DAdverse effect of anthelminthics, subsequent encounter
  • T37.4X5SAdverse effect of anthelminthics, sequela
  • T37.5X5DAdverse effect of antiviral drugs, subsequent encounter
  • T37.5X5SAdverse effect of antiviral drugs, sequela
  • T37.8X5DAdverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
  • T37.8X5SAdverse effect of other specified systemic anti-infectives and antiparasitics, sequela
  • T37.95XDAdverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter
  • T37.95XSAdverse effect of unspecified systemic anti-infective and antiparasitic, sequela
  • T38.0X1APoisoning by glucocorticoids and synthetic analogues, accidental (unintentional), initial encounter
  • T38.0X1DPoisoning by glucocorticoids and synthetic analogues, accidental (unintentional), subsequent encounter
  • T38.0X1SPoisoning by glucocorticoids and synthetic analogues, accidental (unintentional), sequela
  • T38.0X2APoisoning by glucocorticoids and synthetic analogues, intentional self-harm, initial encounter
  • T38.0X2DPoisoning by glucocorticoids and synthetic analogues, intentional self-harm, subsequent encounter
  • T38.0X2SPoisoning by glucocorticoids and synthetic analogues, intentional self-harm, sequela
  • T38.0X3APoisoning by glucocorticoids and synthetic analogues, assault, initial encounter
  • T38.0X3DPoisoning by glucocorticoids and synthetic analogues, assault, subsequent encounter
  • T38.0X3SPoisoning by glucocorticoids and synthetic analogues, assault, sequela
  • T38.0X4APoisoning by glucocorticoids and synthetic analogues, undetermined, initial encounter
  • T38.0X4DPoisoning by glucocorticoids and synthetic analogues, undetermined, subsequent encounter
  • T38.0X4SPoisoning by glucocorticoids and synthetic analogues, undetermined, sequela
  • T38.0X5DAdverse effect of glucocorticoids and synthetic analogues, subsequent encounter
  • T38.0X5SAdverse effect of glucocorticoids and synthetic analogues, sequela
  • T38.1X5DAdverse effect of thyroid hormones and substitutes, subsequent encounter
  • T38.1X5SAdverse effect of thyroid hormones and substitutes, sequela
  • T38.2X5DAdverse effect of antithyroid drugs, subsequent encounter
  • T38.2X5SAdverse effect of antithyroid drugs, sequela
  • T38.3X5DAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
  • T38.3X5SAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
  • T38.4X5DAdverse effect of oral contraceptives, subsequent encounter
  • T38.4X5SAdverse effect of oral contraceptives, sequela
  • T38.5X5DAdverse effect of other estrogens and progestogens, subsequent encounter
  • T38.5X5SAdverse effect of other estrogens and progestogens, sequela
  • T38.6X5DAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
  • T38.6X5SAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
  • T38.7X5DAdverse effect of androgens and anabolic congeners, subsequent encounter
  • T38.7X5SAdverse effect of androgens and anabolic congeners, sequela
  • T38.805DAdverse effect of unspecified hormones and synthetic substitutes, subsequent encounter
  • T38.805SAdverse effect of unspecified hormones and synthetic substitutes, sequela
  • T38.815DAdverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
  • T38.815SAdverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
  • T38.895DAdverse effect of other hormones and synthetic substitutes, subsequent encounter
  • T38.895SAdverse effect of other hormones and synthetic substitutes, sequela
  • T38.905DAdverse effect of unspecified hormone antagonists, subsequent encounter
  • T38.905SAdverse effect of unspecified hormone antagonists, sequela
  • T38.995DAdverse effect of other hormone antagonists, subsequent encounter
  • T38.995SAdverse effect of other hormone antagonists, sequela
  • T39.015DAdverse effect of aspirin, subsequent encounter
  • T39.015SAdverse effect of aspirin, sequela
  • T39.095DAdverse effect of salicylates, subsequent encounter
  • T39.095SAdverse effect of salicylates, sequela
  • T39.1X5DAdverse effect of 4-Aminophenol derivatives, subsequent encounter
  • T39.1X5SAdverse effect of 4-Aminophenol derivatives, sequela
  • T39.2X5DAdverse effect of pyrazolone derivatives, subsequent encounter
  • T39.2X5SAdverse effect of pyrazolone derivatives, sequela
  • T39.315DAdverse effect of propionic acid derivatives, subsequent encounter
  • T39.315SAdverse effect of propionic acid derivatives, sequela
  • T39.395DAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
  • T39.395SAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
  • T39.4X5DAdverse effect of antirheumatics, not elsewhere classified, subsequent encounter
  • T39.4X5SAdverse effect of antirheumatics, not elsewhere classified, sequela
  • T39.8X5DAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
  • T39.8X5SAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
  • T39.95XDAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
  • T39.95XSAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
  • T40.0X5DAdverse effect of opium, subsequent encounter
  • T40.0X5SAdverse effect of opium, sequela
  • T40.2X1APoisoning by other opioids, accidental (unintentional), initial encounter
  • T40.2X1DPoisoning by other opioids, accidental (unintentional), subsequent encounter
  • T40.2X1SPoisoning by other opioids, accidental (unintentional), sequela
  • T40.2X2APoisoning by other opioids, intentional self-harm, initial encounter
  • T40.2X2DPoisoning by other opioids, intentional self-harm, subsequent encounter
  • T40.2X2SPoisoning by other opioids, intentional self-harm, sequela
  • T40.2X3APoisoning by other opioids, assault, initial encounter
  • T40.2X3DPoisoning by other opioids, assault, subsequent encounter
  • T40.2X3SPoisoning by other opioids, assault, sequela
  • T40.2X4APoisoning by other opioids, undetermined, initial encounter
  • T40.2X4DPoisoning by other opioids, undetermined, subsequent encounter
  • T40.2X4SPoisoning by other opioids, undetermined, sequela
  • T40.2X5DAdverse effect of other opioids, subsequent encounter
  • T40.2X5SAdverse effect of other opioids, sequela
  • T40.3X5DAdverse effect of methadone, subsequent encounter
  • T40.3X5SAdverse effect of methadone, sequela
  • T40.5X5DAdverse effect of cocaine, subsequent encounter
  • T40.5X5SAdverse effect of cocaine, sequela
  • T40.605DAdverse effect of unspecified narcotics, subsequent encounter
  • T40.605SAdverse effect of unspecified narcotics, sequela
  • T40.691APoisoning by other narcotics, accidental (unintentional), initial encounter
  • T40.691DPoisoning by other narcotics, accidental (unintentional), subsequent encounter
  • T40.691SPoisoning by other narcotics, accidental (unintentional), sequela
  • T40.692APoisoning by other narcotics, intentional self-harm, initial encounter
  • T40.692DPoisoning by other narcotics, intentional self-harm, subsequent encounter
  • T40.692SPoisoning by other narcotics, intentional self-harm, sequela
  • T40.693APoisoning by other narcotics, assault, initial encounter
  • T40.693DPoisoning by other narcotics, assault, subsequent encounter
  • T40.693SPoisoning by other narcotics, assault, sequela
  • T40.694APoisoning by other narcotics, undetermined, initial encounter
  • T40.694DPoisoning by other narcotics, undetermined, subsequent encounter
  • T40.694SPoisoning by other narcotics, undetermined, sequela
  • T40.695DAdverse effect of other narcotics, subsequent encounter
  • T40.695SAdverse effect of other narcotics, sequela
  • T40.711DPoisoning by cannabis, accidental (unintentional), subsequent encounter
  • T40.711SPoisoning by cannabis, accidental (unintentional), sequela
  • T40.712DPoisoning by cannabis, intentional self-harm, subsequent encounter
  • T40.712SPoisoning by cannabis, intentional self-harm, sequela
  • T40.713DPoisoning by cannabis, assault, subsequent encounter
  • T40.713SPoisoning by cannabis, assault, sequela
  • T40.714DPoisoning by cannabis, undetermined, subsequent encounter
  • T40.714SPoisoning by cannabis, undetermined, sequela
  • T40.715DAdverse effect of cannabis, subsequent encounter
  • T40.715SAdverse effect of cannabis, sequela
  • T40.721DPoisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter
  • T40.721SPoisoning by synthetic cannabinoids, accidental (unintentional), sequela
  • T40.722DPoisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter
  • T40.722SPoisoning by synthetic cannabinoids, intentional self-harm, sequela
  • T40.723DPoisoning by synthetic cannabinoids, assault, subsequent encounter
  • T40.723SPoisoning by synthetic cannabinoids, assault, sequela
  • T40.724DPoisoning by synthetic cannabinoids, undetermined, subsequent encounter
  • T40.724SPoisoning by synthetic cannabinoids, undetermined, sequela
  • T40.725DAdverse effect of synthetic cannabinoids, subsequent encounter
  • T40.725SAdverse effect of synthetic cannabinoids, sequela
  • T40.905DAdverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
  • T40.905SAdverse effect of unspecified psychodysleptics [hallucinogens], sequela
  • T40.995DAdverse effect of other psychodysleptics [hallucinogens], subsequent encounter
  • T40.995SAdverse effect of other psychodysleptics [hallucinogens], sequela
  • T41.0X5DAdverse effect of inhaled anesthetics, subsequent encounter
  • T41.0X5SAdverse effect of inhaled anesthetics, sequela
  • T41.1X5DAdverse effect of intravenous anesthetics, subsequent encounter
  • T41.1X5SAdverse effect of intravenous anesthetics, sequela
  • T41.205DAdverse effect of unspecified general anesthetics, subsequent encounter
  • T41.205SAdverse effect of unspecified general anesthetics, sequela
  • T41.295DAdverse effect of other general anesthetics, subsequent encounter
  • T41.295SAdverse effect of other general anesthetics, sequela
  • T41.3X5DAdverse effect of local anesthetics, subsequent encounter
  • T41.3X5SAdverse effect of local anesthetics, sequela
  • T41.45XDAdverse effect of unspecified anesthetic, subsequent encounter
  • T41.45XSAdverse effect of unspecified anesthetic, sequela
  • T41.5X5DAdverse effect of therapeutic gases, subsequent encounter
  • T41.5X5SAdverse effect of therapeutic gases, sequela
  • T42.0X5DAdverse effect of hydantoin derivatives, subsequent encounter
  • T42.0X5SAdverse effect of hydantoin derivatives, sequela
  • T42.1X5DAdverse effect of iminostilbenes, subsequent encounter
  • T42.1X5SAdverse effect of iminostilbenes, sequela
  • T42.2X5DAdverse effect of succinimides and oxazolidinediones, subsequent encounter
  • T42.2X5SAdverse effect of succinimides and oxazolidinediones, sequela
  • T42.3X5DAdverse effect of barbiturates, subsequent encounter
  • T42.3X5SAdverse effect of barbiturates, sequela
  • T42.4X5DAdverse effect of benzodiazepines, subsequent encounter
  • T42.4X5SAdverse effect of benzodiazepines, sequela
  • T42.5X5DAdverse effect of mixed antiepileptics, subsequent encounter
  • T42.5X5SAdverse effect of mixed antiepileptics, sequela
  • T42.6X5DAdverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
  • T42.6X5SAdverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
  • T42.75XDAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
  • T42.75XSAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela
  • T42.8X5DAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
  • T42.8X5SAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
  • T43.015DAdverse effect of tricyclic antidepressants, subsequent encounter
  • T43.015SAdverse effect of tricyclic antidepressants, sequela
  • T43.025DAdverse effect of tetracyclic antidepressants, subsequent encounter
  • T43.025SAdverse effect of tetracyclic antidepressants, sequela
  • T43.1X5DAdverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
  • T43.1X5SAdverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
  • T43.205DAdverse effect of unspecified antidepressants, subsequent encounter
  • T43.205SAdverse effect of unspecified antidepressants, sequela
  • T43.215DAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
  • T43.215SAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
  • T43.225DAdverse effect of selective serotonin reuptake inhibitors, subsequent encounter
  • T43.225SAdverse effect of selective serotonin reuptake inhibitors, sequela
  • T43.295DAdverse effect of other antidepressants, subsequent encounter
  • T43.295SAdverse effect of other antidepressants, sequela
  • T43.3X5DAdverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
  • T43.3X5SAdverse effect of phenothiazine antipsychotics and neuroleptics, sequela
  • T43.4X5DAdverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
  • T43.4X5SAdverse effect of butyrophenone and thiothixene neuroleptics, sequela
  • T43.505DAdverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter
  • T43.505SAdverse effect of unspecified antipsychotics and neuroleptics, sequela
  • T43.595DAdverse effect of other antipsychotics and neuroleptics, subsequent encounter
  • T43.595SAdverse effect of other antipsychotics and neuroleptics, sequela
  • T43.605DAdverse effect of unspecified psychostimulants, subsequent encounter
  • T43.605SAdverse effect of unspecified psychostimulants, sequela
  • T43.615DAdverse effect of caffeine, subsequent encounter
  • T43.615SAdverse effect of caffeine, sequela
  • T43.625DAdverse effect of amphetamines, subsequent encounter
  • T43.625SAdverse effect of amphetamines, sequela
  • T43.635DAdverse effect of methylphenidate, subsequent encounter
  • T43.635SAdverse effect of methylphenidate, sequela
  • T43.651APoisoning by methamphetamines accidental (unintentional), initial encounter
  • T43.651DPoisoning by methamphetamines accidental (unintentional), subsequent encounter
  • T43.651SPoisoning by methamphetamines accidental (unintentional), sequela
  • T43.652APoisoning by methamphetamines intentional self-harm, initial encounter
  • T43.652DPoisoning by methamphetamines intentional self-harm, subsequent encounter
  • T43.652SPoisoning by methamphetamines intentional self-harm, sequela
  • T43.653APoisoning by methamphetamines, assault, initial encounter
  • T43.653DPoisoning by methamphetamines, assault, subsequent encounter
  • T43.653SPoisoning by methamphetamines, assault, sequela
  • T43.654APoisoning by methamphetamines, undetermined, initial encounter
  • T43.654DPoisoning by methamphetamines, undetermined, subsequent encounter
  • T43.654SPoisoning by methamphetamines, undetermined, sequela
  • T43.655AAdverse effect of methamphetamines, initial encounter
  • T43.655DAdverse effect of methamphetamines, subsequent encounter
  • T43.655SAdverse effect of methamphetamines, sequela
  • T43.656AUnderdosing of methamphetamines, initial encounter
  • T43.656DUnderdosing of methamphetamines, subsequent encounter
  • T43.656SUnderdosing of methamphetamines, sequela
  • T43.695DAdverse effect of other psychostimulants, subsequent encounter
  • T43.695SAdverse effect of other psychostimulants, sequela
  • T43.8X5DAdverse effect of other psychotropic drugs, subsequent encounter
  • T43.8X5SAdverse effect of other psychotropic drugs, sequela
  • T43.95XDAdverse effect of unspecified psychotropic drug, subsequent encounter
  • T43.95XSAdverse effect of unspecified psychotropic drug, sequela
  • T44.0X5DAdverse effect of anticholinesterase agents, subsequent encounter
  • T44.0X5SAdverse effect of anticholinesterase agents, sequela
  • T44.1X5DAdverse effect of other parasympathomimetics [cholinergics], subsequent encounter
  • T44.1X5SAdverse effect of other parasympathomimetics [cholinergics], sequela
  • T44.2X5DAdverse effect of ganglionic blocking drugs, subsequent encounter
  • T44.2X5SAdverse effect of ganglionic blocking drugs, sequela
  • T44.3X5DAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
  • T44.3X5SAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
  • T44.4X5DAdverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
  • T44.4X5SAdverse effect of predominantly alpha-adrenoreceptor agonists, sequela
  • T44.5X5DAdverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
  • T44.5X5SAdverse effect of predominantly beta-adrenoreceptor agonists, sequela
  • T44.6X5DAdverse effect of alpha-adrenoreceptor antagonists, subsequent encounter
  • T44.6X5SAdverse effect of alpha-adrenoreceptor antagonists, sequela
  • T44.7X5DAdverse effect of beta-adrenoreceptor antagonists, subsequent encounter
  • T44.7X5SAdverse effect of beta-adrenoreceptor antagonists, sequela
  • T44.8X5DAdverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
  • T44.8X5SAdverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
  • T44.905DAdverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
  • T44.905SAdverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela
  • T44.995DAdverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter
  • T44.995SAdverse effect of other drug primarily affecting the autonomic nervous system, sequela
  • T45.0X5DAdverse effect of antiallergic and antiemetic drugs, subsequent encounter
  • T45.0X5SAdverse effect of antiallergic and antiemetic drugs, sequela
  • T45.1X1APoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), initial encounter
  • T45.1X1DPoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter
  • T45.1X1SPoisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), sequela
  • T45.1X2APoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, initial encounter
  • T45.1X2DPoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter
  • T45.1X2SPoisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, sequela
  • T45.1X3APoisoning by antineoplastic and immunosuppressive drugs, assault, initial encounter
  • T45.1X3DPoisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter
  • T45.1X3SPoisoning by antineoplastic and immunosuppressive drugs, assault, sequela
  • T45.1X4APoisoning by antineoplastic and immunosuppressive drugs, undetermined, initial encounter
  • T45.1X4DPoisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter
  • T45.1X4SPoisoning by antineoplastic and immunosuppressive drugs, undetermined, sequela
  • T45.1X5AAdverse effect of antineoplastic and immunosuppressive drugs, initial encounter
  • T45.1X5DAdverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
  • T45.1X5SAdverse effect of antineoplastic and immunosuppressive drugs, sequela
  • T45.2X5DAdverse effect of vitamins, subsequent encounter
  • T45.2X5SAdverse effect of vitamins, sequela
  • T45.3X5DAdverse effect of enzymes, subsequent encounter
  • T45.3X5SAdverse effect of enzymes, sequela
  • T45.4X5DAdverse effect of iron and its compounds, subsequent encounter
  • T45.4X5SAdverse effect of iron and its compounds, sequela
  • T45.515DAdverse effect of anticoagulants, subsequent encounter
  • T45.515SAdverse effect of anticoagulants, sequela
  • T45.525DAdverse effect of antithrombotic drugs, subsequent encounter
  • T45.525SAdverse effect of antithrombotic drugs, sequela
  • T45.605DAdverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
  • T45.605SAdverse effect of unspecified fibrinolysis-affecting drugs, sequela
  • T45.615DAdverse effect of thrombolytic drugs, subsequent encounter
  • T45.615SAdverse effect of thrombolytic drugs, sequela
  • T45.625DAdverse effect of hemostatic drug, subsequent encounter
  • T45.625SAdverse effect of hemostatic drug, sequela
  • T45.695DAdverse effect of other fibrinolysis-affecting drugs, subsequent encounter
  • T45.695SAdverse effect of other fibrinolysis-affecting drugs, sequela
  • T45.7X5DAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
  • T45.7X5SAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
  • T45.8X5DAdverse effect of other primarily systemic and hematological agents, subsequent encounter
  • T45.8X5SAdverse effect of other primarily systemic and hematological agents, sequela
  • T45.95XDAdverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
  • T45.95XSAdverse effect of unspecified primarily systemic and hematological agent, sequela
  • T46.0X5DAdverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
  • T46.0X5SAdverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
  • T46.1X5DAdverse effect of calcium-channel blockers, subsequent encounter
  • T46.1X5SAdverse effect of calcium-channel blockers, sequela
  • T46.2X5DAdverse effect of other antidysrhythmic drugs, subsequent encounter
  • T46.2X5SAdverse effect of other antidysrhythmic drugs, sequela
  • T46.3X5DAdverse effect of coronary vasodilators, subsequent encounter
  • T46.3X5SAdverse effect of coronary vasodilators, sequela
  • T46.4X5DAdverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
  • T46.4X5SAdverse effect of angiotensin-converting-enzyme inhibitors, sequela
  • T46.5X5DAdverse effect of other antihypertensive drugs, subsequent encounter
  • T46.5X5SAdverse effect of other antihypertensive drugs, sequela
  • T46.6X5DAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
  • T46.6X5SAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
  • T46.7X5DAdverse effect of peripheral vasodilators, subsequent encounter
  • T46.7X5SAdverse effect of peripheral vasodilators, sequela
  • T46.8X5DAdverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
  • T46.8X5SAdverse effect of antivaricose drugs, including sclerosing agents, sequela
  • T46.905DAdverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
  • T46.905SAdverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
  • T46.995DAdverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
  • T46.995SAdverse effect of other agents primarily affecting the cardiovascular system, sequela
  • T47.0X5DAdverse effect of histamine H2-receptor blockers, subsequent encounter
  • T47.0X5SAdverse effect of histamine H2-receptor blockers, sequela
  • T47.1X5DAdverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
  • T47.1X5SAdverse effect of other antacids and anti-gastric-secretion drugs, sequela
  • T47.2X5DAdverse effect of stimulant laxatives, subsequent encounter
  • T47.2X5SAdverse effect of stimulant laxatives, sequela
  • T47.3X5DAdverse effect of saline and osmotic laxatives, subsequent encounter
  • T47.3X5SAdverse effect of saline and osmotic laxatives, sequela
  • T47.4X5DAdverse effect of other laxatives, subsequent encounter
  • T47.4X5SAdverse effect of other laxatives, sequela
  • T47.5X5DAdverse effect of digestants, subsequent encounter
  • T47.5X5SAdverse effect of digestants, sequela
  • T47.6X5DAdverse effect of antidiarrheal drugs, subsequent encounter
  • T47.6X5SAdverse effect of antidiarrheal drugs, sequela
  • T47.7X5DAdverse effect of emetics, subsequent encounter
  • T47.7X5SAdverse effect of emetics, sequela
  • T47.8X5DAdverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
  • T47.8X5SAdverse effect of other agents primarily affecting gastrointestinal system, sequela
  • T47.95XDAdverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
  • T47.95XSAdverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
  • T48.0X5DAdverse effect of oxytocic drugs, subsequent encounter
  • T48.0X5SAdverse effect of oxytocic drugs, sequela
  • T48.1X5DAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
  • T48.1X5SAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
  • T48.205DAdverse effect of unspecified drugs acting on muscles, subsequent encounter
  • T48.205SAdverse effect of unspecified drugs acting on muscles, sequela
  • T48.295DAdverse effect of other drugs acting on muscles, subsequent encounter
  • T48.295SAdverse effect of other drugs acting on muscles, sequela
  • T48.3X5DAdverse effect of antitussives, subsequent encounter
  • T48.3X5SAdverse effect of antitussives, sequela
  • T48.4X5DAdverse effect of expectorants, subsequent encounter
  • T48.4X5SAdverse effect of expectorants, sequela
  • T48.5X5DAdverse effect of other anti-common-cold drugs, subsequent encounter
  • T48.5X5SAdverse effect of other anti-common-cold drugs, sequela
  • T48.6X5DAdverse effect of antiasthmatics, subsequent encounter
  • T48.6X5SAdverse effect of antiasthmatics, sequela
  • T48.905DAdverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter
  • T48.905SAdverse effect of unspecified agents primarily acting on the respiratory system, sequela
  • T48.995DAdverse effect of other agents primarily acting on the respiratory system, subsequent encounter
  • T48.995SAdverse effect of other agents primarily acting on the respiratory system, sequela
  • T49.0X5DAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
  • T49.0X5SAdverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
  • T49.1X5DAdverse effect of antipruritics, subsequent encounter
  • T49.1X5SAdverse effect of antipruritics, sequela
  • T49.2X5DAdverse effect of local astringents and local detergents, subsequent encounter
  • T49.2X5SAdverse effect of local astringents and local detergents, sequela
  • T49.3X5DAdverse effect of emollients, demulcents and protectants, subsequent encounter
  • T49.3X5SAdverse effect of emollients, demulcents and protectants, sequela
  • T49.4X5DAdverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
  • T49.4X5SAdverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
  • T49.5X5DAdverse effect of ophthalmological drugs and preparations, subsequent encounter
  • T49.5X5SAdverse effect of ophthalmological drugs and preparations, sequela
  • T49.6X5DAdverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
  • T49.6X5SAdverse effect of otorhinolaryngological drugs and preparations, sequela
  • T49.7X5DAdverse effect of dental drugs, topically applied, subsequent encounter
  • T49.7X5SAdverse effect of dental drugs, topically applied, sequela
  • T49.8X5DAdverse effect of other topical agents, subsequent encounter
  • T49.8X5SAdverse effect of other topical agents, sequela
  • T49.95XDAdverse effect of unspecified topical agent, subsequent encounter
  • T49.95XSAdverse effect of unspecified topical agent, sequela
  • T50.0X1APoisoning by mineralocorticoids and their antagonists, accidental (unintentional), initial encounter
  • T50.0X1DPoisoning by mineralocorticoids and their antagonists, accidental (unintentional), subsequent encounter
  • T50.0X1SPoisoning by mineralocorticoids and their antagonists, accidental (unintentional), sequela
  • T50.0X2APoisoning by mineralocorticoids and their antagonists, intentional self-harm, initial encounter
  • T50.0X2DPoisoning by mineralocorticoids and their antagonists, intentional self-harm, subsequent encounter
  • T50.0X2SPoisoning by mineralocorticoids and their antagonists, intentional self-harm, sequela
  • T50.0X3APoisoning by mineralocorticoids and their antagonists, assault, initial encounter
  • T50.0X3DPoisoning by mineralocorticoids and their antagonists, assault, subsequent encounter
  • T50.0X3SPoisoning by mineralocorticoids and their antagonists, assault, sequela
  • T50.0X4APoisoning by mineralocorticoids and their antagonists, undetermined, initial encounter
  • T50.0X4DPoisoning by mineralocorticoids and their antagonists, undetermined, subsequent encounter
  • T50.0X4SPoisoning by mineralocorticoids and their antagonists, undetermined, sequela
  • T50.0X5DAdverse effect of mineralocorticoids and their antagonists, subsequent encounter
  • T50.0X5SAdverse effect of mineralocorticoids and their antagonists, sequela
  • T50.1X5DAdverse effect of loop [high-ceiling] diuretics, subsequent encounter
  • T50.1X5SAdverse effect of loop [high-ceiling] diuretics, sequela
  • T50.2X5DAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
  • T50.2X5SAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
  • T50.3X5DAdverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
  • T50.3X5SAdverse effect of electrolytic, caloric and water-balance agents, sequela
  • T50.4X5DAdverse effect of drugs affecting uric acid metabolism, subsequent encounter
  • T50.4X5SAdverse effect of drugs affecting uric acid metabolism, sequela
  • T50.5X5DAdverse effect of appetite depressants, subsequent encounter
  • T50.5X5SAdverse effect of appetite depressants, sequela
  • T50.6X5DAdverse effect of antidotes and chelating agents, subsequent encounter
  • T50.6X5SAdverse effect of antidotes and chelating agents, sequela
  • T50.7X5DAdverse effect of analeptics and opioid receptor antagonists, subsequent encounter
  • T50.7X5SAdverse effect of analeptics and opioid receptor antagonists, sequela
  • T50.8X5DAdverse effect of diagnostic agents, subsequent encounter
  • T50.8X5SAdverse effect of diagnostic agents, sequela
  • T50.A15DAdverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
  • T50.A15SAdverse effect of pertussis vaccine, including combinations with a pertussis component, sequela
  • T50.A25DAdverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter
  • T50.A25SAdverse effect of mixed bacterial vaccines without a pertussis component, sequela
  • T50.A95DAdverse effect of other bacterial vaccines, subsequent encounter
  • T50.A95SAdverse effect of other bacterial vaccines, sequela
  • T50.B15DAdverse effect of smallpox vaccines, subsequent encounter
  • T50.B15SAdverse effect of smallpox vaccines, sequela
  • T50.B95DAdverse effect of other viral vaccines, subsequent encounter
  • T50.B95SAdverse effect of other viral vaccines, sequela
  • T50.Z15DAdverse effect of immunoglobulin, subsequent encounter
  • T50.Z15SAdverse effect of immunoglobulin, sequela
  • T50.Z95DAdverse effect of other vaccines and biological substances, subsequent encounter
  • T50.Z95SAdverse effect of other vaccines and biological substances, sequela
  • T50.905DAdverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter
  • T50.905SAdverse effect of unspecified drugs, medicaments and biological substances, sequela
  • T50.915AAdverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter
  • T50.915DAdverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
  • T50.915SAdverse effect of multiple unspecified drugs, medicaments and biological substances, sequela
  • T50.916AUnderdosing of multiple unspecified drugs, medicaments and biological substances, initial encounter
  • T50.916DUnderdosing of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
  • T50.916SUnderdosing of multiple unspecified drugs, medicaments and biological substances, sequela
  • T50.995DAdverse effect of other drugs, medicaments and biological substances, subsequent encounter
  • T50.995SAdverse effect of other drugs, medicaments and biological substances, sequela
  • T51.3X1AToxic effect of fusel oil, accidental (unintentional), initial encounter
  • T51.3X1DToxic effect of fusel oil, accidental (unintentional), subsequent encounter
  • T51.3X1SToxic effect of fusel oil, accidental (unintentional), sequela
  • T51.3X2AToxic effect of fusel oil, intentional self-harm, initial encounter
  • T51.3X2DToxic effect of fusel oil, intentional self-harm, subsequent encounter
  • T51.3X2SToxic effect of fusel oil, intentional self-harm, sequela
  • T51.3X3AToxic effect of fusel oil, assault, initial encounter
  • T51.3X3DToxic effect of fusel oil, assault, subsequent encounter
  • T51.3X3SToxic effect of fusel oil, assault, sequela
  • T51.3X4AToxic effect of fusel oil, undetermined, initial encounter
  • T51.3X4DToxic effect of fusel oil, undetermined, subsequent encounter
  • T51.3X4SToxic effect of fusel oil, undetermined, sequela
  • T58.01XAToxic effect of carbon monoxide from motor vehicle exhaust, accidental (unintentional), initial encounter
  • T58.01XDToxic effect of carbon monoxide from motor vehicle exhaust, accidental (unintentional), subsequent encounter
  • T58.01XSToxic effect of carbon monoxide from motor vehicle exhaust, accidental (unintentional), sequela
  • T58.02XAToxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, initial encounter
  • T58.02XDToxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, subsequent encounter
  • T58.02XSToxic effect of carbon monoxide from motor vehicle exhaust, intentional self-harm, sequela
  • T58.03XAToxic effect of carbon monoxide from motor vehicle exhaust, assault, initial encounter
  • T58.03XDToxic effect of carbon monoxide from motor vehicle exhaust, assault, subsequent encounter
  • T58.03XSToxic effect of carbon monoxide from motor vehicle exhaust, assault, sequela
  • T58.04XAToxic effect of carbon monoxide from motor vehicle exhaust, undetermined, initial encounter
  • T58.04XDToxic effect of carbon monoxide from motor vehicle exhaust, undetermined, subsequent encounter
  • T58.04XSToxic effect of carbon monoxide from motor vehicle exhaust, undetermined, sequela
  • T58.11XAToxic effect of carbon monoxide from utility gas, accidental (unintentional), initial encounter
  • T58.11XDToxic effect of carbon monoxide from utility gas, accidental (unintentional), subsequent encounter
  • T58.11XSToxic effect of carbon monoxide from utility gas, accidental (unintentional), sequela
  • T58.12XAToxic effect of carbon monoxide from utility gas, intentional self-harm, initial encounter
  • T58.12XDToxic effect of carbon monoxide from utility gas, intentional self-harm, subsequent encounter
  • T58.12XSToxic effect of carbon monoxide from utility gas, intentional self-harm, sequela
  • T58.13XAToxic effect of carbon monoxide from utility gas, assault, initial encounter
  • T58.13XDToxic effect of carbon monoxide from utility gas, assault, subsequent encounter
  • T58.13XSToxic effect of carbon monoxide from utility gas, assault, sequela
  • T58.14XAToxic effect of carbon monoxide from utility gas, undetermined, initial encounter
  • T58.14XDToxic effect of carbon monoxide from utility gas, undetermined, subsequent encounter
  • T58.14XSToxic effect of carbon monoxide from utility gas, undetermined, sequela
  • T58.2X1AToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, accidental (unintentional), initial encounter
  • T58.2X1DToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, accidental (unintentional), subsequent encounter
  • T58.2X1SToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, accidental (unintentional), sequela
  • T58.2X2AToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, initial encounter
  • T58.2X2DToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, subsequent encounter
  • T58.2X2SToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, intentional self-harm, sequela
  • T58.2X3AToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, assault, initial encounter
  • T58.2X3DToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, assault, subsequent encounter
  • T58.2X3SToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, assault, sequela
  • T58.2X4AToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, undetermined, initial encounter
  • T58.2X4DToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, undetermined, subsequent encounter
  • T58.2X4SToxic effect of carbon monoxide from incomplete combustion of other domestic fuels, undetermined, sequela
  • T58.8X1AToxic effect of carbon monoxide from other source, accidental (unintentional), initial encounter
  • T58.8X1DToxic effect of carbon monoxide from other source, accidental (unintentional), subsequent encounter
  • T58.8X1SToxic effect of carbon monoxide from other source, accidental (unintentional), sequela
  • T58.8X2AToxic effect of carbon monoxide from other source, intentional self-harm, initial encounter
  • T58.8X2DToxic effect of carbon monoxide from other source, intentional self-harm, subsequent encounter
  • T58.8X2SToxic effect of carbon monoxide from other source, intentional self-harm, sequela
  • T58.8X3AToxic effect of carbon monoxide from other source, assault, initial encounter
  • T58.8X3DToxic effect of carbon monoxide from other source, assault, subsequent encounter
  • T58.8X3SToxic effect of carbon monoxide from other source, assault, sequela
  • T58.8X4AToxic effect of carbon monoxide from other source, undetermined, initial encounter
  • T58.8X4DToxic effect of carbon monoxide from other source, undetermined, subsequent encounter
  • T58.8X4SToxic effect of carbon monoxide from other source, undetermined, sequela
  • T58.91XAToxic effect of carbon monoxide from unspecified source, accidental (unintentional), initial encounter
  • T58.91XDToxic effect of carbon monoxide from unspecified source, accidental (unintentional), subsequent encounter
  • T58.91XSToxic effect of carbon monoxide from unspecified source, accidental (unintentional), sequela
  • T58.92XAToxic effect of carbon monoxide from unspecified source, intentional self-harm, initial encounter
  • T58.92XDToxic effect of carbon monoxide from unspecified source, intentional self-harm, subsequent encounter
  • T58.92XSToxic effect of carbon monoxide from unspecified source, intentional self-harm, sequela
  • T58.93XAToxic effect of carbon monoxide from unspecified source, assault, initial encounter
  • T58.93XDToxic effect of carbon monoxide from unspecified source, assault, subsequent encounter
  • T58.93XSToxic effect of carbon monoxide from unspecified source, assault, sequela
  • T58.94XAToxic effect of carbon monoxide from unspecified source, undetermined, initial encounter
  • T58.94XDToxic effect of carbon monoxide from unspecified source, undetermined, subsequent encounter
  • T58.94XSToxic effect of carbon monoxide from unspecified source, undetermined, sequela
  • T66.XXXARadiation sickness, unspecified, initial encounter
  • T66.XXXDRadiation sickness, unspecified, subsequent encounter
  • T66.XXXSRadiation sickness, unspecified, sequela
  • T70.3XXACaisson disease [decompression sickness], initial encounter
  • T70.3XXDCaisson disease [decompression sickness], subsequent encounter
  • T70.3XXSCaisson disease [decompression sickness], sequela
  • T75.00XAUnspecified effects of lightning, initial encounter
  • T75.00XDUnspecified effects of lightning, subsequent encounter
  • T75.00XSUnspecified effects of lightning, sequela
  • T75.01XAShock due to being struck by lightning, initial encounter
  • T75.01XDShock due to being struck by lightning, subsequent encounter
  • T75.01XSShock due to being struck by lightning, sequela
  • T75.09XAOther effects of lightning, initial encounter
  • T75.09XDOther effects of lightning, subsequent encounter
  • T75.09XSOther effects of lightning, sequela
  • T75.4XXAElectrocution, initial encounter
  • T75.4XXDElectrocution, subsequent encounter
  • T75.4XXSElectrocution, sequela
  • T78.3XXAAngioneurotic edema, initial encounter
  • T78.3XXDAngioneurotic edema, subsequent encounter
  • T78.3XXSAngioneurotic edema, sequela
  • T79.0XXAAir embolism (traumatic), initial encounter
  • T79.0XXDAir embolism (traumatic), subsequent encounter
  • T79.0XXSAir embolism (traumatic), sequela
  • T79.1XXAFat embolism (traumatic), initial encounter
  • T79.1XXDFat embolism (traumatic), subsequent encounter
  • T79.1XXSFat embolism (traumatic), sequela
  • T79.4XXATraumatic shock, initial encounter
  • T79.4XXDTraumatic shock, subsequent encounter
  • T79.4XXSTraumatic shock, sequela
  • T80.0XXAAir embolism following infusion, transfusion and therapeutic injection, initial encounter
  • T80.0XXDAir embolism following infusion, transfusion and therapeutic injection, subsequent encounter
  • T80.0XXSAir embolism following infusion, transfusion and therapeutic injection, sequela
  • T80.211ABloodstream infection due to central venous catheter, initial encounter
  • T80.211DBloodstream infection due to central venous catheter, subsequent encounter
  • T80.211SBloodstream infection due to central venous catheter, sequela
  • T80.212ALocal infection due to central venous catheter, initial encounter
  • T80.212DLocal infection due to central venous catheter, subsequent encounter
  • T80.212SLocal infection due to central venous catheter, sequela
  • T80.218AOther infection due to central venous catheter, initial encounter
  • T80.218DOther infection due to central venous catheter, subsequent encounter
  • T80.218SOther infection due to central venous catheter, sequela
  • T80.219AUnspecified infection due to central venous catheter, initial encounter
  • T80.219DUnspecified infection due to central venous catheter, subsequent encounter
  • T80.219SUnspecified infection due to central venous catheter, sequela
  • T80.22XAAcute infection following transfusion, infusion, or injection of blood and blood products, initial encounter
  • T80.22XDAcute infection following transfusion, infusion, or injection of blood and blood products, subsequent encounter
  • T80.22XSAcute infection following transfusion, infusion, or injection of blood and blood products, sequela
  • T80.29XAInfection following other infusion, transfusion and therapeutic injection, initial encounter
  • T80.29XDInfection following other infusion, transfusion and therapeutic injection, subsequent encounter
  • T80.29XSInfection following other infusion, transfusion and therapeutic injection, sequela
  • T81.10XAPostprocedural shock unspecified, initial encounter
  • T81.10XDPostprocedural shock unspecified, subsequent encounter
  • T81.10XSPostprocedural shock unspecified, sequela
  • T81.11XAPostprocedural cardiogenic shock, initial encounter
  • T81.11XDPostprocedural cardiogenic shock, subsequent encounter
  • T81.11XSPostprocedural cardiogenic shock, sequela
  • T81.12XAPostprocedural septic shock, initial encounter
  • T81.12XDPostprocedural septic shock, subsequent encounter
  • T81.12XSPostprocedural septic shock, sequela
  • T81.19XAOther postprocedural shock, initial encounter
  • T81.19XDOther postprocedural shock, subsequent encounter
  • T81.19XSOther postprocedural shock, sequela
  • T81.40XAInfection following a procedure, unspecified, initial encounter
  • T81.40XDInfection following a procedure, unspecified, subsequent encounter
  • T81.40XSInfection following a procedure, unspecified, sequela
  • T81.41XAInfection following a procedure, superficial incisional surgical site, initial encounter
  • T81.41XDInfection following a procedure, superficial incisional surgical site, subsequent encounter
  • T81.41XSInfection following a procedure, superficial incisional surgical site, sequela
  • T81.42XAInfection following a procedure, deep incisional surgical site, initial encounter
  • T81.42XDInfection following a procedure, deep incisional surgical site, subsequent encounter
  • T81.42XSInfection following a procedure, deep incisional surgical site, sequela
  • T81.43XAInfection following a procedure, organ and space surgical site, initial encounter
  • T81.43XDInfection following a procedure, organ and space surgical site, subsequent encounter
  • T81.43XSInfection following a procedure, organ and space surgical site, sequela
  • T81.44XASepsis following a procedure, initial encounter
  • T81.44XDSepsis following a procedure, subsequent encounter
  • T81.44XSSepsis following a procedure, sequela
  • T81.49XAInfection following a procedure, other surgical site, initial encounter
  • T81.49XDInfection following a procedure, other surgical site, subsequent encounter
  • T81.49XSInfection following a procedure, other surgical site, sequela
  • T82.01XABreakdown (mechanical) of heart valve prosthesis, initial encounter
  • T82.01XDBreakdown (mechanical) of heart valve prosthesis, subsequent encounter
  • T82.01XSBreakdown (mechanical) of heart valve prosthesis, sequela
  • T82.110ABreakdown (mechanical) of cardiac electrode, initial encounter
  • T82.110DBreakdown (mechanical) of cardiac electrode, subsequent encounter
  • T82.110SBreakdown (mechanical) of cardiac electrode, sequela
  • T82.111ABreakdown (mechanical) of cardiac pulse generator (battery), initial encounter
  • T82.111DBreakdown (mechanical) of cardiac pulse generator (battery), subsequent encounter
  • T82.111SBreakdown (mechanical) of cardiac pulse generator (battery), sequela
  • T82.118ABreakdown (mechanical) of other cardiac electronic device, initial encounter
  • T82.118DBreakdown (mechanical) of other cardiac electronic device, subsequent encounter
  • T82.118SBreakdown (mechanical) of other cardiac electronic device, sequela
  • T82.120ADisplacement of cardiac electrode, initial encounter
  • T82.120DDisplacement of cardiac electrode, subsequent encounter
  • T82.120SDisplacement of cardiac electrode, sequela
  • T82.121ADisplacement of cardiac pulse generator (battery), initial encounter
  • T82.121DDisplacement of cardiac pulse generator (battery), subsequent encounter
  • T82.121SDisplacement of cardiac pulse generator (battery), sequela
  • T82.128ADisplacement of other cardiac electronic device, initial encounter
  • T82.128DDisplacement of other cardiac electronic device, subsequent encounter
  • T82.128SDisplacement of other cardiac electronic device, sequela
  • T82.129ADisplacement of unspecified cardiac electronic device, initial encounter
  • T82.129DDisplacement of unspecified cardiac electronic device, subsequent encounter
  • T82.129SDisplacement of unspecified cardiac electronic device, sequela
  • T82.190AOther mechanical complication of cardiac electrode, initial encounter
  • T82.190DOther mechanical complication of cardiac electrode, subsequent encounter
  • T82.190SOther mechanical complication of cardiac electrode, sequela
  • T82.191AOther mechanical complication of cardiac pulse generator (battery), initial encounter
  • T82.191DOther mechanical complication of cardiac pulse generator (battery), subsequent encounter
  • T82.191SOther mechanical complication of cardiac pulse generator (battery), sequela
  • T82.198AOther mechanical complication of other cardiac electronic device, initial encounter
  • T82.198DOther mechanical complication of other cardiac electronic device, subsequent encounter
  • T82.198SOther mechanical complication of other cardiac electronic device, sequela
  • T82.211ABreakdown (mechanical) of coronary artery bypass graft, initial encounter
  • T82.211DBreakdown (mechanical) of coronary artery bypass graft, subsequent encounter
  • T82.211SBreakdown (mechanical) of coronary artery bypass graft, sequela
  • T82.221ABreakdown (mechanical) of biological heart valve graft, initial encounter
  • T82.221DBreakdown (mechanical) of biological heart valve graft, subsequent encounter
  • T82.221SBreakdown (mechanical) of biological heart valve graft, sequela
  • T82.512ABreakdown (mechanical) of artificial heart, initial encounter
  • T82.512DBreakdown (mechanical) of artificial heart, subsequent encounter
  • T82.512SBreakdown (mechanical) of artificial heart, sequela
  • T82.513ABreakdown (mechanical) of balloon (counterpulsation) device, initial encounter
  • T82.513DBreakdown (mechanical) of balloon (counterpulsation) device, subsequent encounter
  • T82.513SBreakdown (mechanical) of balloon (counterpulsation) device, sequela
  • T82.518ABreakdown (mechanical) of other cardiac and vascular devices and implants, initial encounter
  • T82.518DBreakdown (mechanical) of other cardiac and vascular devices and implants, subsequent encounter
  • T82.518SBreakdown (mechanical) of other cardiac and vascular devices and implants, sequela
  • T82.528ADisplacement of other cardiac and vascular devices and implants, initial encounter
  • T82.528DDisplacement of other cardiac and vascular devices and implants, subsequent encounter
  • T82.528SDisplacement of other cardiac and vascular devices and implants, sequela
  • T82.598AOther mechanical complication of other cardiac and vascular devices and implants, initial encounter
  • T82.598DOther mechanical complication of other cardiac and vascular devices and implants, subsequent encounter
  • T82.598SOther mechanical complication of other cardiac and vascular devices and implants, sequela
  • T82.6XXAInfection and inflammatory reaction due to cardiac valve prosthesis, initial encounter
  • T82.6XXDInfection and inflammatory reaction due to cardiac valve prosthesis, subsequent encounter
  • T82.6XXSInfection and inflammatory reaction due to cardiac valve prosthesis, sequela
  • T82.7XXAInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter
  • T82.7XXDInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, subsequent encounter
  • T82.7XXSInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, sequela
  • T82.817AEmbolism due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.817DEmbolism due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.817SEmbolism due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.827AFibrosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.827DFibrosis due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.827SFibrosis due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.837AHemorrhage due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.837DHemorrhage due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.837SHemorrhage due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.847APain due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.847DPain due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.847SPain due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.857AStenosis of other cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.857DStenosis of other cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.857SStenosis of other cardiac prosthetic devices, implants and grafts, sequela
  • T82.867AThrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.867DThrombosis due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.867SThrombosis due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.897AOther specified complication of cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.897DOther specified complication of cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.897SOther specified complication of cardiac prosthetic devices, implants and grafts, sequela
  • T86.20Unspecified complication of heart transplant
  • T86.21Heart transplant rejection
  • T86.22Heart transplant failure
  • T86.23Heart transplant infection
  • T86.290Cardiac allograft vasculopathy
  • T86.298Other complications of heart transplant
  • T86.30Unspecified complication of heart-lung transplant
  • T86.31Heart-lung transplant rejection
  • T86.32Heart-lung transplant failure
  • T86.33Heart-lung transplant infection
  • T86.39Other complications of heart-lung transplant
  • T88.0XXAInfection following immunization, initial encounter
  • T88.0XXDInfection following immunization, subsequent encounter
  • T88.0XXSInfection following immunization, sequela
  • T88.6XXDAnaphylactic reaction due to adverse effect of correct drug or medicament properly administered, subsequent encounter
  • T88.6XXSAnaphylactic reaction due to adverse effect of correct drug or medicament properly administered, sequela
  • X83.1XXAIntentional self-harm by electrocution, initial encounter
  • X83.1XXDIntentional self-harm by electrocution, subsequent encounter
  • X83.1XXSIntentional self-harm by electrocution, sequela
  • Z01.810Encounter for preprocedural cardiovascular examination
  • Z01.89Encounter for other specified special examinations
  • Z08Encounter for follow-up examination after completed treatment for malignant neoplasm
  • Z48.21Encounter for aftercare following heart transplant
  • Z48.24Encounter for aftercare following lung transplant
  • Z48.280Encounter for aftercare following heart-lung transplant
  • Z79.85Long-term (current) use of injectable non-insulin antidiabetic drugs
  • Z79.899Other long term (current) drug therapy
  • Z94.1Heart transplant status
  • Z94.2Lung transplant status
  • Z94.3Heart and lungs transplant status
  • Z95.2Presence of prosthetic heart valve
  • Z95.3Presence of xenogenic heart valve
  • Z95.4Presence of other heart-valve replacement

Group 3 · 784 codes

  • A18.84Tuberculosis of heart
  • A52.01Syphilitic aneurysm of aorta
  • A52.02Syphilitic aortitis
  • A52.03Syphilitic endocarditis
  • A52.06Other syphilitic heart involvement
  • A54.83Gonococcal heart infection
  • B33.20Viral carditis, unspecified
  • B33.21Viral endocarditis
  • B33.22Viral myocarditis
  • B33.23Viral pericarditis
  • B37.6Candidal endocarditis
  • B44.81Allergic bronchopulmonary aspergillosis
  • B57.0Acute Chagas' disease with heart involvement
  • B57.2Chagas' disease (chronic) with heart involvement
  • B58.81Toxoplasma myocarditis
  • C38.0Malignant neoplasm of heart
  • C38.8Malignant neoplasm of overlapping sites of heart, mediastinum and pleura
  • C45.2Mesothelioma of pericardium
  • D15.1Benign neoplasm of heart
  • E83.110Hereditary hemochromatosis
  • E83.111Hemochromatosis due to repeated red blood cell transfusions
  • E83.118Other hemochromatosis
  • E83.119Hemochromatosis, unspecified
  • E83.19Other disorders of iron metabolism
  • E85.0Non-neuropathic heredofamilial amyloidosis
  • E85.1Neuropathic heredofamilial amyloidosis
  • E85.2Heredofamilial amyloidosis, unspecified
  • E85.3Secondary systemic amyloidosis
  • E85.4Organ-limited amyloidosis
  • E85.81Light chain (AL) amyloidosis
  • E85.82Wild-type transthyretin-related (ATTR) amyloidosis
  • E85.89Other amyloidosis
  • E85.9Amyloidosis, unspecified
  • E87.70Fluid overload, unspecified
  • E87.71Transfusion associated circulatory overload
  • E87.79Other fluid overload
  • G45.1Carotid artery syndrome (hemispheric)
  • G45.2Multiple and bilateral precerebral artery syndromes
  • G45.3Amaurosis fugax
  • G45.8Other transient cerebral ischemic attacks and related syndromes
  • G45.9Transient cerebral ischemic attack, unspecified
  • G46.0Middle cerebral artery syndrome
  • G46.1Anterior cerebral artery syndrome
  • G46.2Posterior cerebral artery syndrome
  • H34.01Transient retinal artery occlusion, right eye
  • H34.02Transient retinal artery occlusion, left eye
  • H34.03Transient retinal artery occlusion, bilateral
  • I01.0Acute rheumatic pericarditis
  • I01.1Acute rheumatic endocarditis
  • I01.2Acute rheumatic myocarditis
  • I01.8Other acute rheumatic heart disease
  • I02.0Rheumatic chorea with heart involvement
  • I05.0Rheumatic mitral stenosis
  • I05.1Rheumatic mitral insufficiency
  • I05.2Rheumatic mitral stenosis with insufficiency
  • I05.8Other rheumatic mitral valve diseases
  • I05.9Rheumatic mitral valve disease, unspecified
  • I06.0Rheumatic aortic stenosis
  • I06.1Rheumatic aortic insufficiency
  • I06.2Rheumatic aortic stenosis with insufficiency
  • I06.8Other rheumatic aortic valve diseases
  • I06.9Rheumatic aortic valve disease, unspecified
  • I07.0Rheumatic tricuspid stenosis
  • I07.1Rheumatic tricuspid insufficiency
  • I07.2Rheumatic tricuspid stenosis and insufficiency
  • I07.8Other rheumatic tricuspid valve diseases
  • I07.9Rheumatic tricuspid valve disease, unspecified
  • I08.0Rheumatic disorders of both mitral and aortic valves
  • I08.1Rheumatic disorders of both mitral and tricuspid valves
  • I08.2Rheumatic disorders of both aortic and tricuspid valves
  • I08.3Combined rheumatic disorders of mitral, aortic and tricuspid valves
  • I08.8Other rheumatic multiple valve diseases
  • I08.9Rheumatic multiple valve disease, unspecified
  • I09.0Rheumatic myocarditis
  • I09.1Rheumatic diseases of endocardium, valve unspecified
  • I09.2Chronic rheumatic pericarditis
  • I09.81Rheumatic heart failure
  • I09.89Other specified rheumatic heart diseases
  • I09.9Rheumatic heart disease, unspecified
  • I10Essential (primary) hypertension
  • I11.0Hypertensive heart disease with heart failure
  • I11.9Hypertensive heart disease without heart failure
  • I12.0Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease
  • I12.9Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
  • I13.0Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
  • I13.10Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
  • I13.11Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
  • I13.2Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
  • I15.0Renovascular hypertension
  • I15.1Hypertension secondary to other renal disorders
  • I15.8Other secondary hypertension
  • I20.0Unstable angina
  • I20.1Angina pectoris with documented spasm
  • I20.81Angina pectoris with coronary microvascular dysfunction
  • I20.89Other forms of angina pectoris
  • I20.9Angina pectoris, unspecified
  • I21.01ST elevation (STEMI) myocardial infarction involving left main coronary artery
  • I21.02ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
  • I21.09ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall
  • I21.11ST elevation (STEMI) myocardial infarction involving right coronary artery
  • I21.19ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
  • I21.21ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery
  • I21.29ST elevation (STEMI) myocardial infarction involving other sites
  • I21.4Non-ST elevation (NSTEMI) myocardial infarction
  • I21.9Acute myocardial infarction, unspecified
  • I21.A1Myocardial infarction type 2
  • I21.A9Other myocardial infarction type
  • I21.BMyocardial infarction with coronary microvascular dysfunction
  • I22.0Subsequent ST elevation (STEMI) myocardial infarction of anterior wall
  • I22.1Subsequent ST elevation (STEMI) myocardial infarction of inferior wall
  • I22.2Subsequent non-ST elevation (NSTEMI) myocardial infarction
  • I22.8Subsequent ST elevation (STEMI) myocardial infarction of other sites
  • I23.0Hemopericardium as current complication following acute myocardial infarction
  • I23.1Atrial septal defect as current complication following acute myocardial infarction
  • I23.2Ventricular septal defect as current complication following acute myocardial infarction
  • I23.3Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction
  • I23.4Rupture of chordae tendineae as current complication following acute myocardial infarction
  • I23.5Rupture of papillary muscle as current complication following acute myocardial infarction
  • I23.6Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction
  • I23.7Postinfarction angina
  • I23.8Other current complications following acute myocardial infarction
  • I24.0Acute coronary thrombosis not resulting in myocardial infarction
  • I24.1Dressler's syndrome
  • I24.81Acute coronary microvascular dysfunction
  • I24.89Other forms of acute ischemic heart disease
  • I24.9Acute ischemic heart disease, unspecified
  • I25.10Atherosclerotic heart disease of native coronary artery without angina pectoris
  • I25.110Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
  • I25.111Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm
  • I25.112Atherosclerotic heart disease of native coronary artery with refractory angina pectoris
  • I25.118Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
  • I25.119Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris
  • I25.2Old myocardial infarction
  • I25.3Aneurysm of heart
  • I25.41Coronary artery aneurysm
  • I25.42Coronary artery dissection
  • I25.5Ischemic cardiomyopathy
  • I25.6Silent myocardial ischemia
  • I25.700Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris
  • I25.701Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm
  • I25.702Atherosclerosis of coronary artery bypass graft(s), unspecified, with refractory angina pectoris
  • I25.708Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris
  • I25.709Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris
  • I25.710Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris
  • I25.711Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.712Atherosclerosis of autologous vein coronary artery bypass graft(s) with refractory angina pectoris
  • I25.718Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.719Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.720Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris
  • I25.721Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.722Atherosclerosis of autologous artery coronary artery bypass graft(s) with refractory angina pectoris
  • I25.728Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.729Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.730Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris
  • I25.731Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.732Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris
  • I25.738Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.739Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.750Atherosclerosis of native coronary artery of transplanted heart with unstable angina
  • I25.751Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm
  • I25.752Atherosclerosis of native coronary artery of transplanted heart with refractory angina pectoris
  • I25.758Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris
  • I25.759Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris
  • I25.760Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina
  • I25.761Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm
  • I25.762Atherosclerosis of bypass graft of coronary artery of transplanted heart with refractory angina pectoris
  • I25.768Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris
  • I25.769Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris
  • I25.790Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris
  • I25.791Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.792Atherosclerosis of other coronary artery bypass graft(s) with refractory angina pectoris
  • I25.798Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.799Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.810Atherosclerosis of coronary artery bypass graft(s) without angina pectoris
  • I25.811Atherosclerosis of native coronary artery of transplanted heart without angina pectoris
  • I25.812Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris
  • I25.82Chronic total occlusion of coronary artery
  • I25.85Chronic coronary microvascular dysfunction
  • I25.89Other forms of chronic ischemic heart disease
  • I25.9Chronic ischemic heart disease, unspecified
  • I26.01Septic pulmonary embolism with acute cor pulmonale
  • I26.02Saddle embolus of pulmonary artery with acute cor pulmonale
  • I26.03Cement embolism of pulmonary artery with acute cor pulmonale
  • I26.04Fat embolism of pulmonary artery with acute cor pulmonale
  • I26.09Other pulmonary embolism with acute cor pulmonale
  • I26.90Septic pulmonary embolism without acute cor pulmonale
  • I26.93Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale
  • I26.94Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale
  • I26.95Cement embolism of pulmonary artery without acute cor pulmonale
  • I26.96Fat embolism of pulmonary artery without acute cor pulmonale
  • I27.0Primary pulmonary hypertension
  • I27.20Pulmonary hypertension, unspecified
  • I27.21Secondary pulmonary arterial hypertension
  • I27.22Pulmonary hypertension due to left heart disease
  • I27.23Pulmonary hypertension due to lung diseases and hypoxia
  • I27.24Chronic thromboembolic pulmonary hypertension
  • I27.29Other secondary pulmonary hypertension
  • I27.82Chronic pulmonary embolism
  • I27.83Eisenmenger's syndrome
  • I27.840Fontan-associated liver disease [FALD]
  • I27.841Fontan-associated lymphatic dysfunction
  • I27.848Other Fontan-associated condition
  • I27.849Fontan related circulation, unspecified
  • I27.89Other specified pulmonary heart diseases
  • I28.0Arteriovenous fistula of pulmonary vessels
  • I28.1Aneurysm of pulmonary artery
  • I30.0Acute nonspecific idiopathic pericarditis
  • I30.1Infective pericarditis
  • I30.8Other forms of acute pericarditis
  • I30.9Acute pericarditis, unspecified
  • I31.0Chronic adhesive pericarditis
  • I31.1Chronic constrictive pericarditis
  • I31.2Hemopericardium, not elsewhere classified
  • I31.4Cardiac tamponade
  • I31.8Other specified diseases of pericardium
  • I31.9Disease of pericardium, unspecified
  • I32Pericarditis in diseases classified elsewhere
  • I33.0Acute and subacute infective endocarditis
  • I33.9Acute and subacute endocarditis, unspecified
  • I34.0Nonrheumatic mitral (valve) insufficiency
  • I34.1Nonrheumatic mitral (valve) prolapse
  • I34.2Nonrheumatic mitral (valve) stenosis
  • I34.9Nonrheumatic mitral valve disorder, unspecified
  • I35.0Nonrheumatic aortic (valve) stenosis
  • I35.1Nonrheumatic aortic (valve) insufficiency
  • I35.2Nonrheumatic aortic (valve) stenosis with insufficiency
  • I35.8Other nonrheumatic aortic valve disorders
  • I35.9Nonrheumatic aortic valve disorder, unspecified
  • I36.0Nonrheumatic tricuspid (valve) stenosis
  • I36.1Nonrheumatic tricuspid (valve) insufficiency
  • I36.2Nonrheumatic tricuspid (valve) stenosis with insufficiency
  • I36.8Other nonrheumatic tricuspid valve disorders
  • I36.9Nonrheumatic tricuspid valve disorder, unspecified
  • I37.0Nonrheumatic pulmonary valve stenosis
  • I37.1Nonrheumatic pulmonary valve insufficiency
  • I37.2Nonrheumatic pulmonary valve stenosis with insufficiency
  • I37.8Other nonrheumatic pulmonary valve disorders
  • I37.9Nonrheumatic pulmonary valve disorder, unspecified
  • I38Endocarditis, valve unspecified
  • I39Endocarditis and heart valve disorders in diseases classified elsewhere
  • I40.0Infective myocarditis
  • I40.1Isolated myocarditis
  • I40.8Other acute myocarditis
  • I41Myocarditis in diseases classified elsewhere
  • I42.00Dilated cardiomyopathy, unspecified
  • I42.01Familial-genetic dilated cardiomyopathy
  • I42.09Other dilated cardiomyopathy
  • I42.1Obstructive hypertrophic cardiomyopathy
  • I42.2Other hypertrophic cardiomyopathy
  • I42.3Endomyocardial (eosinophilic) disease
  • I42.4Endocardial fibroelastosis
  • I42.5Other restrictive cardiomyopathy
  • I42.6Alcoholic cardiomyopathy
  • I42.7Cardiomyopathy due to drug and external agent
  • I42.81Arrhythmogenic cardiomyopathy
  • I42.89Other cardiomyopathies not elsewhere classified
  • I42.9Cardiomyopathy, unspecified
  • I43Cardiomyopathy in diseases classified elsewhere
  • I44.0Atrioventricular block, first degree
  • I44.1Atrioventricular block, second degree
  • I44.2Atrioventricular block, complete
  • I44.30Unspecified atrioventricular block
  • I44.4Left anterior fascicular block
  • I44.5Left posterior fascicular block
  • I44.60Unspecified fascicular block
  • I44.69Other fascicular block
  • I44.7Left bundle-branch block, unspecified
  • I45.0Right fascicular block
  • I45.10Unspecified right bundle-branch block
  • I45.19Other right bundle-branch block
  • I46.2Cardiac arrest due to underlying cardiac condition
  • I46.8Cardiac arrest due to other underlying condition
  • I46.9Cardiac arrest, cause unspecified
  • I47.0Re-entry ventricular arrhythmia
  • I47.11Inappropriate sinus tachycardia, so stated
  • I48.0Paroxysmal atrial fibrillation
  • I48.11Longstanding persistent atrial fibrillation
  • I48.19Other persistent atrial fibrillation
  • I48.20Chronic atrial fibrillation, unspecified
  • I48.21Permanent atrial fibrillation
  • I48.3Typical atrial flutter
  • I48.4Atypical atrial flutter
  • I48.91Unspecified atrial fibrillation
  • I48.92Unspecified atrial flutter
  • I49.01Ventricular fibrillation
  • I49.02Ventricular flutter
  • I49.2Junctional premature depolarization
  • I49.5Sick sinus syndrome
  • I50.1Left ventricular failure, unspecified
  • I50.20Unspecified systolic (congestive) heart failure
  • I50.21Acute systolic (congestive) heart failure
  • I50.22Chronic systolic (congestive) heart failure
  • I50.23Acute on chronic systolic (congestive) heart failure
  • I50.30Unspecified diastolic (congestive) heart failure
  • I50.31Acute diastolic (congestive) heart failure
  • I50.32Chronic diastolic (congestive) heart failure
  • I50.33Acute on chronic diastolic (congestive) heart failure
  • I50.40Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.41Acute combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.42Chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.43Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.810Right heart failure, unspecified
  • I50.811Acute right heart failure
  • I50.812Chronic right heart failure
  • I50.813Acute on chronic right heart failure
  • I50.814Right heart failure due to left heart failure
  • I50.82Biventricular heart failure
  • I50.83High output heart failure
  • I50.84End stage heart failure
  • I50.89Other heart failure
  • I50.9Heart failure, unspecified
  • I51.0Cardiac septal defect, acquired
  • I51.1Rupture of chordae tendineae, not elsewhere classified
  • I51.2Rupture of papillary muscle, not elsewhere classified
  • I51.3Intracardiac thrombosis, not elsewhere classified
  • I51.4Myocarditis, unspecified
  • I51.5Myocardial degeneration
  • I51.7Cardiomegaly
  • I51.81Takotsubo syndrome
  • I51.89Other ill-defined heart diseases
  • I51.9Heart disease, unspecified
  • I52Other heart disorders in diseases classified elsewhere
  • I63.411Cerebral infarction due to embolism of right middle cerebral artery
  • I63.412Cerebral infarction due to embolism of left middle cerebral artery
  • I63.421Cerebral infarction due to embolism of right anterior cerebral artery
  • I63.422Cerebral infarction due to embolism of left anterior cerebral artery
  • I63.431Cerebral infarction due to embolism of right posterior cerebral artery
  • I63.432Cerebral infarction due to embolism of left posterior cerebral artery
  • I63.441Cerebral infarction due to embolism of right cerebellar artery
  • I63.442Cerebral infarction due to embolism of left cerebellar artery
  • I63.49Cerebral infarction due to embolism of other cerebral artery
  • I63.511Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery
  • I63.512Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery
  • I63.521Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery
  • I63.522Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery
  • I63.531Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery
  • I63.532Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery
  • I63.541Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery
  • I63.542Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery
  • I63.59Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery
  • I63.81Other cerebral infarction due to occlusion or stenosis of small artery
  • I63.89Other cerebral infarction
  • I66.01Occlusion and stenosis of right middle cerebral artery
  • I66.02Occlusion and stenosis of left middle cerebral artery
  • I66.03Occlusion and stenosis of bilateral middle cerebral arteries
  • I66.11Occlusion and stenosis of right anterior cerebral artery
  • I66.12Occlusion and stenosis of left anterior cerebral artery
  • I66.13Occlusion and stenosis of bilateral anterior cerebral arteries
  • I66.21Occlusion and stenosis of right posterior cerebral artery
  • I66.22Occlusion and stenosis of left posterior cerebral artery
  • I66.23Occlusion and stenosis of bilateral posterior cerebral arteries
  • I66.29Occlusion and stenosis of unspecified posterior cerebral artery
  • I66.3Occlusion and stenosis of cerebellar arteries
  • I66.8Occlusion and stenosis of other cerebral arteries
  • I67.841Reversible cerebrovascular vasoconstriction syndrome
  • I67.848Other cerebrovascular vasospasm and vasoconstriction
  • I67.89Other cerebrovascular disease
  • I70.0Atherosclerosis of aorta
  • I71.010Dissection of ascending aorta
  • I71.011Dissection of aortic arch
  • I71.012Dissection of descending thoracic aorta
  • I71.019Dissection of thoracic aorta, unspecified
  • I71.03Dissection of thoracoabdominal aorta
  • I74.11Embolism and thrombosis of thoracic aorta
  • I79.0Aneurysm of aorta in diseases classified elsewhere
  • I87.1Compression of vein
  • I95.1Orthostatic hypotension
  • I95.89Other hypotension
  • I95.9Hypotension, unspecified
  • I97.0Postcardiotomy syndrome
  • I97.110Postprocedural cardiac insufficiency following cardiac surgery
  • I97.111Postprocedural cardiac insufficiency following other surgery
  • I97.120Postprocedural cardiac arrest following cardiac surgery
  • I97.121Postprocedural cardiac arrest following other surgery
  • I97.130Postprocedural heart failure following cardiac surgery
  • I97.131Postprocedural heart failure following other surgery
  • I97.190Other postprocedural cardiac functional disturbances following cardiac surgery
  • I97.710Intraoperative cardiac arrest during cardiac surgery
  • I97.711Intraoperative cardiac arrest during other surgery
  • I97.790Other intraoperative cardiac functional disturbances during cardiac surgery
  • I97.791Other intraoperative cardiac functional disturbances during other surgery
  • I97.88Other intraoperative complications of the circulatory system, not elsewhere classified
  • I97.89Other postprocedural complications and disorders of the circulatory system, not elsewhere classified
  • J80Acute respiratory distress syndrome
  • J81.0Acute pulmonary edema
  • J95.1Acute pulmonary insufficiency following thoracic surgery
  • J95.2Acute pulmonary insufficiency following nonthoracic surgery
  • J95.3Chronic pulmonary insufficiency following surgery
  • J95.821Acute postprocedural respiratory failure
  • J95.822Acute and chronic postprocedural respiratory failure
  • J95.84Transfusion-related acute lung injury (TRALI)
  • J95.87Transfusion-associated dyspnea (TAD)
  • J96.00Acute respiratory failure, unspecified whether with hypoxia or hypercapnia
  • J96.01Acute respiratory failure with hypoxia
  • J96.02Acute respiratory failure with hypercapnia
  • J96.20Acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia
  • J96.21Acute and chronic respiratory failure with hypoxia
  • J96.22Acute and chronic respiratory failure with hypercapnia
  • K68.11Postprocedural retroperitoneal abscess
  • K68.3Retroperitoneal hematoma
  • M30.3Mucocutaneous lymph node syndrome [Kawasaki]
  • M31.4Aortic arch syndrome [Takayasu]
  • M32.0Drug-induced systemic lupus erythematosus
  • M32.11Endocarditis in systemic lupus erythematosus
  • M32.12Pericarditis in systemic lupus erythematosus
  • M32.19Other organ or system involvement in systemic lupus erythematosus
  • M32.8Other forms of systemic lupus erythematosus
  • Q20.0Common arterial trunk
  • Q20.1Double outlet right ventricle
  • Q20.2Double outlet left ventricle
  • Q20.3Discordant ventriculoarterial connection
  • Q20.4Double inlet ventricle
  • Q20.5Discordant atrioventricular connection
  • Q20.6Isomerism of atrial appendages
  • Q20.8Other congenital malformations of cardiac chambers and connections
  • Q21.0Ventricular septal defect
  • Q21.10Atrial septal defect, unspecified
  • Q21.11Secundum atrial septal defect
  • Q21.12Patent foramen ovale
  • Q21.13Coronary sinus atrial septal defect
  • Q21.14Superior sinus venosus atrial septal defect
  • Q21.15Inferior sinus venosus atrial septal defect
  • Q21.16Sinus venosus atrial septal defect, unspecified
  • Q21.19Other specified atrial septal defect
  • Q21.20Atrioventricular septal defect, unspecified as to partial or complete
  • Q21.21Partial atrioventricular septal defect
  • Q21.22Transitional atrioventricular septal defect
  • Q21.23Complete atrioventricular septal defect
  • Q21.3Tetralogy of Fallot
  • Q21.4Aortopulmonary septal defect
  • Q21.8Other congenital malformations of cardiac septa
  • Q21.9Congenital malformation of cardiac septum, unspecified
  • Q22.0Pulmonary valve atresia
  • Q22.1Congenital pulmonary valve stenosis
  • Q22.2Congenital pulmonary valve insufficiency
  • Q22.3Other congenital malformations of pulmonary valve
  • Q22.4Congenital tricuspid stenosis
  • Q22.5Ebstein's anomaly
  • Q22.6Hypoplastic right heart syndrome
  • Q22.8Other congenital malformations of tricuspid valve
  • Q22.9Congenital malformation of tricuspid valve, unspecified
  • Q23.0Congenital stenosis of aortic valve
  • Q23.1Congenital insufficiency of aortic valve
  • Q23.2Congenital mitral stenosis
  • Q23.3Congenital mitral insufficiency
  • Q23.4Hypoplastic left heart syndrome
  • Q23.81Bicuspid aortic valve
  • Q23.82Congenital mitral valve cleft leaflet
  • Q23.88Other congenital malformations of aortic and mitral valves
  • Q23.9Congenital malformation of aortic and mitral valves, unspecified
  • Q24.0Dextrocardia
  • Q24.1Levocardia
  • Q24.2Cor triatriatum
  • Q24.3Pulmonary infundibular stenosis
  • Q24.4Congenital subaortic stenosis
  • Q24.5Malformation of coronary vessels
  • Q24.6Congenital heart block
  • Q24.8Other specified congenital malformations of heart
  • Q25.0Patent ductus arteriosus
  • Q25.1Coarctation of aorta
  • Q25.21Interruption of aortic arch
  • Q25.29Other atresia of aorta
  • Q25.3Supravalvular aortic stenosis
  • Q25.40Congenital malformation of aorta unspecified
  • Q25.41Absence and aplasia of aorta
  • Q25.42Hypoplasia of aorta
  • Q25.43Congenital aneurysm of aorta
  • Q25.44Congenital dilation of aorta
  • Q25.45Double aortic arch
  • Q25.46Tortuous aortic arch
  • Q25.47Right aortic arch
  • Q25.48Anomalous origin of subclavian artery
  • Q25.49Other congenital malformations of aorta
  • Q25.5Atresia of pulmonary artery
  • Q25.6Stenosis of pulmonary artery
  • Q25.71Coarctation of pulmonary artery
  • Q25.72Congenital pulmonary arteriovenous malformation
  • Q25.79Other congenital malformations of pulmonary artery
  • Q25.8Other congenital malformations of other great arteries
  • Q25.9Congenital malformation of great arteries, unspecified
  • Q26.0Congenital stenosis of vena cava
  • Q26.1Persistent left superior vena cava
  • Q26.2Total anomalous pulmonary venous connection
  • Q26.3Partial anomalous pulmonary venous connection
  • Q26.4Anomalous pulmonary venous connection, unspecified
  • Q26.8Other congenital malformations of great veins
  • Q26.9Congenital malformation of great vein, unspecified
  • Q87.40Marfan syndrome, unspecified
  • Q87.410Marfan syndrome with aortic dilation
  • Q87.418Marfan syndrome with other cardiovascular manifestations
  • Q87.42Marfan syndrome with ocular manifestations
  • Q87.43Marfan syndrome with skeletal manifestation
  • Q87.86Kleefstra syndrome
  • Q87.88CTNNB1 syndrome
  • Q89.3Situs inversus
  • R00.1Bradycardia, unspecified
  • R00.8Other abnormalities of heart beat
  • R01.1Cardiac murmur, unspecified
  • R01.2Other cardiac sounds
  • R06.01Orthopnea
  • R06.02Shortness of breath
  • R06.03Acute respiratory distress
  • R07.2Precordial pain
  • R07.82Intercostal pain
  • R07.89Other chest pain
  • R07.9Chest pain, unspecified
  • R50.2Drug induced fever
  • R50.81Fever presenting with conditions classified elsewhere
  • R50.9Fever, unspecified
  • R55Syncope and collapse
  • R57.0Cardiogenic shock
  • R57.1Hypovolemic shock
  • R57.8Other shock
  • R57.9Shock, unspecified
  • R65.21Severe sepsis with septic shock
  • R78.81Bacteremia
  • R94.31Abnormal electrocardiogram [ECG] [EKG]
  • S22.5XXAFlail chest, initial encounter for closed fracture
  • S22.5XXBFlail chest, initial encounter for open fracture
  • S22.5XXDFlail chest, subsequent encounter for fracture with routine healing
  • S22.5XXGFlail chest, subsequent encounter for fracture with delayed healing
  • S22.5XXKFlail chest, subsequent encounter for fracture with nonunion
  • S22.5XXSFlail chest, sequela
  • S25.00XAUnspecified injury of thoracic aorta, initial encounter
  • S25.00XDUnspecified injury of thoracic aorta, subsequent encounter
  • S25.00XSUnspecified injury of thoracic aorta, sequela
  • S25.01XAMinor laceration of thoracic aorta, initial encounter
  • S25.01XDMinor laceration of thoracic aorta, subsequent encounter
  • S25.01XSMinor laceration of thoracic aorta, sequela
  • S25.02XAMajor laceration of thoracic aorta, initial encounter
  • S25.02XDMajor laceration of thoracic aorta, subsequent encounter
  • S25.02XSMajor laceration of thoracic aorta, sequela
  • S25.09XAOther specified injury of thoracic aorta, initial encounter
  • S25.09XDOther specified injury of thoracic aorta, subsequent encounter
  • S25.09XSOther specified injury of thoracic aorta, sequela
  • S25.20XAUnspecified injury of superior vena cava, initial encounter
  • S25.20XDUnspecified injury of superior vena cava, subsequent encounter
  • S25.20XSUnspecified injury of superior vena cava, sequela
  • S25.21XAMinor laceration of superior vena cava, initial encounter
  • S25.21XDMinor laceration of superior vena cava, subsequent encounter
  • S25.21XSMinor laceration of superior vena cava, sequela
  • S25.22XAMajor laceration of superior vena cava, initial encounter
  • S25.22XDMajor laceration of superior vena cava, subsequent encounter
  • S25.22XSMajor laceration of superior vena cava, sequela
  • S25.29XAOther specified injury of superior vena cava, initial encounter
  • S25.29XDOther specified injury of superior vena cava, subsequent encounter
  • S25.29XSOther specified injury of superior vena cava, sequela
  • S25.401AUnspecified injury of right pulmonary blood vessels, initial encounter
  • S25.401DUnspecified injury of right pulmonary blood vessels, subsequent encounter
  • S25.401SUnspecified injury of right pulmonary blood vessels, sequela
  • S25.402AUnspecified injury of left pulmonary blood vessels, initial encounter
  • S25.402DUnspecified injury of left pulmonary blood vessels, subsequent encounter
  • S25.402SUnspecified injury of left pulmonary blood vessels, sequela
  • S25.411AMinor laceration of right pulmonary blood vessels, initial encounter
  • S25.411DMinor laceration of right pulmonary blood vessels, subsequent encounter
  • S25.411SMinor laceration of right pulmonary blood vessels, sequela
  • S25.412AMinor laceration of left pulmonary blood vessels, initial encounter
  • S25.412DMinor laceration of left pulmonary blood vessels, subsequent encounter
  • S25.412SMinor laceration of left pulmonary blood vessels, sequela
  • S25.421AMajor laceration of right pulmonary blood vessels, initial encounter
  • S25.421DMajor laceration of right pulmonary blood vessels, subsequent encounter
  • S25.421SMajor laceration of right pulmonary blood vessels, sequela
  • S25.422AMajor laceration of left pulmonary blood vessels, initial encounter
  • S25.422DMajor laceration of left pulmonary blood vessels, subsequent encounter
  • S25.422SMajor laceration of left pulmonary blood vessels, sequela
  • S25.491AOther specified injury of right pulmonary blood vessels, initial encounter
  • S25.491DOther specified injury of right pulmonary blood vessels, subsequent encounter
  • S25.491SOther specified injury of right pulmonary blood vessels, sequela
  • S25.492AOther specified injury of left pulmonary blood vessels, initial encounter
  • S25.492DOther specified injury of left pulmonary blood vessels, subsequent encounter
  • S25.492SOther specified injury of left pulmonary blood vessels, sequela
  • S26.00XAUnspecified injury of heart with hemopericardium, initial encounter
  • S26.00XDUnspecified injury of heart with hemopericardium, subsequent encounter
  • S26.00XSUnspecified injury of heart with hemopericardium, sequela
  • S26.01XAContusion of heart with hemopericardium, initial encounter
  • S26.01XDContusion of heart with hemopericardium, subsequent encounter
  • S26.01XSContusion of heart with hemopericardium, sequela
  • S26.020AMild laceration of heart with hemopericardium, initial encounter
  • S26.020DMild laceration of heart with hemopericardium, subsequent encounter
  • S26.020SMild laceration of heart with hemopericardium, sequela
  • S26.021AModerate laceration of heart with hemopericardium, initial encounter
  • S26.021DModerate laceration of heart with hemopericardium, subsequent encounter
  • S26.021SModerate laceration of heart with hemopericardium, sequela
  • S26.022AMajor laceration of heart with hemopericardium, initial encounter
  • S26.022DMajor laceration of heart with hemopericardium, subsequent encounter
  • S26.022SMajor laceration of heart with hemopericardium, sequela
  • S26.09XAOther injury of heart with hemopericardium, initial encounter
  • S26.09XDOther injury of heart with hemopericardium, subsequent encounter
  • S26.09XSOther injury of heart with hemopericardium, sequela
  • S26.10XAUnspecified injury of heart without hemopericardium, initial encounter
  • S26.10XDUnspecified injury of heart without hemopericardium, subsequent encounter
  • S26.10XSUnspecified injury of heart without hemopericardium, sequela
  • S26.11XAContusion of heart without hemopericardium, initial encounter
  • S26.11XDContusion of heart without hemopericardium, subsequent encounter
  • S26.11XSContusion of heart without hemopericardium, sequela
  • S26.12XALaceration of heart without hemopericardium, initial encounter
  • S26.12XDLaceration of heart without hemopericardium, subsequent encounter
  • S26.12XSLaceration of heart without hemopericardium, sequela
  • S26.19XAOther injury of heart without hemopericardium, initial encounter
  • S26.19XDOther injury of heart without hemopericardium, subsequent encounter
  • S26.19XSOther injury of heart without hemopericardium, sequela
  • S26.90XAUnspecified injury of heart, unspecified with or without hemopericardium, initial encounter
  • S26.90XDUnspecified injury of heart, unspecified with or without hemopericardium, subsequent encounter
  • S26.90XSUnspecified injury of heart, unspecified with or without hemopericardium, sequela
  • S26.91XAContusion of heart, unspecified with or without hemopericardium, initial encounter
  • S26.91XDContusion of heart, unspecified with or without hemopericardium, subsequent encounter
  • S26.91XSContusion of heart, unspecified with or without hemopericardium, sequela
  • S26.92XALaceration of heart, unspecified with or without hemopericardium, initial encounter
  • S26.92XDLaceration of heart, unspecified with or without hemopericardium, subsequent encounter
  • S26.92XSLaceration of heart, unspecified with or without hemopericardium, sequela
  • S26.99XAOther injury of heart, unspecified with or without hemopericardium, initial encounter
  • S26.99XDOther injury of heart, unspecified with or without hemopericardium, subsequent encounter
  • S26.99XSOther injury of heart, unspecified with or without hemopericardium, sequela
  • T78.3XXAAngioneurotic edema, initial encounter
  • T78.3XXDAngioneurotic edema, subsequent encounter
  • T78.3XXSAngioneurotic edema, sequela
  • T79.0XXAAir embolism (traumatic), initial encounter
  • T79.0XXDAir embolism (traumatic), subsequent encounter
  • T79.0XXSAir embolism (traumatic), sequela
  • T79.1XXAFat embolism (traumatic), initial encounter
  • T79.1XXDFat embolism (traumatic), subsequent encounter
  • T79.1XXSFat embolism (traumatic), sequela
  • T79.4XXATraumatic shock, initial encounter
  • T79.4XXDTraumatic shock, subsequent encounter
  • T79.4XXSTraumatic shock, sequela
  • T80.0XXAAir embolism following infusion, transfusion and therapeutic injection, initial encounter
  • T80.0XXDAir embolism following infusion, transfusion and therapeutic injection, subsequent encounter
  • T80.0XXSAir embolism following infusion, transfusion and therapeutic injection, sequela
  • T80.211ABloodstream infection due to central venous catheter, initial encounter
  • T80.211DBloodstream infection due to central venous catheter, subsequent encounter
  • T80.211SBloodstream infection due to central venous catheter, sequela
  • T80.212ALocal infection due to central venous catheter, initial encounter
  • T80.212DLocal infection due to central venous catheter, subsequent encounter
  • T80.212SLocal infection due to central venous catheter, sequela
  • T80.218AOther infection due to central venous catheter, initial encounter
  • T80.218DOther infection due to central venous catheter, subsequent encounter
  • T80.218SOther infection due to central venous catheter, sequela
  • T80.219AUnspecified infection due to central venous catheter, initial encounter
  • T80.219DUnspecified infection due to central venous catheter, subsequent encounter
  • T80.219SUnspecified infection due to central venous catheter, sequela
  • T80.22XAAcute infection following transfusion, infusion, or injection of blood and blood products, initial encounter
  • T80.22XDAcute infection following transfusion, infusion, or injection of blood and blood products, subsequent encounter
  • T80.22XSAcute infection following transfusion, infusion, or injection of blood and blood products, sequela
  • T80.29XAInfection following other infusion, transfusion and therapeutic injection, initial encounter
  • T80.29XDInfection following other infusion, transfusion and therapeutic injection, subsequent encounter
  • T80.29XSInfection following other infusion, transfusion and therapeutic injection, sequela
  • T81.10XAPostprocedural shock unspecified, initial encounter
  • T81.10XDPostprocedural shock unspecified, subsequent encounter
  • T81.10XSPostprocedural shock unspecified, sequela
  • T81.11XAPostprocedural cardiogenic shock, initial encounter
  • T81.11XDPostprocedural cardiogenic shock, subsequent encounter
  • T81.11XSPostprocedural cardiogenic shock, sequela
  • T81.12XAPostprocedural septic shock, initial encounter
  • T81.12XDPostprocedural septic shock, subsequent encounter
  • T81.12XSPostprocedural septic shock, sequela
  • T81.19XAOther postprocedural shock, initial encounter
  • T81.19XDOther postprocedural shock, subsequent encounter
  • T81.19XSOther postprocedural shock, sequela
  • T81.40XAInfection following a procedure, unspecified, initial encounter
  • T81.40XDInfection following a procedure, unspecified, subsequent encounter
  • T81.40XSInfection following a procedure, unspecified, sequela
  • T81.41XAInfection following a procedure, superficial incisional surgical site, initial encounter
  • T81.41XDInfection following a procedure, superficial incisional surgical site, subsequent encounter
  • T81.41XSInfection following a procedure, superficial incisional surgical site, sequela
  • T81.42XAInfection following a procedure, deep incisional surgical site, initial encounter
  • T81.42XDInfection following a procedure, deep incisional surgical site, subsequent encounter
  • T81.42XSInfection following a procedure, deep incisional surgical site, sequela
  • T81.43XAInfection following a procedure, organ and space surgical site, initial encounter
  • T81.43XDInfection following a procedure, organ and space surgical site, subsequent encounter
  • T81.43XSInfection following a procedure, organ and space surgical site, sequela
  • T81.44XASepsis following a procedure, initial encounter
  • T81.44XDSepsis following a procedure, subsequent encounter
  • T81.44XSSepsis following a procedure, sequela
  • T81.49XAInfection following a procedure, other surgical site, initial encounter
  • T81.49XDInfection following a procedure, other surgical site, subsequent encounter
  • T81.49XSInfection following a procedure, other surgical site, sequela
  • T82.01XABreakdown (mechanical) of heart valve prosthesis, initial encounter
  • T82.01XDBreakdown (mechanical) of heart valve prosthesis, subsequent encounter
  • T82.01XSBreakdown (mechanical) of heart valve prosthesis, sequela
  • T82.110ABreakdown (mechanical) of cardiac electrode, initial encounter
  • T82.110DBreakdown (mechanical) of cardiac electrode, subsequent encounter
  • T82.110SBreakdown (mechanical) of cardiac electrode, sequela
  • T82.111ABreakdown (mechanical) of cardiac pulse generator (battery), initial encounter
  • T82.111DBreakdown (mechanical) of cardiac pulse generator (battery), subsequent encounter
  • T82.111SBreakdown (mechanical) of cardiac pulse generator (battery), sequela
  • T82.118ABreakdown (mechanical) of other cardiac electronic device, initial encounter
  • T82.118DBreakdown (mechanical) of other cardiac electronic device, subsequent encounter
  • T82.118SBreakdown (mechanical) of other cardiac electronic device, sequela
  • T82.120ADisplacement of cardiac electrode, initial encounter
  • T82.120DDisplacement of cardiac electrode, subsequent encounter
  • T82.120SDisplacement of cardiac electrode, sequela
  • T82.121ADisplacement of cardiac pulse generator (battery), initial encounter
  • T82.121DDisplacement of cardiac pulse generator (battery), subsequent encounter
  • T82.121SDisplacement of cardiac pulse generator (battery), sequela
  • T82.128ADisplacement of other cardiac electronic device, initial encounter
  • T82.128DDisplacement of other cardiac electronic device, subsequent encounter
  • T82.128SDisplacement of other cardiac electronic device, sequela
  • T82.129ADisplacement of unspecified cardiac electronic device, initial encounter
  • T82.129DDisplacement of unspecified cardiac electronic device, subsequent encounter
  • T82.129SDisplacement of unspecified cardiac electronic device, sequela
  • T82.190AOther mechanical complication of cardiac electrode, initial encounter
  • T82.190DOther mechanical complication of cardiac electrode, subsequent encounter
  • T82.190SOther mechanical complication of cardiac electrode, sequela
  • T82.191AOther mechanical complication of cardiac pulse generator (battery), initial encounter
  • T82.191DOther mechanical complication of cardiac pulse generator (battery), subsequent encounter
  • T82.191SOther mechanical complication of cardiac pulse generator (battery), sequela
  • T82.198AOther mechanical complication of other cardiac electronic device, initial encounter
  • T82.198DOther mechanical complication of other cardiac electronic device, subsequent encounter
  • T82.198SOther mechanical complication of other cardiac electronic device, sequela
  • T82.211ABreakdown (mechanical) of coronary artery bypass graft, initial encounter
  • T82.211DBreakdown (mechanical) of coronary artery bypass graft, subsequent encounter
  • T82.211SBreakdown (mechanical) of coronary artery bypass graft, sequela
  • T82.221ABreakdown (mechanical) of biological heart valve graft, initial encounter
  • T82.221DBreakdown (mechanical) of biological heart valve graft, subsequent encounter
  • T82.221SBreakdown (mechanical) of biological heart valve graft, sequela
  • T82.512ABreakdown (mechanical) of artificial heart, initial encounter
  • T82.512DBreakdown (mechanical) of artificial heart, subsequent encounter
  • T82.512SBreakdown (mechanical) of artificial heart, sequela
  • T82.513ABreakdown (mechanical) of balloon (counterpulsation) device, initial encounter
  • T82.513DBreakdown (mechanical) of balloon (counterpulsation) device, subsequent encounter
  • T82.513SBreakdown (mechanical) of balloon (counterpulsation) device, sequela
  • T82.518ABreakdown (mechanical) of other cardiac and vascular devices and implants, initial encounter
  • T82.518DBreakdown (mechanical) of other cardiac and vascular devices and implants, subsequent encounter
  • T82.518SBreakdown (mechanical) of other cardiac and vascular devices and implants, sequela
  • T82.528ADisplacement of other cardiac and vascular devices and implants, initial encounter
  • T82.528DDisplacement of other cardiac and vascular devices and implants, subsequent encounter
  • T82.528SDisplacement of other cardiac and vascular devices and implants, sequela
  • T82.598AOther mechanical complication of other cardiac and vascular devices and implants, initial encounter
  • T82.598DOther mechanical complication of other cardiac and vascular devices and implants, subsequent encounter
  • T82.598SOther mechanical complication of other cardiac and vascular devices and implants, sequela
  • T82.6XXAInfection and inflammatory reaction due to cardiac valve prosthesis, initial encounter
  • T82.6XXDInfection and inflammatory reaction due to cardiac valve prosthesis, subsequent encounter
  • T82.6XXSInfection and inflammatory reaction due to cardiac valve prosthesis, sequela
  • T82.7XXAInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter
  • T82.7XXDInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, subsequent encounter
  • T82.7XXSInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, sequela
  • T82.817AEmbolism due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.817DEmbolism due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.817SEmbolism due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.827AFibrosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.827DFibrosis due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.827SFibrosis due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.837AHemorrhage due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.837DHemorrhage due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.837SHemorrhage due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.847APain due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.847DPain due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.847SPain due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.857AStenosis of other cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.857DStenosis of other cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.857SStenosis of other cardiac prosthetic devices, implants and grafts, sequela
  • T82.867AThrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.867DThrombosis due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.867SThrombosis due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.897AOther specified complication of cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.897DOther specified complication of cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.897SOther specified complication of cardiac prosthetic devices, implants and grafts, sequela
  • T86.20Unspecified complication of heart transplant
  • T86.21Heart transplant rejection
  • T86.22Heart transplant failure
  • T86.23Heart transplant infection
  • T86.290Cardiac allograft vasculopathy
  • T86.298Other complications of heart transplant
  • T86.30Unspecified complication of heart-lung transplant
  • T86.31Heart-lung transplant rejection
  • T86.32Heart-lung transplant failure
  • T86.33Heart-lung transplant infection
  • T86.39Other complications of heart-lung transplant
  • T88.0XXAInfection following immunization, initial encounter
  • T88.0XXDInfection following immunization, subsequent encounter
  • T88.0XXSInfection following immunization, sequela
  • Z08Encounter for follow-up examination after completed treatment for malignant neoplasm
  • Z09Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
  • Z48.21Encounter for aftercare following heart transplant
  • Z48.24Encounter for aftercare following lung transplant
  • Z48.280Encounter for aftercare following heart-lung transplant
  • Z79.85Long-term (current) use of injectable non-insulin antidiabetic drugs
  • Z79.899Other long term (current) drug therapy
  • Z94.1Heart transplant status
  • Z94.2Lung transplant status
  • Z94.3Heart and lungs transplant status
  • Z95.2Presence of prosthetic heart valve
  • Z95.3Presence of xenogenic heart valve
  • Z95.4Presence of other heart-valve replacement

Group 4 · 671 codes

  • A18.84Tuberculosis of heart
  • E10.10Type 1 diabetes mellitus with ketoacidosis without coma
  • E10.11Type 1 diabetes mellitus with ketoacidosis with coma
  • E10.21Type 1 diabetes mellitus with diabetic nephropathy
  • E10.22Type 1 diabetes mellitus with diabetic chronic kidney disease
  • E10.29Type 1 diabetes mellitus with other diabetic kidney complication
  • E10.59Type 1 diabetes mellitus with other circulatory complications
  • E10.641Type 1 diabetes mellitus with hypoglycemia with coma
  • E10.649Type 1 diabetes mellitus with hypoglycemia without coma
  • E10.65Type 1 diabetes mellitus with hyperglycemia
  • E10.69Type 1 diabetes mellitus with other specified complication
  • E10.8Type 1 diabetes mellitus with unspecified complications
  • E10.9Type 1 diabetes mellitus without complications
  • E11.00Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
  • E11.01Type 2 diabetes mellitus with hyperosmolarity with coma
  • E11.10Type 2 diabetes mellitus with ketoacidosis without coma
  • E11.11Type 2 diabetes mellitus with ketoacidosis with coma
  • E11.21Type 2 diabetes mellitus with diabetic nephropathy
  • E11.22Type 2 diabetes mellitus with diabetic chronic kidney disease
  • E11.29Type 2 diabetes mellitus with other diabetic kidney complication
  • E11.59Type 2 diabetes mellitus with other circulatory complications
  • E11.641Type 2 diabetes mellitus with hypoglycemia with coma
  • E11.649Type 2 diabetes mellitus with hypoglycemia without coma
  • E11.65Type 2 diabetes mellitus with hyperglycemia
  • E11.69Type 2 diabetes mellitus with other specified complication
  • E11.8Type 2 diabetes mellitus with unspecified complications
  • E11.9Type 2 diabetes mellitus without complications
  • E13.00Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
  • E13.01Other specified diabetes mellitus with hyperosmolarity with coma
  • E13.10Other specified diabetes mellitus with ketoacidosis without coma
  • E13.11Other specified diabetes mellitus with ketoacidosis with coma
  • E13.21Other specified diabetes mellitus with diabetic nephropathy
  • E13.22Other specified diabetes mellitus with diabetic chronic kidney disease
  • E13.29Other specified diabetes mellitus with other diabetic kidney complication
  • E13.59Other specified diabetes mellitus with other circulatory complications
  • E13.641Other specified diabetes mellitus with hypoglycemia with coma
  • E13.649Other specified diabetes mellitus with hypoglycemia without coma
  • E13.65Other specified diabetes mellitus with hyperglycemia
  • E13.69Other specified diabetes mellitus with other specified complication
  • E13.8Other specified diabetes mellitus with unspecified complications
  • E13.9Other specified diabetes mellitus without complications
  • I05.0Rheumatic mitral stenosis
  • I05.1Rheumatic mitral insufficiency
  • I05.2Rheumatic mitral stenosis with insufficiency
  • I05.8Other rheumatic mitral valve diseases
  • I05.9Rheumatic mitral valve disease, unspecified
  • I06.0Rheumatic aortic stenosis
  • I06.1Rheumatic aortic insufficiency
  • I06.2Rheumatic aortic stenosis with insufficiency
  • I06.9Rheumatic aortic valve disease, unspecified
  • I08.0Rheumatic disorders of both mitral and aortic valves
  • I08.9Rheumatic multiple valve disease, unspecified
  • I20.0Unstable angina
  • I20.1Angina pectoris with documented spasm
  • I20.81Angina pectoris with coronary microvascular dysfunction
  • I20.89Other forms of angina pectoris
  • I20.9Angina pectoris, unspecified
  • I21.01ST elevation (STEMI) myocardial infarction involving left main coronary artery
  • I21.02ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
  • I21.09ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall
  • I21.11ST elevation (STEMI) myocardial infarction involving right coronary artery
  • I21.19ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
  • I21.21ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery
  • I21.29ST elevation (STEMI) myocardial infarction involving other sites
  • I21.4Non-ST elevation (NSTEMI) myocardial infarction
  • I21.9Acute myocardial infarction, unspecified
  • I21.A1Myocardial infarction type 2
  • I21.A9Other myocardial infarction type
  • I21.BMyocardial infarction with coronary microvascular dysfunction
  • I22.0Subsequent ST elevation (STEMI) myocardial infarction of anterior wall
  • I22.1Subsequent ST elevation (STEMI) myocardial infarction of inferior wall
  • I22.2Subsequent non-ST elevation (NSTEMI) myocardial infarction
  • I22.8Subsequent ST elevation (STEMI) myocardial infarction of other sites
  • I23.1Atrial septal defect as current complication following acute myocardial infarction
  • I23.2Ventricular septal defect as current complication following acute myocardial infarction
  • I23.4Rupture of chordae tendineae as current complication following acute myocardial infarction
  • I23.5Rupture of papillary muscle as current complication following acute myocardial infarction
  • I24.0Acute coronary thrombosis not resulting in myocardial infarction
  • I24.1Dressler's syndrome
  • I24.81Acute coronary microvascular dysfunction
  • I24.89Other forms of acute ischemic heart disease
  • I24.9Acute ischemic heart disease, unspecified
  • I25.10Atherosclerotic heart disease of native coronary artery without angina pectoris
  • I25.110Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
  • I25.111Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm
  • I25.112Atherosclerotic heart disease of native coronary artery with refractory angina pectoris
  • I25.118Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
  • I25.119Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris
  • I25.2Old myocardial infarction
  • I25.5Ischemic cardiomyopathy
  • I25.6Silent myocardial ischemia
  • I25.700Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris
  • I25.701Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm
  • I25.702Atherosclerosis of coronary artery bypass graft(s), unspecified, with refractory angina pectoris
  • I25.708Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris
  • I25.709Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris
  • I25.710Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris
  • I25.711Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.712Atherosclerosis of autologous vein coronary artery bypass graft(s) with refractory angina pectoris
  • I25.718Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.719Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.720Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris
  • I25.721Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.722Atherosclerosis of autologous artery coronary artery bypass graft(s) with refractory angina pectoris
  • I25.728Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.729Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.730Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris
  • I25.731Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.732Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris
  • I25.738Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.739Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.750Atherosclerosis of native coronary artery of transplanted heart with unstable angina
  • I25.751Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm
  • I25.752Atherosclerosis of native coronary artery of transplanted heart with refractory angina pectoris
  • I25.758Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris
  • I25.759Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris
  • I25.760Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina
  • I25.761Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm
  • I25.762Atherosclerosis of bypass graft of coronary artery of transplanted heart with refractory angina pectoris
  • I25.768Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris
  • I25.769Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris
  • I25.790Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris
  • I25.791Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm
  • I25.792Atherosclerosis of other coronary artery bypass graft(s) with refractory angina pectoris
  • I25.798Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris
  • I25.799Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris
  • I25.810Atherosclerosis of coronary artery bypass graft(s) without angina pectoris
  • I25.811Atherosclerosis of native coronary artery of transplanted heart without angina pectoris
  • I25.812Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris
  • I25.85Chronic coronary microvascular dysfunction
  • I25.89Other forms of chronic ischemic heart disease
  • I25.9Chronic ischemic heart disease, unspecified
  • I27.0Primary pulmonary hypertension
  • I27.20Pulmonary hypertension, unspecified
  • I27.21Secondary pulmonary arterial hypertension
  • I27.22Pulmonary hypertension due to left heart disease
  • I27.23Pulmonary hypertension due to lung diseases and hypoxia
  • I27.24Chronic thromboembolic pulmonary hypertension
  • I27.29Other secondary pulmonary hypertension
  • I27.81Cor pulmonale (chronic)
  • I27.83Eisenmenger's syndrome
  • I27.840Fontan-associated liver disease [FALD]
  • I27.841Fontan-associated lymphatic dysfunction
  • I27.848Other Fontan-associated condition
  • I27.849Fontan related circulation, unspecified
  • I27.9Pulmonary heart disease, unspecified
  • I34.0Nonrheumatic mitral (valve) insufficiency
  • I34.1Nonrheumatic mitral (valve) prolapse
  • I34.2Nonrheumatic mitral (valve) stenosis
  • I34.9Nonrheumatic mitral valve disorder, unspecified
  • I35.0Nonrheumatic aortic (valve) stenosis
  • I35.1Nonrheumatic aortic (valve) insufficiency
  • I35.2Nonrheumatic aortic (valve) stenosis with insufficiency
  • I35.8Other nonrheumatic aortic valve disorders
  • I35.9Nonrheumatic aortic valve disorder, unspecified
  • I36.0Nonrheumatic tricuspid (valve) stenosis
  • I36.1Nonrheumatic tricuspid (valve) insufficiency
  • I36.2Nonrheumatic tricuspid (valve) stenosis with insufficiency
  • I36.8Other nonrheumatic tricuspid valve disorders
  • I36.9Nonrheumatic tricuspid valve disorder, unspecified
  • I37.0Nonrheumatic pulmonary valve stenosis
  • I37.1Nonrheumatic pulmonary valve insufficiency
  • I37.2Nonrheumatic pulmonary valve stenosis with insufficiency
  • I37.8Other nonrheumatic pulmonary valve disorders
  • I37.9Nonrheumatic pulmonary valve disorder, unspecified
  • I42.00Dilated cardiomyopathy, unspecified
  • I42.01Familial-genetic dilated cardiomyopathy
  • I42.09Other dilated cardiomyopathy
  • I42.1Obstructive hypertrophic cardiomyopathy
  • I42.2Other hypertrophic cardiomyopathy
  • I42.3Endomyocardial (eosinophilic) disease
  • I42.4Endocardial fibroelastosis
  • I42.5Other restrictive cardiomyopathy
  • I42.6Alcoholic cardiomyopathy
  • I42.7Cardiomyopathy due to drug and external agent
  • I42.81Arrhythmogenic cardiomyopathy
  • I42.89Other cardiomyopathies not elsewhere classified
  • I42.9Cardiomyopathy, unspecified
  • I43Cardiomyopathy in diseases classified elsewhere
  • I44.0Atrioventricular block, first degree
  • I44.30Unspecified atrioventricular block
  • I46.2Cardiac arrest due to underlying cardiac condition
  • I46.8Cardiac arrest due to other underlying condition
  • I46.9Cardiac arrest, cause unspecified
  • I47.0Re-entry ventricular arrhythmia
  • I47.11Inappropriate sinus tachycardia, so stated
  • I47.9Paroxysmal tachycardia, unspecified
  • I48.0Paroxysmal atrial fibrillation
  • I48.11Longstanding persistent atrial fibrillation
  • I48.19Other persistent atrial fibrillation
  • I48.20Chronic atrial fibrillation, unspecified
  • I48.21Permanent atrial fibrillation
  • I48.3Typical atrial flutter
  • I48.4Atypical atrial flutter
  • I48.91Unspecified atrial fibrillation
  • I48.92Unspecified atrial flutter
  • I49.01Ventricular fibrillation
  • I49.02Ventricular flutter
  • I49.1Atrial premature depolarization
  • I49.2Junctional premature depolarization
  • I49.3Ventricular premature depolarization
  • I49.40Unspecified premature depolarization
  • I49.49Other premature depolarization
  • I49.5Sick sinus syndrome
  • I49.81Brugada syndrome
  • I49.82Ventricular bigeminy
  • I49.89Other specified cardiac arrhythmias not elsewhere classified
  • I50.1Left ventricular failure, unspecified
  • I50.20Unspecified systolic (congestive) heart failure
  • I50.21Acute systolic (congestive) heart failure
  • I50.22Chronic systolic (congestive) heart failure
  • I50.23Acute on chronic systolic (congestive) heart failure
  • I50.30Unspecified diastolic (congestive) heart failure
  • I50.31Acute diastolic (congestive) heart failure
  • I50.32Chronic diastolic (congestive) heart failure
  • I50.33Acute on chronic diastolic (congestive) heart failure
  • I50.40Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.41Acute combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.42Chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.43Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.810Right heart failure, unspecified
  • I50.811Acute right heart failure
  • I50.812Chronic right heart failure
  • I50.813Acute on chronic right heart failure
  • I50.814Right heart failure due to left heart failure
  • I50.82Biventricular heart failure
  • I50.83High output heart failure
  • I50.84End stage heart failure
  • I50.89Other heart failure
  • I50.9Heart failure, unspecified
  • I51.4Myocarditis, unspecified
  • I51.5Myocardial degeneration
  • I51.7Cardiomegaly
  • I97.0Postcardiotomy syndrome
  • I97.110Postprocedural cardiac insufficiency following cardiac surgery
  • I97.111Postprocedural cardiac insufficiency following other surgery
  • I97.120Postprocedural cardiac arrest following cardiac surgery
  • I97.121Postprocedural cardiac arrest following other surgery
  • I97.130Postprocedural heart failure following cardiac surgery
  • I97.131Postprocedural heart failure following other surgery
  • I97.190Other postprocedural cardiac functional disturbances following cardiac surgery
  • I97.191Other postprocedural cardiac functional disturbances following other surgery
  • R00.1Bradycardia, unspecified
  • R06.00Dyspnea, unspecified
  • R06.01Orthopnea
  • R06.02Shortness of breath
  • R06.03Acute respiratory distress
  • R06.09Other forms of dyspnea
  • R06.83Snoring
  • R06.89Other abnormalities of breathing
  • R07.2Precordial pain
  • R07.82Intercostal pain
  • R07.89Other chest pain
  • R07.9Chest pain, unspecified
  • R55Syncope and collapse
  • R94.31Abnormal electrocardiogram [ECG] [EKG]
  • R94.39Abnormal result of other cardiovascular function study
  • T36.0X5DAdverse effect of penicillins, subsequent encounter
  • T36.0X5SAdverse effect of penicillins, sequela
  • T36.1X5DAdverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
  • T36.1X5SAdverse effect of cephalosporins and other beta-lactam antibiotics, sequela
  • T36.2X5DAdverse effect of chloramphenicol group, subsequent encounter
  • T36.2X5SAdverse effect of chloramphenicol group, sequela
  • T36.3X5DAdverse effect of macrolides, subsequent encounter
  • T36.3X5SAdverse effect of macrolides, sequela
  • T36.4X5DAdverse effect of tetracyclines, subsequent encounter
  • T36.4X5SAdverse effect of tetracyclines, sequela
  • T36.5X5DAdverse effect of aminoglycosides, subsequent encounter
  • T36.5X5SAdverse effect of aminoglycosides, sequela
  • T36.6X5DAdverse effect of rifampicins, subsequent encounter
  • T36.6X5SAdverse effect of rifampicins, sequela
  • T36.7X5DAdverse effect of antifungal antibiotics, systemically used, subsequent encounter
  • T36.7X5SAdverse effect of antifungal antibiotics, systemically used, sequela
  • T36.8X5DAdverse effect of other systemic antibiotics, subsequent encounter
  • T36.8X5SAdverse effect of other systemic antibiotics, sequela
  • T36.95XDAdverse effect of unspecified systemic antibiotic, subsequent encounter
  • T36.95XSAdverse effect of unspecified systemic antibiotic, sequela
  • T37.0X5DAdverse effect of sulfonamides, subsequent encounter
  • T37.0X5SAdverse effect of sulfonamides, sequela
  • T37.1X5DAdverse effect of antimycobacterial drugs, subsequent encounter
  • T37.1X5SAdverse effect of antimycobacterial drugs, sequela
  • T37.2X5DAdverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter
  • T37.2X5SAdverse effect of antimalarials and drugs acting on other blood protozoa, sequela
  • T37.3X5DAdverse effect of other antiprotozoal drugs, subsequent encounter
  • T37.3X5SAdverse effect of other antiprotozoal drugs, sequela
  • T37.4X5DAdverse effect of anthelminthics, subsequent encounter
  • T37.4X5SAdverse effect of anthelminthics, sequela
  • T37.5X5DAdverse effect of antiviral drugs, subsequent encounter
  • T37.5X5SAdverse effect of antiviral drugs, sequela
  • T37.8X5DAdverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
  • T37.8X5SAdverse effect of other specified systemic anti-infectives and antiparasitics, sequela
  • T37.95XDAdverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter
  • T37.95XSAdverse effect of unspecified systemic anti-infective and antiparasitic, sequela
  • T38.0X5DAdverse effect of glucocorticoids and synthetic analogues, subsequent encounter
  • T38.0X5SAdverse effect of glucocorticoids and synthetic analogues, sequela
  • T38.1X5DAdverse effect of thyroid hormones and substitutes, subsequent encounter
  • T38.1X5SAdverse effect of thyroid hormones and substitutes, sequela
  • T38.2X5DAdverse effect of antithyroid drugs, subsequent encounter
  • T38.2X5SAdverse effect of antithyroid drugs, sequela
  • T38.3X5DAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
  • T38.3X5SAdverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
  • T38.4X5DAdverse effect of oral contraceptives, subsequent encounter
  • T38.4X5SAdverse effect of oral contraceptives, sequela
  • T38.5X5DAdverse effect of other estrogens and progestogens, subsequent encounter
  • T38.5X5SAdverse effect of other estrogens and progestogens, sequela
  • T38.6X5DAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
  • T38.6X5SAdverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
  • T38.7X5DAdverse effect of androgens and anabolic congeners, subsequent encounter
  • T38.7X5SAdverse effect of androgens and anabolic congeners, sequela
  • T38.805DAdverse effect of unspecified hormones and synthetic substitutes, subsequent encounter
  • T38.805SAdverse effect of unspecified hormones and synthetic substitutes, sequela
  • T38.815DAdverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
  • T38.815SAdverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
  • T38.895DAdverse effect of other hormones and synthetic substitutes, subsequent encounter
  • T38.895SAdverse effect of other hormones and synthetic substitutes, sequela
  • T38.905DAdverse effect of unspecified hormone antagonists, subsequent encounter
  • T38.905SAdverse effect of unspecified hormone antagonists, sequela
  • T38.995DAdverse effect of other hormone antagonists, subsequent encounter
  • T38.995SAdverse effect of other hormone antagonists, sequela
  • T39.015DAdverse effect of aspirin, subsequent encounter
  • T39.015SAdverse effect of aspirin, sequela
  • T39.095DAdverse effect of salicylates, subsequent encounter
  • T39.095SAdverse effect of salicylates, sequela
  • T39.1X5DAdverse effect of 4-Aminophenol derivatives, subsequent encounter
  • T39.1X5SAdverse effect of 4-Aminophenol derivatives, sequela
  • T39.2X5DAdverse effect of pyrazolone derivatives, subsequent encounter
  • T39.2X5SAdverse effect of pyrazolone derivatives, sequela
  • T39.315DAdverse effect of propionic acid derivatives, subsequent encounter
  • T39.315SAdverse effect of propionic acid derivatives, sequela
  • T39.395DAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
  • T39.395SAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
  • T40.0X5DAdverse effect of opium, subsequent encounter
  • T40.0X5SAdverse effect of opium, sequela
  • T40.2X5DAdverse effect of other opioids, subsequent encounter
  • T40.2X5SAdverse effect of other opioids, sequela
  • T40.3X5DAdverse effect of methadone, subsequent encounter
  • T40.3X5SAdverse effect of methadone, sequela
  • T40.5X5DAdverse effect of cocaine, subsequent encounter
  • T40.5X5SAdverse effect of cocaine, sequela
  • T40.605DAdverse effect of unspecified narcotics, subsequent encounter
  • T40.605SAdverse effect of unspecified narcotics, sequela
  • T40.695DAdverse effect of other narcotics, subsequent encounter
  • T40.695SAdverse effect of other narcotics, sequela
  • T40.711DPoisoning by cannabis, accidental (unintentional), subsequent encounter
  • T40.711SPoisoning by cannabis, accidental (unintentional), sequela
  • T40.712DPoisoning by cannabis, intentional self-harm, subsequent encounter
  • T40.712SPoisoning by cannabis, intentional self-harm, sequela
  • T40.713DPoisoning by cannabis, assault, subsequent encounter
  • T40.713SPoisoning by cannabis, assault, sequela
  • T40.714DPoisoning by cannabis, undetermined, subsequent encounter
  • T40.714SPoisoning by cannabis, undetermined, sequela
  • T40.715DAdverse effect of cannabis, subsequent encounter
  • T40.715SAdverse effect of cannabis, sequela
  • T40.721DPoisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter
  • T40.721SPoisoning by synthetic cannabinoids, accidental (unintentional), sequela
  • T40.722DPoisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter
  • T40.722SPoisoning by synthetic cannabinoids, intentional self-harm, sequela
  • T40.723DPoisoning by synthetic cannabinoids, assault, subsequent encounter
  • T40.723SPoisoning by synthetic cannabinoids, assault, sequela
  • T40.724DPoisoning by synthetic cannabinoids, undetermined, subsequent encounter
  • T40.724SPoisoning by synthetic cannabinoids, undetermined, sequela
  • T40.725DAdverse effect of synthetic cannabinoids, subsequent encounter
  • T40.725SAdverse effect of synthetic cannabinoids, sequela
  • T40.905DAdverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
  • T40.905SAdverse effect of unspecified psychodysleptics [hallucinogens], sequela
  • T40.995DAdverse effect of other psychodysleptics [hallucinogens], subsequent encounter
  • T40.995SAdverse effect of other psychodysleptics [hallucinogens], sequela
  • T41.0X5DAdverse effect of inhaled anesthetics, subsequent encounter
  • T41.0X5SAdverse effect of inhaled anesthetics, sequela
  • T41.1X5DAdverse effect of intravenous anesthetics, subsequent encounter
  • T41.1X5SAdverse effect of intravenous anesthetics, sequela
  • T41.205DAdverse effect of unspecified general anesthetics, subsequent encounter
  • T41.205SAdverse effect of unspecified general anesthetics, sequela
  • T41.295DAdverse effect of other general anesthetics, subsequent encounter
  • T41.295SAdverse effect of other general anesthetics, sequela
  • T41.3X5DAdverse effect of local anesthetics, subsequent encounter
  • T41.3X5SAdverse effect of local anesthetics, sequela
  • T41.45XDAdverse effect of unspecified anesthetic, subsequent encounter
  • T41.45XSAdverse effect of unspecified anesthetic, sequela
  • T41.5X5DAdverse effect of therapeutic gases, subsequent encounter
  • T41.5X5SAdverse effect of therapeutic gases, sequela
  • T42.0X5DAdverse effect of hydantoin derivatives, subsequent encounter
  • T42.0X5SAdverse effect of hydantoin derivatives, sequela
  • T42.1X5DAdverse effect of iminostilbenes, subsequent encounter
  • T42.1X5SAdverse effect of iminostilbenes, sequela
  • T42.2X5DAdverse effect of succinimides and oxazolidinediones, subsequent encounter
  • T42.2X5SAdverse effect of succinimides and oxazolidinediones, sequela
  • T42.3X5DAdverse effect of barbiturates, subsequent encounter
  • T42.3X5SAdverse effect of barbiturates, sequela
  • T42.4X5DAdverse effect of benzodiazepines, subsequent encounter
  • T42.4X5SAdverse effect of benzodiazepines, sequela
  • T42.5X5DAdverse effect of mixed antiepileptics, subsequent encounter
  • T42.5X5SAdverse effect of mixed antiepileptics, sequela
  • T42.6X5DAdverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
  • T42.6X5SAdverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
  • T42.75XDAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
  • T42.75XSAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela
  • T42.8X5DAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
  • T42.8X5SAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
  • T43.015DAdverse effect of tricyclic antidepressants, subsequent encounter
  • T43.015SAdverse effect of tricyclic antidepressants, sequela
  • T43.025DAdverse effect of tetracyclic antidepressants, subsequent encounter
  • T43.025SAdverse effect of tetracyclic antidepressants, sequela
  • T43.1X5DAdverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
  • T43.1X5SAdverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
  • T43.205DAdverse effect of unspecified antidepressants, subsequent encounter
  • T43.205SAdverse effect of unspecified antidepressants, sequela
  • T43.215DAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
  • T43.215SAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
  • T43.225DAdverse effect of selective serotonin reuptake inhibitors, subsequent encounter
  • T43.225SAdverse effect of selective serotonin reuptake inhibitors, sequela
  • T43.295DAdverse effect of other antidepressants, subsequent encounter
  • T43.295SAdverse effect of other antidepressants, sequela
  • T43.3X5DAdverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
  • T43.3X5SAdverse effect of phenothiazine antipsychotics and neuroleptics, sequela
  • T43.4X5DAdverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
  • T43.4X5SAdverse effect of butyrophenone and thiothixene neuroleptics, sequela
  • T43.615DAdverse effect of caffeine, subsequent encounter
  • T43.615SAdverse effect of caffeine, sequela
  • T43.625DAdverse effect of amphetamines, subsequent encounter
  • T43.625SAdverse effect of amphetamines, sequela
  • T43.635DAdverse effect of methylphenidate, subsequent encounter
  • T43.635SAdverse effect of methylphenidate, sequela
  • T43.651APoisoning by methamphetamines accidental (unintentional), initial encounter
  • T43.651DPoisoning by methamphetamines accidental (unintentional), subsequent encounter
  • T43.651SPoisoning by methamphetamines accidental (unintentional), sequela
  • T43.652APoisoning by methamphetamines intentional self-harm, initial encounter
  • T43.652DPoisoning by methamphetamines intentional self-harm, subsequent encounter
  • T43.652SPoisoning by methamphetamines intentional self-harm, sequela
  • T43.653APoisoning by methamphetamines, assault, initial encounter
  • T43.653DPoisoning by methamphetamines, assault, subsequent encounter
  • T43.653SPoisoning by methamphetamines, assault, sequela
  • T43.654APoisoning by methamphetamines, undetermined, initial encounter
  • T43.654DPoisoning by methamphetamines, undetermined, subsequent encounter
  • T43.654SPoisoning by methamphetamines, undetermined, sequela
  • T43.655AAdverse effect of methamphetamines, initial encounter
  • T43.655DAdverse effect of methamphetamines, subsequent encounter
  • T43.655SAdverse effect of methamphetamines, sequela
  • T43.656AUnderdosing of methamphetamines, initial encounter
  • T43.656DUnderdosing of methamphetamines, subsequent encounter
  • T43.656SUnderdosing of methamphetamines, sequela
  • T44.0X5DAdverse effect of anticholinesterase agents, subsequent encounter
  • T44.0X5SAdverse effect of anticholinesterase agents, sequela
  • T44.1X5DAdverse effect of other parasympathomimetics [cholinergics], subsequent encounter
  • T44.1X5SAdverse effect of other parasympathomimetics [cholinergics], sequela
  • T44.2X5DAdverse effect of ganglionic blocking drugs, subsequent encounter
  • T44.2X5SAdverse effect of ganglionic blocking drugs, sequela
  • T44.3X5DAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
  • T44.3X5SAdverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
  • T44.4X5DAdverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
  • T44.4X5SAdverse effect of predominantly alpha-adrenoreceptor agonists, sequela
  • T44.5X5DAdverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
  • T44.5X5SAdverse effect of predominantly beta-adrenoreceptor agonists, sequela
  • T44.6X5DAdverse effect of alpha-adrenoreceptor antagonists, subsequent encounter
  • T44.6X5SAdverse effect of alpha-adrenoreceptor antagonists, sequela
  • T44.7X5DAdverse effect of beta-adrenoreceptor antagonists, subsequent encounter
  • T44.7X5SAdverse effect of beta-adrenoreceptor antagonists, sequela
  • T45.0X5DAdverse effect of antiallergic and antiemetic drugs, subsequent encounter
  • T45.0X5SAdverse effect of antiallergic and antiemetic drugs, sequela
  • T45.1X5DAdverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
  • T45.1X5SAdverse effect of antineoplastic and immunosuppressive drugs, sequela
  • T45.2X5DAdverse effect of vitamins, subsequent encounter
  • T45.2X5SAdverse effect of vitamins, sequela
  • T45.3X5DAdverse effect of enzymes, subsequent encounter
  • T45.3X5SAdverse effect of enzymes, sequela
  • T45.4X5DAdverse effect of iron and its compounds, subsequent encounter
  • T45.4X5SAdverse effect of iron and its compounds, sequela
  • T45.515DAdverse effect of anticoagulants, subsequent encounter
  • T45.515SAdverse effect of anticoagulants, sequela
  • T45.525DAdverse effect of antithrombotic drugs, subsequent encounter
  • T45.525SAdverse effect of antithrombotic drugs, sequela
  • T45.605DAdverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
  • T45.605SAdverse effect of unspecified fibrinolysis-affecting drugs, sequela
  • T45.615DAdverse effect of thrombolytic drugs, subsequent encounter
  • T45.615SAdverse effect of thrombolytic drugs, sequela
  • T45.625DAdverse effect of hemostatic drug, subsequent encounter
  • T45.625SAdverse effect of hemostatic drug, sequela
  • T45.695DAdverse effect of other fibrinolysis-affecting drugs, subsequent encounter
  • T45.695SAdverse effect of other fibrinolysis-affecting drugs, sequela
  • T45.7X5DAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
  • T45.7X5SAdverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
  • T45.8X5DAdverse effect of other primarily systemic and hematological agents, subsequent encounter
  • T45.8X5SAdverse effect of other primarily systemic and hematological agents, sequela
  • T46.0X5DAdverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
  • T46.0X5SAdverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
  • T46.1X5DAdverse effect of calcium-channel blockers, subsequent encounter
  • T46.1X5SAdverse effect of calcium-channel blockers, sequela
  • T46.2X5DAdverse effect of other antidysrhythmic drugs, subsequent encounter
  • T46.2X5SAdverse effect of other antidysrhythmic drugs, sequela
  • T46.3X5DAdverse effect of coronary vasodilators, subsequent encounter
  • T46.3X5SAdverse effect of coronary vasodilators, sequela
  • T46.4X5DAdverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
  • T46.4X5SAdverse effect of angiotensin-converting-enzyme inhibitors, sequela
  • T46.5X5DAdverse effect of other antihypertensive drugs, subsequent encounter
  • T46.5X5SAdverse effect of other antihypertensive drugs, sequela
  • T46.6X5DAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
  • T46.6X5SAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
  • T46.7X5DAdverse effect of peripheral vasodilators, subsequent encounter
  • T46.7X5SAdverse effect of peripheral vasodilators, sequela
  • T47.0X5DAdverse effect of histamine H2-receptor blockers, subsequent encounter
  • T47.0X5SAdverse effect of histamine H2-receptor blockers, sequela
  • T47.1X5DAdverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
  • T47.1X5SAdverse effect of other antacids and anti-gastric-secretion drugs, sequela
  • T47.2X5DAdverse effect of stimulant laxatives, subsequent encounter
  • T47.2X5SAdverse effect of stimulant laxatives, sequela
  • T47.3X5DAdverse effect of saline and osmotic laxatives, subsequent encounter
  • T47.3X5SAdverse effect of saline and osmotic laxatives, sequela
  • T47.4X5DAdverse effect of other laxatives, subsequent encounter
  • T47.4X5SAdverse effect of other laxatives, sequela
  • T47.5X5DAdverse effect of digestants, subsequent encounter
  • T47.5X5SAdverse effect of digestants, sequela
  • T47.6X5DAdverse effect of antidiarrheal drugs, subsequent encounter
  • T47.6X5SAdverse effect of antidiarrheal drugs, sequela
  • T47.7X5DAdverse effect of emetics, subsequent encounter
  • T47.7X5SAdverse effect of emetics, sequela
  • T48.0X5DAdverse effect of oxytocic drugs, subsequent encounter
  • T48.0X5SAdverse effect of oxytocic drugs, sequela
  • T48.1X5DAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
  • T48.1X5SAdverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
  • T48.205DAdverse effect of unspecified drugs acting on muscles, subsequent encounter
  • T48.205SAdverse effect of unspecified drugs acting on muscles, sequela
  • T48.295DAdverse effect of other drugs acting on muscles, subsequent encounter
  • T48.295SAdverse effect of other drugs acting on muscles, sequela
  • T48.3X5DAdverse effect of antitussives, subsequent encounter
  • T48.3X5SAdverse effect of antitussives, sequela
  • T48.4X5DAdverse effect of expectorants, subsequent encounter
  • T48.4X5SAdverse effect of expectorants, sequela
  • T48.5X5DAdverse effect of other anti-common-cold drugs, subsequent encounter
  • T48.5X5SAdverse effect of other anti-common-cold drugs, sequela
  • T48.6X5DAdverse effect of antiasthmatics, subsequent encounter
  • T48.6X5SAdverse effect of antiasthmatics, sequela
  • T49.1X5DAdverse effect of antipruritics, subsequent encounter
  • T49.1X5SAdverse effect of antipruritics, sequela
  • T50.0X5DAdverse effect of mineralocorticoids and their antagonists, subsequent encounter
  • T50.0X5SAdverse effect of mineralocorticoids and their antagonists, sequela
  • T50.1X5DAdverse effect of loop [high-ceiling] diuretics, subsequent encounter
  • T50.1X5SAdverse effect of loop [high-ceiling] diuretics, sequela
  • T50.2X5DAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
  • T50.2X5SAdverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
  • T50.4X5DAdverse effect of drugs affecting uric acid metabolism, subsequent encounter
  • T50.4X5SAdverse effect of drugs affecting uric acid metabolism, sequela
  • T50.905AAdverse effect of unspecified drugs, medicaments and biological substances, initial encounter
  • T50.905DAdverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter
  • T50.905SAdverse effect of unspecified drugs, medicaments and biological substances, sequela
  • T50.915AAdverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter
  • T50.915DAdverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
  • T50.915SAdverse effect of multiple unspecified drugs, medicaments and biological substances, sequela
  • T50.916AUnderdosing of multiple unspecified drugs, medicaments and biological substances, initial encounter
  • T50.916DUnderdosing of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
  • T50.916SUnderdosing of multiple unspecified drugs, medicaments and biological substances, sequela
  • T50.995AAdverse effect of other drugs, medicaments and biological substances, initial encounter
  • T50.995DAdverse effect of other drugs, medicaments and biological substances, subsequent encounter
  • T50.995SAdverse effect of other drugs, medicaments and biological substances, sequela
  • T80.211ABloodstream infection due to central venous catheter, initial encounter
  • T80.211DBloodstream infection due to central venous catheter, subsequent encounter
  • T80.211SBloodstream infection due to central venous catheter, sequela
  • T80.212ALocal infection due to central venous catheter, initial encounter
  • T80.212DLocal infection due to central venous catheter, subsequent encounter
  • T80.212SLocal infection due to central venous catheter, sequela
  • T82.318ABreakdown (mechanical) of other vascular grafts, initial encounter
  • T82.318DBreakdown (mechanical) of other vascular grafts, subsequent encounter
  • T82.318SBreakdown (mechanical) of other vascular grafts, sequela
  • T82.328ADisplacement of other vascular grafts, initial encounter
  • T82.328DDisplacement of other vascular grafts, subsequent encounter
  • T82.328SDisplacement of other vascular grafts, sequela
  • T82.338ALeakage of other vascular grafts, initial encounter
  • T82.338DLeakage of other vascular grafts, subsequent encounter
  • T82.338SLeakage of other vascular grafts, sequela
  • T82.398AOther mechanical complication of other vascular grafts, initial encounter
  • T82.398DOther mechanical complication of other vascular grafts, subsequent encounter
  • T82.398SOther mechanical complication of other vascular grafts, sequela
  • T82.513ABreakdown (mechanical) of balloon (counterpulsation) device, initial encounter
  • T82.513DBreakdown (mechanical) of balloon (counterpulsation) device, subsequent encounter
  • T82.513SBreakdown (mechanical) of balloon (counterpulsation) device, sequela
  • T82.518ABreakdown (mechanical) of other cardiac and vascular devices and implants, initial encounter
  • T82.518DBreakdown (mechanical) of other cardiac and vascular devices and implants, subsequent encounter
  • T82.518SBreakdown (mechanical) of other cardiac and vascular devices and implants, sequela
  • T82.523ADisplacement of balloon (counterpulsation) device, initial encounter
  • T82.523DDisplacement of balloon (counterpulsation) device, subsequent encounter
  • T82.523SDisplacement of balloon (counterpulsation) device, sequela
  • T82.528ADisplacement of other cardiac and vascular devices and implants, initial encounter
  • T82.528DDisplacement of other cardiac and vascular devices and implants, subsequent encounter
  • T82.528SDisplacement of other cardiac and vascular devices and implants, sequela
  • T82.533ALeakage of balloon (counterpulsation) device, initial encounter
  • T82.533DLeakage of balloon (counterpulsation) device, subsequent encounter
  • T82.533SLeakage of balloon (counterpulsation) device, sequela
  • T82.538ALeakage of other cardiac and vascular devices and implants, initial encounter
  • T82.538DLeakage of other cardiac and vascular devices and implants, subsequent encounter
  • T82.538SLeakage of other cardiac and vascular devices and implants, sequela
  • T82.593AOther mechanical complication of balloon (counterpulsation) device, initial encounter
  • T82.593DOther mechanical complication of balloon (counterpulsation) device, subsequent encounter
  • T82.593SOther mechanical complication of balloon (counterpulsation) device, sequela
  • T82.598AOther mechanical complication of other cardiac and vascular devices and implants, initial encounter
  • T82.598DOther mechanical complication of other cardiac and vascular devices and implants, subsequent encounter
  • T82.598SOther mechanical complication of other cardiac and vascular devices and implants, sequela
  • T82.6XXAInfection and inflammatory reaction due to cardiac valve prosthesis, initial encounter
  • T82.6XXDInfection and inflammatory reaction due to cardiac valve prosthesis, subsequent encounter
  • T82.6XXSInfection and inflammatory reaction due to cardiac valve prosthesis, sequela
  • T82.7XXAInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter
  • T82.7XXDInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, subsequent encounter
  • T82.7XXSInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, sequela
  • T82.817AEmbolism due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.817DEmbolism due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.817SEmbolism due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.818AEmbolism due to vascular prosthetic devices, implants and grafts, initial encounter
  • T82.818DEmbolism due to vascular prosthetic devices, implants and grafts, subsequent encounter
  • T82.818SEmbolism due to vascular prosthetic devices, implants and grafts, sequela
  • T82.827AFibrosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.827DFibrosis due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.827SFibrosis due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.828AFibrosis due to vascular prosthetic devices, implants and grafts, initial encounter
  • T82.828DFibrosis due to vascular prosthetic devices, implants and grafts, subsequent encounter
  • T82.828SFibrosis due to vascular prosthetic devices, implants and grafts, sequela
  • T82.837AHemorrhage due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.837DHemorrhage due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.837SHemorrhage due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.838AHemorrhage due to vascular prosthetic devices, implants and grafts, initial encounter
  • T82.838DHemorrhage due to vascular prosthetic devices, implants and grafts, subsequent encounter
  • T82.838SHemorrhage due to vascular prosthetic devices, implants and grafts, sequela
  • T82.847APain due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.847DPain due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.847SPain due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.848APain due to vascular prosthetic devices, implants and grafts, initial encounter
  • T82.848DPain due to vascular prosthetic devices, implants and grafts, subsequent encounter
  • T82.848SPain due to vascular prosthetic devices, implants and grafts, sequela
  • T82.857AStenosis of other cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.857DStenosis of other cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.857SStenosis of other cardiac prosthetic devices, implants and grafts, sequela
  • T82.858AStenosis of other vascular prosthetic devices, implants and grafts, initial encounter
  • T82.858DStenosis of other vascular prosthetic devices, implants and grafts, subsequent encounter
  • T82.858SStenosis of other vascular prosthetic devices, implants and grafts, sequela
  • T82.867AThrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.867DThrombosis due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.867SThrombosis due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.868AThrombosis due to vascular prosthetic devices, implants and grafts, initial encounter
  • T82.868DThrombosis due to vascular prosthetic devices, implants and grafts, subsequent encounter
  • T82.868SThrombosis due to vascular prosthetic devices, implants and grafts, sequela
  • T82.897AOther specified complication of cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.897DOther specified complication of cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.897SOther specified complication of cardiac prosthetic devices, implants and grafts, sequela
  • T82.898AOther specified complication of vascular prosthetic devices, implants and grafts, initial encounter
  • T82.898DOther specified complication of vascular prosthetic devices, implants and grafts, subsequent encounter
  • T82.898SOther specified complication of vascular prosthetic devices, implants and grafts, sequela
  • T82.9XXAUnspecified complication of cardiac and vascular prosthetic device, implant and graft, initial encounter
  • T86.20Unspecified complication of heart transplant
  • T86.21Heart transplant rejection
  • T86.22Heart transplant failure
  • T86.23Heart transplant infection
  • T86.290Cardiac allograft vasculopathy
  • T86.298Other complications of heart transplant
  • T86.30Unspecified complication of heart-lung transplant
  • T86.31Heart-lung transplant rejection
  • T86.32Heart-lung transplant failure
  • T86.33Heart-lung transplant infection
  • T86.39Other complications of heart-lung transplant
  • Z01.810Encounter for preprocedural cardiovascular examination
  • Z48.21Encounter for aftercare following heart transplant
  • Z48.280Encounter for aftercare following heart-lung transplant
  • Z79.02Long term (current) use of antithrombotics/antiplatelets
  • Z79.1Long term (current) use of non-steroidal anti-inflammatories (NSAID)
  • Z79.3Long term (current) use of hormonal contraceptives
  • Z79.51Long term (current) use of inhaled steroids
  • Z79.52Long term (current) use of systemic steroids
  • Z79.85Long-term (current) use of injectable non-insulin antidiabetic drugs
  • Z79.891Long term (current) use of opiate analgesic
  • Z79.899Other long term (current) drug therapy
  • Z94.1Heart transplant status
  • Z94.3Heart and lungs transplant status
  • Z95.1Presence of aortocoronary bypass graft
  • Z95.5Presence of coronary angioplasty implant and graft
  • Z98.61Coronary angioplasty status

Group 5 · 531 codes

  • A18.84Tuberculosis of heart
  • A40.0Sepsis due to streptococcus, group A
  • A40.1Sepsis due to streptococcus, group B
  • A40.3Sepsis due to Streptococcus pneumoniae
  • A40.8Other streptococcal sepsis
  • A40.9Streptococcal sepsis, unspecified
  • A41.01Sepsis due to Methicillin susceptible Staphylococcus aureus
  • A41.02Sepsis due to Methicillin resistant Staphylococcus aureus
  • A41.1Sepsis due to other specified staphylococcus
  • A41.2Sepsis due to unspecified staphylococcus
  • A41.3Sepsis due to Hemophilus influenzae
  • A41.4Sepsis due to anaerobes
  • A41.50Gram-negative sepsis, unspecified
  • A41.51Sepsis due to Escherichia coli [E. coli]
  • A41.52Sepsis due to Pseudomonas
  • A41.53Sepsis due to Serratia
  • A41.54Sepsis due to Acinetobacter baumannii
  • A41.59Other Gram-negative sepsis
  • A41.81Sepsis due to Enterococcus
  • A41.89Other specified sepsis
  • A41.9Sepsis, unspecified organism
  • A42.7Actinomycotic sepsis
  • A52.00Cardiovascular syphilis, unspecified
  • A52.01Syphilitic aneurysm of aorta
  • A52.02Syphilitic aortitis
  • A52.03Syphilitic endocarditis
  • A52.04Syphilitic cerebral arteritis
  • A52.05Other cerebrovascular syphilis
  • A52.06Other syphilitic heart involvement
  • A52.09Other cardiovascular syphilis
  • B37.6Candidal endocarditis
  • C38.0Malignant neoplasm of heart
  • C45.2Mesothelioma of pericardium
  • D15.1Benign neoplasm of heart
  • D35.7Benign neoplasm of other specified endocrine glands
  • G45.3Amaurosis fugax
  • G45.8Other transient cerebral ischemic attacks and related syndromes
  • G45.9Transient cerebral ischemic attack, unspecified
  • I01.0Acute rheumatic pericarditis
  • I01.1Acute rheumatic endocarditis
  • I01.2Acute rheumatic myocarditis
  • I01.8Other acute rheumatic heart disease
  • I01.9Acute rheumatic heart disease, unspecified
  • I02.0Rheumatic chorea with heart involvement
  • I05.0Rheumatic mitral stenosis
  • I05.1Rheumatic mitral insufficiency
  • I05.2Rheumatic mitral stenosis with insufficiency
  • I05.8Other rheumatic mitral valve diseases
  • I05.9Rheumatic mitral valve disease, unspecified
  • I06.0Rheumatic aortic stenosis
  • I06.1Rheumatic aortic insufficiency
  • I06.2Rheumatic aortic stenosis with insufficiency
  • I06.8Other rheumatic aortic valve diseases
  • I06.9Rheumatic aortic valve disease, unspecified
  • I07.0Rheumatic tricuspid stenosis
  • I07.1Rheumatic tricuspid insufficiency
  • I07.2Rheumatic tricuspid stenosis and insufficiency
  • I07.8Other rheumatic tricuspid valve diseases
  • I07.9Rheumatic tricuspid valve disease, unspecified
  • I08.0Rheumatic disorders of both mitral and aortic valves
  • I08.1Rheumatic disorders of both mitral and tricuspid valves
  • I08.2Rheumatic disorders of both aortic and tricuspid valves
  • I08.3Combined rheumatic disorders of mitral, aortic and tricuspid valves
  • I08.8Other rheumatic multiple valve diseases
  • I08.9Rheumatic multiple valve disease, unspecified
  • I09.0Rheumatic myocarditis
  • I09.1Rheumatic diseases of endocardium, valve unspecified
  • I09.2Chronic rheumatic pericarditis
  • I09.81Rheumatic heart failure
  • I09.89Other specified rheumatic heart diseases
  • I09.9Rheumatic heart disease, unspecified
  • I11.0Hypertensive heart disease with heart failure
  • I11.9Hypertensive heart disease without heart failure
  • I13.0Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
  • I13.10Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
  • I13.11Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
  • I13.2Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
  • I20.0Unstable angina
  • I20.81Angina pectoris with coronary microvascular dysfunction
  • I20.89Other forms of angina pectoris
  • I21.9Acute myocardial infarction, unspecified
  • I21.A1Myocardial infarction type 2
  • I21.A9Other myocardial infarction type
  • I21.BMyocardial infarction with coronary microvascular dysfunction
  • I23.0Hemopericardium as current complication following acute myocardial infarction
  • I23.1Atrial septal defect as current complication following acute myocardial infarction
  • I23.2Ventricular septal defect as current complication following acute myocardial infarction
  • I23.3Rupture of cardiac wall without hemopericardium as current complication following acute myocardial infarction
  • I23.4Rupture of chordae tendineae as current complication following acute myocardial infarction
  • I23.5Rupture of papillary muscle as current complication following acute myocardial infarction
  • I23.6Thrombosis of atrium, auricular appendage, and ventricle as current complications following acute myocardial infarction
  • I23.8Other current complications following acute myocardial infarction
  • I25.2Old myocardial infarction
  • I25.3Aneurysm of heart
  • I25.41Coronary artery aneurysm
  • I25.42Coronary artery dissection
  • I26.01Septic pulmonary embolism with acute cor pulmonale
  • I26.02Saddle embolus of pulmonary artery with acute cor pulmonale
  • I26.03Cement embolism of pulmonary artery with acute cor pulmonale
  • I26.04Fat embolism of pulmonary artery with acute cor pulmonale
  • I26.09Other pulmonary embolism with acute cor pulmonale
  • I26.90Septic pulmonary embolism without acute cor pulmonale
  • I26.92Saddle embolus of pulmonary artery without acute cor pulmonale
  • I26.93Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale
  • I26.94Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale
  • I26.95Cement embolism of pulmonary artery without acute cor pulmonale
  • I26.96Fat embolism of pulmonary artery without acute cor pulmonale
  • I26.99Other pulmonary embolism without acute cor pulmonale
  • I27.0Primary pulmonary hypertension
  • I27.1Kyphoscoliotic heart disease
  • I27.20Pulmonary hypertension, unspecified
  • I27.21Secondary pulmonary arterial hypertension
  • I27.22Pulmonary hypertension due to left heart disease
  • I27.23Pulmonary hypertension due to lung diseases and hypoxia
  • I27.24Chronic thromboembolic pulmonary hypertension
  • I27.29Other secondary pulmonary hypertension
  • I27.81Cor pulmonale (chronic)
  • I27.82Chronic pulmonary embolism
  • I27.83Eisenmenger's syndrome
  • I27.840Fontan-associated liver disease [FALD]
  • I27.841Fontan-associated lymphatic dysfunction
  • I27.848Other Fontan-associated condition
  • I27.849Fontan related circulation, unspecified
  • I27.89Other specified pulmonary heart diseases
  • I27.9Pulmonary heart disease, unspecified
  • I28.0Arteriovenous fistula of pulmonary vessels
  • I28.1Aneurysm of pulmonary artery
  • I28.8Other diseases of pulmonary vessels
  • I28.9Disease of pulmonary vessels, unspecified
  • I30.0Acute nonspecific idiopathic pericarditis
  • I30.1Infective pericarditis
  • I30.8Other forms of acute pericarditis
  • I30.9Acute pericarditis, unspecified
  • I31.0Chronic adhesive pericarditis
  • I31.1Chronic constrictive pericarditis
  • I31.2Hemopericardium, not elsewhere classified
  • I31.4Cardiac tamponade
  • I31.8Other specified diseases of pericardium
  • I31.9Disease of pericardium, unspecified
  • I32Pericarditis in diseases classified elsewhere
  • I33.0Acute and subacute infective endocarditis
  • I33.9Acute and subacute endocarditis, unspecified
  • I34.0Nonrheumatic mitral (valve) insufficiency
  • I34.1Nonrheumatic mitral (valve) prolapse
  • I34.2Nonrheumatic mitral (valve) stenosis
  • I34.9Nonrheumatic mitral valve disorder, unspecified
  • I35.0Nonrheumatic aortic (valve) stenosis
  • I35.1Nonrheumatic aortic (valve) insufficiency
  • I35.2Nonrheumatic aortic (valve) stenosis with insufficiency
  • I35.8Other nonrheumatic aortic valve disorders
  • I35.9Nonrheumatic aortic valve disorder, unspecified
  • I36.0Nonrheumatic tricuspid (valve) stenosis
  • I36.1Nonrheumatic tricuspid (valve) insufficiency
  • I36.2Nonrheumatic tricuspid (valve) stenosis with insufficiency
  • I36.8Other nonrheumatic tricuspid valve disorders
  • I36.9Nonrheumatic tricuspid valve disorder, unspecified
  • I37.0Nonrheumatic pulmonary valve stenosis
  • I37.1Nonrheumatic pulmonary valve insufficiency
  • I37.2Nonrheumatic pulmonary valve stenosis with insufficiency
  • I37.8Other nonrheumatic pulmonary valve disorders
  • I37.9Nonrheumatic pulmonary valve disorder, unspecified
  • I38Endocarditis, valve unspecified
  • I39Endocarditis and heart valve disorders in diseases classified elsewhere
  • I40.0Infective myocarditis
  • I40.1Isolated myocarditis
  • I40.8Other acute myocarditis
  • I40.9Acute myocarditis, unspecified
  • I41Myocarditis in diseases classified elsewhere
  • I42.00Dilated cardiomyopathy, unspecified
  • I42.01Familial-genetic dilated cardiomyopathy
  • I42.09Other dilated cardiomyopathy
  • I42.1Obstructive hypertrophic cardiomyopathy
  • I42.2Other hypertrophic cardiomyopathy
  • I42.4Endocardial fibroelastosis
  • I42.6Alcoholic cardiomyopathy
  • I42.7Cardiomyopathy due to drug and external agent
  • I42.81Arrhythmogenic cardiomyopathy
  • I42.89Other cardiomyopathies not elsewhere classified
  • I42.9Cardiomyopathy, unspecified
  • I43Cardiomyopathy in diseases classified elsewhere
  • I46.2Cardiac arrest due to underlying cardiac condition
  • I46.8Cardiac arrest due to other underlying condition
  • I46.9Cardiac arrest, cause unspecified
  • I48.0Paroxysmal atrial fibrillation
  • I48.11Longstanding persistent atrial fibrillation
  • I48.19Other persistent atrial fibrillation
  • I48.20Chronic atrial fibrillation, unspecified
  • I48.21Permanent atrial fibrillation
  • I48.3Typical atrial flutter
  • I48.4Atypical atrial flutter
  • I48.91Unspecified atrial fibrillation
  • I48.92Unspecified atrial flutter
  • I49.01Ventricular fibrillation
  • I49.02Ventricular flutter
  • I49.1Atrial premature depolarization
  • I49.2Junctional premature depolarization
  • I49.3Ventricular premature depolarization
  • I49.40Unspecified premature depolarization
  • I49.49Other premature depolarization
  • I49.5Sick sinus syndrome
  • I50.1Left ventricular failure, unspecified
  • I50.20Unspecified systolic (congestive) heart failure
  • I50.21Acute systolic (congestive) heart failure
  • I50.22Chronic systolic (congestive) heart failure
  • I50.23Acute on chronic systolic (congestive) heart failure
  • I50.30Unspecified diastolic (congestive) heart failure
  • I50.31Acute diastolic (congestive) heart failure
  • I50.32Chronic diastolic (congestive) heart failure
  • I50.33Acute on chronic diastolic (congestive) heart failure
  • I50.40Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.41Acute combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.42Chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.43Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
  • I50.810Right heart failure, unspecified
  • I50.811Acute right heart failure
  • I50.812Chronic right heart failure
  • I50.813Acute on chronic right heart failure
  • I50.814Right heart failure due to left heart failure
  • I50.82Biventricular heart failure
  • I50.83High output heart failure
  • I50.84End stage heart failure
  • I50.89Other heart failure
  • I50.9Heart failure, unspecified
  • I51.0Cardiac septal defect, acquired
  • I51.1Rupture of chordae tendineae, not elsewhere classified
  • I51.2Rupture of papillary muscle, not elsewhere classified
  • I51.3Intracardiac thrombosis, not elsewhere classified
  • I51.4Myocarditis, unspecified
  • I51.81Takotsubo syndrome
  • I51.89Other ill-defined heart diseases
  • I63.111Cerebral infarction due to embolism of right vertebral artery
  • I63.112Cerebral infarction due to embolism of left vertebral artery
  • I63.113Cerebral infarction due to embolism of bilateral vertebral arteries
  • I63.12Cerebral infarction due to embolism of basilar artery
  • I63.131Cerebral infarction due to embolism of right carotid artery
  • I63.132Cerebral infarction due to embolism of left carotid artery
  • I63.133Cerebral infarction due to embolism of bilateral carotid arteries
  • I63.19Cerebral infarction due to embolism of other precerebral artery
  • I63.211Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery
  • I63.212Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery
  • I63.22Cerebral infarction due to unspecified occlusion or stenosis of basilar artery
  • I63.231Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries
  • I63.232Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries
  • I63.29Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries
  • I63.411Cerebral infarction due to embolism of right middle cerebral artery
  • I63.412Cerebral infarction due to embolism of left middle cerebral artery
  • I63.413Cerebral infarction due to embolism of bilateral middle cerebral arteries
  • I63.421Cerebral infarction due to embolism of right anterior cerebral artery
  • I63.422Cerebral infarction due to embolism of left anterior cerebral artery
  • I63.423Cerebral infarction due to embolism of bilateral anterior cerebral arteries
  • I63.431Cerebral infarction due to embolism of right posterior cerebral artery
  • I63.432Cerebral infarction due to embolism of left posterior cerebral artery
  • I63.433Cerebral infarction due to embolism of bilateral posterior cerebral arteries
  • I63.441Cerebral infarction due to embolism of right cerebellar artery
  • I63.442Cerebral infarction due to embolism of left cerebellar artery
  • I63.443Cerebral infarction due to embolism of bilateral cerebellar arteries
  • I63.49Cerebral infarction due to embolism of other cerebral artery
  • I63.511Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery
  • I63.512Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery
  • I63.521Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery
  • I63.522Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery
  • I63.531Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery
  • I63.532Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery
  • I63.541Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery
  • I63.542Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery
  • I63.59Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery
  • I63.6Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
  • I63.81Other cerebral infarction due to occlusion or stenosis of small artery
  • I63.89Other cerebral infarction
  • I63.9Cerebral infarction, unspecified
  • I70.0Atherosclerosis of aorta
  • I71.010Dissection of ascending aorta
  • I71.011Dissection of aortic arch
  • I71.012Dissection of descending thoracic aorta
  • I71.019Dissection of thoracic aorta, unspecified
  • I71.02Dissection of abdominal aorta
  • I71.03Dissection of thoracoabdominal aorta
  • I74.11Embolism and thrombosis of thoracic aorta
  • I79.0Aneurysm of aorta in diseases classified elsewhere
  • I95.89Other hypotension
  • M32.0Drug-induced systemic lupus erythematosus
  • M32.11Endocarditis in systemic lupus erythematosus
  • M32.12Pericarditis in systemic lupus erythematosus
  • M32.19Other organ or system involvement in systemic lupus erythematosus
  • M32.8Other forms of systemic lupus erythematosus
  • M32.9Systemic lupus erythematosus, unspecified
  • Q20.0Common arterial trunk
  • Q20.1Double outlet right ventricle
  • Q20.2Double outlet left ventricle
  • Q20.3Discordant ventriculoarterial connection
  • Q20.4Double inlet ventricle
  • Q20.5Discordant atrioventricular connection
  • Q20.6Isomerism of atrial appendages
  • Q20.8Other congenital malformations of cardiac chambers and connections
  • Q21.0Ventricular septal defect
  • Q21.10Atrial septal defect, unspecified
  • Q21.11Secundum atrial septal defect
  • Q21.12Patent foramen ovale
  • Q21.13Coronary sinus atrial septal defect
  • Q21.14Superior sinus venosus atrial septal defect
  • Q21.15Inferior sinus venosus atrial septal defect
  • Q21.16Sinus venosus atrial septal defect, unspecified
  • Q21.19Other specified atrial septal defect
  • Q21.20Atrioventricular septal defect, unspecified as to partial or complete
  • Q21.21Partial atrioventricular septal defect
  • Q21.22Transitional atrioventricular septal defect
  • Q21.23Complete atrioventricular septal defect
  • Q21.3Tetralogy of Fallot
  • Q21.4Aortopulmonary septal defect
  • Q21.8Other congenital malformations of cardiac septa
  • Q21.9Congenital malformation of cardiac septum, unspecified
  • Q22.0Pulmonary valve atresia
  • Q22.1Congenital pulmonary valve stenosis
  • Q22.2Congenital pulmonary valve insufficiency
  • Q22.3Other congenital malformations of pulmonary valve
  • Q22.4Congenital tricuspid stenosis
  • Q22.5Ebstein's anomaly
  • Q22.6Hypoplastic right heart syndrome
  • Q22.8Other congenital malformations of tricuspid valve
  • Q22.9Congenital malformation of tricuspid valve, unspecified
  • Q23.0Congenital stenosis of aortic valve
  • Q23.1Congenital insufficiency of aortic valve
  • Q23.2Congenital mitral stenosis
  • Q23.3Congenital mitral insufficiency
  • Q23.4Hypoplastic left heart syndrome
  • Q23.81Bicuspid aortic valve
  • Q23.82Congenital mitral valve cleft leaflet
  • Q23.88Other congenital malformations of aortic and mitral valves
  • Q23.9Congenital malformation of aortic and mitral valves, unspecified
  • Q24.0Dextrocardia
  • Q24.1Levocardia
  • Q24.2Cor triatriatum
  • Q24.3Pulmonary infundibular stenosis
  • Q24.4Congenital subaortic stenosis
  • Q24.5Malformation of coronary vessels
  • Q24.6Congenital heart block
  • Q24.8Other specified congenital malformations of heart
  • Q25.0Patent ductus arteriosus
  • Q25.1Coarctation of aorta
  • Q25.21Interruption of aortic arch
  • Q25.29Other atresia of aorta
  • Q25.3Supravalvular aortic stenosis
  • Q25.40Congenital malformation of aorta unspecified
  • Q25.41Absence and aplasia of aorta
  • Q25.42Hypoplasia of aorta
  • Q25.43Congenital aneurysm of aorta
  • Q25.44Congenital dilation of aorta
  • Q25.45Double aortic arch
  • Q25.46Tortuous aortic arch
  • Q25.47Right aortic arch
  • Q25.48Anomalous origin of subclavian artery
  • Q25.49Other congenital malformations of aorta
  • Q25.5Atresia of pulmonary artery
  • Q25.6Stenosis of pulmonary artery
  • Q25.71Coarctation of pulmonary artery
  • Q25.72Congenital pulmonary arteriovenous malformation
  • Q25.79Other congenital malformations of pulmonary artery
  • Q25.8Other congenital malformations of other great arteries
  • Q25.9Congenital malformation of great arteries, unspecified
  • Q26.0Congenital stenosis of vena cava
  • Q26.1Persistent left superior vena cava
  • Q26.2Total anomalous pulmonary venous connection
  • Q26.3Partial anomalous pulmonary venous connection
  • Q26.4Anomalous pulmonary venous connection, unspecified
  • Q26.8Other congenital malformations of great veins
  • Q26.9Congenital malformation of great vein, unspecified
  • Q87.82Arterial tortuosity syndrome
  • Q87.83Bardet-Biedl syndrome
  • Q87.84Laurence-Moon syndrome
  • Q87.85MED13L syndrome
  • Q87.86Kleefstra syndrome
  • Q87.88CTNNB1 syndrome
  • R06.03Acute respiratory distress
  • R07.1Chest pain on breathing
  • R07.2Precordial pain
  • R07.81Pleurodynia
  • R07.82Intercostal pain
  • R07.89Other chest pain
  • R07.9Chest pain, unspecified
  • R40.2ANontraumatic coma due to underlying condition
  • R40.3Persistent vegetative state
  • R40.4Transient alteration of awareness
  • R50.81Fever presenting with conditions classified elsewhere
  • R55Syncope and collapse
  • R57.0Cardiogenic shock
  • R93.1Abnormal findings on diagnostic imaging of heart and coronary circulation
  • R94.30Abnormal result of cardiovascular function study, unspecified
  • R94.39Abnormal result of other cardiovascular function study
  • S25.00XAUnspecified injury of thoracic aorta, initial encounter
  • S25.00XDUnspecified injury of thoracic aorta, subsequent encounter
  • S25.00XSUnspecified injury of thoracic aorta, sequela
  • S25.01XAMinor laceration of thoracic aorta, initial encounter
  • S25.01XDMinor laceration of thoracic aorta, subsequent encounter
  • S25.01XSMinor laceration of thoracic aorta, sequela
  • S25.02XAMajor laceration of thoracic aorta, initial encounter
  • S25.02XDMajor laceration of thoracic aorta, subsequent encounter
  • S25.02XSMajor laceration of thoracic aorta, sequela
  • S25.09XAOther specified injury of thoracic aorta, initial encounter
  • S25.09XDOther specified injury of thoracic aorta, subsequent encounter
  • S25.09XSOther specified injury of thoracic aorta, sequela
  • T80.0XXAAir embolism following infusion, transfusion and therapeutic injection, initial encounter
  • T80.0XXDAir embolism following infusion, transfusion and therapeutic injection, subsequent encounter
  • T80.0XXSAir embolism following infusion, transfusion and therapeutic injection, sequela
  • T82.01XABreakdown (mechanical) of heart valve prosthesis, initial encounter
  • T82.01XDBreakdown (mechanical) of heart valve prosthesis, subsequent encounter
  • T82.01XSBreakdown (mechanical) of heart valve prosthesis, sequela
  • T82.02XADisplacement of heart valve prosthesis, initial encounter
  • T82.02XDDisplacement of heart valve prosthesis, subsequent encounter
  • T82.02XSDisplacement of heart valve prosthesis, sequela
  • T82.03XALeakage of heart valve prosthesis, initial encounter
  • T82.03XDLeakage of heart valve prosthesis, subsequent encounter
  • T82.03XSLeakage of heart valve prosthesis, sequela
  • T82.09XAOther mechanical complication of heart valve prosthesis, initial encounter
  • T82.09XDOther mechanical complication of heart valve prosthesis, subsequent encounter
  • T82.09XSOther mechanical complication of heart valve prosthesis, sequela
  • T82.110ABreakdown (mechanical) of cardiac electrode, initial encounter
  • T82.110DBreakdown (mechanical) of cardiac electrode, subsequent encounter
  • T82.110SBreakdown (mechanical) of cardiac electrode, sequela
  • T82.118ABreakdown (mechanical) of other cardiac electronic device, initial encounter
  • T82.118DBreakdown (mechanical) of other cardiac electronic device, subsequent encounter
  • T82.118SBreakdown (mechanical) of other cardiac electronic device, sequela
  • T82.119ABreakdown (mechanical) of unspecified cardiac electronic device, initial encounter
  • T82.119DBreakdown (mechanical) of unspecified cardiac electronic device, subsequent encounter
  • T82.119SBreakdown (mechanical) of unspecified cardiac electronic device, sequela
  • T82.120ADisplacement of cardiac electrode, initial encounter
  • T82.120DDisplacement of cardiac electrode, subsequent encounter
  • T82.120SDisplacement of cardiac electrode, sequela
  • T82.190AOther mechanical complication of cardiac electrode, initial encounter
  • T82.190DOther mechanical complication of cardiac electrode, subsequent encounter
  • T82.190SOther mechanical complication of cardiac electrode, sequela
  • T82.198AOther mechanical complication of other cardiac electronic device, initial encounter
  • T82.198DOther mechanical complication of other cardiac electronic device, subsequent encounter
  • T82.198SOther mechanical complication of other cardiac electronic device, sequela
  • T82.199AOther mechanical complication of unspecified cardiac device, initial encounter
  • T82.199DOther mechanical complication of unspecified cardiac device, subsequent encounter
  • T82.199SOther mechanical complication of unspecified cardiac device, sequela
  • T82.221ABreakdown (mechanical) of biological heart valve graft, initial encounter
  • T82.221DBreakdown (mechanical) of biological heart valve graft, subsequent encounter
  • T82.221SBreakdown (mechanical) of biological heart valve graft, sequela
  • T82.222ADisplacement of biological heart valve graft, initial encounter
  • T82.222DDisplacement of biological heart valve graft, subsequent encounter
  • T82.222SDisplacement of biological heart valve graft, sequela
  • T82.223ALeakage of biological heart valve graft, initial encounter
  • T82.223DLeakage of biological heart valve graft, subsequent encounter
  • T82.223SLeakage of biological heart valve graft, sequela
  • T82.228AOther mechanical complication of biological heart valve graft, initial encounter
  • T82.228DOther mechanical complication of biological heart valve graft, subsequent encounter
  • T82.228SOther mechanical complication of biological heart valve graft, sequela
  • T82.514ABreakdown (mechanical) of infusion catheter, initial encounter
  • T82.514DBreakdown (mechanical) of infusion catheter, subsequent encounter
  • T82.514SBreakdown (mechanical) of infusion catheter, sequela
  • T82.518ABreakdown (mechanical) of other cardiac and vascular devices and implants, initial encounter
  • T82.518DBreakdown (mechanical) of other cardiac and vascular devices and implants, subsequent encounter
  • T82.518SBreakdown (mechanical) of other cardiac and vascular devices and implants, sequela
  • T82.519ABreakdown (mechanical) of unspecified cardiac and vascular devices and implants, initial encounter
  • T82.519DBreakdown (mechanical) of unspecified cardiac and vascular devices and implants, subsequent encounter
  • T82.519SBreakdown (mechanical) of unspecified cardiac and vascular devices and implants, sequela
  • T82.524ADisplacement of infusion catheter, initial encounter
  • T82.524DDisplacement of infusion catheter, subsequent encounter
  • T82.524SDisplacement of infusion catheter, sequela
  • T82.528ADisplacement of other cardiac and vascular devices and implants, initial encounter
  • T82.528DDisplacement of other cardiac and vascular devices and implants, subsequent encounter
  • T82.528SDisplacement of other cardiac and vascular devices and implants, sequela
  • T82.529ADisplacement of unspecified cardiac and vascular devices and implants, initial encounter
  • T82.529DDisplacement of unspecified cardiac and vascular devices and implants, subsequent encounter
  • T82.529SDisplacement of unspecified cardiac and vascular devices and implants, sequela
  • T82.532ALeakage of artificial heart, initial encounter
  • T82.532DLeakage of artificial heart, subsequent encounter
  • T82.532SLeakage of artificial heart, sequela
  • T82.534ALeakage of infusion catheter, initial encounter
  • T82.534DLeakage of infusion catheter, subsequent encounter
  • T82.534SLeakage of infusion catheter, sequela
  • T82.538ALeakage of other cardiac and vascular devices and implants, initial encounter
  • T82.538DLeakage of other cardiac and vascular devices and implants, subsequent encounter
  • T82.538SLeakage of other cardiac and vascular devices and implants, sequela
  • T82.539ALeakage of unspecified cardiac and vascular devices and implants, initial encounter
  • T82.539DLeakage of unspecified cardiac and vascular devices and implants, subsequent encounter
  • T82.539SLeakage of unspecified cardiac and vascular devices and implants, sequela
  • T82.592AOther mechanical complication of artificial heart, initial encounter
  • T82.592DOther mechanical complication of artificial heart, subsequent encounter
  • T82.592SOther mechanical complication of artificial heart, sequela
  • T82.594AOther mechanical complication of infusion catheter, initial encounter
  • T82.594DOther mechanical complication of infusion catheter, subsequent encounter
  • T82.594SOther mechanical complication of infusion catheter, sequela
  • T82.598AOther mechanical complication of other cardiac and vascular devices and implants, initial encounter
  • T82.598DOther mechanical complication of other cardiac and vascular devices and implants, subsequent encounter
  • T82.598SOther mechanical complication of other cardiac and vascular devices and implants, sequela
  • T82.599AOther mechanical complication of unspecified cardiac and vascular devices and implants, initial encounter
  • T82.599DOther mechanical complication of unspecified cardiac and vascular devices and implants, subsequent encounter
  • T82.599SOther mechanical complication of unspecified cardiac and vascular devices and implants, sequela
  • T82.6XXAInfection and inflammatory reaction due to cardiac valve prosthesis, initial encounter
  • T82.6XXDInfection and inflammatory reaction due to cardiac valve prosthesis, subsequent encounter
  • T82.6XXSInfection and inflammatory reaction due to cardiac valve prosthesis, sequela
  • T82.7XXAInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, initial encounter
  • T82.7XXDInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, subsequent encounter
  • T82.7XXSInfection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts, sequela
  • T82.817AEmbolism due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.817DEmbolism due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.817SEmbolism due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.827AFibrosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.827DFibrosis due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.827SFibrosis due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.837AHemorrhage due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.837DHemorrhage due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.837SHemorrhage due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.847APain due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.847DPain due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.847SPain due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.857AStenosis of other cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.857DStenosis of other cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.857SStenosis of other cardiac prosthetic devices, implants and grafts, sequela
  • T82.867AThrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.867DThrombosis due to cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.867SThrombosis due to cardiac prosthetic devices, implants and grafts, sequela
  • T82.897AOther specified complication of cardiac prosthetic devices, implants and grafts, initial encounter
  • T82.897DOther specified complication of cardiac prosthetic devices, implants and grafts, subsequent encounter
  • T82.897SOther specified complication of cardiac prosthetic devices, implants and grafts, sequela
  • T82.9XXAUnspecified complication of cardiac and vascular prosthetic device, implant and graft, initial encounter
  • T82.9XXDUnspecified complication of cardiac and vascular prosthetic device, implant and graft, subsequent encounter
  • T82.9XXSUnspecified complication of cardiac and vascular prosthetic device, implant and graft, sequela
  • Z48.21Encounter for aftercare following heart transplant
  • Z48.24Encounter for aftercare following lung transplant
  • Z48.280Encounter for aftercare following heart-lung transplant
  • Z94.1Heart transplant status
  • Z94.2Lung transplant status
  • Z94.3Heart and lungs transplant status
  • Z95.2Presence of prosthetic heart valve
  • Z95.3Presence of xenogenic heart valve
  • Z95.4Presence of other heart-valve replacement
  • Z95.811Presence of heart assist device
  • Z95.812Presence of fully implantable artificial heart

Disclaimer. This application provides informational coding and reimbursement reference data. It does not constitute legal, clinical, coding, or billing advice. Codes, payment amounts, payer rules, and coverage policies can change. Verify all information with current CMS publications, the applicable payer, and your organization’s compliance policies before submitting a claim. CodeRx is not affiliated with or endorsed by CMS, FDA, Medicare, or any payer.